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ABSTRACT 
The bacterial phosphatidylinositol-specific phospholipase C (PI-PLC) from Bacillus 
thuringiensis is specifically activated by low concentrations of a non-substrate lipid, 
phosphatidylcholine (PC), presented as an interface. However, if the PC concentration in 
the interface is too high relative to substrate, the enzyme exhibits surface dilution 
inhibition. Understanding this bacterial enzyme, which shares many kinetic features with 
the larger and more complex mammalian PI-PLC enzymes, requires elucidating the 
mechanism for PC activation and inhibition. Various techniques were applied to study the 
interaction of the protein with vesicles composed of both the activator lipid PC and the 
substrate lipid (or a nonhydrolyzable analogue). Fluorescence correlation spectroscopy 
(FCS), used to monitor bulk partitioning of the enzyme on vesicles, revealed that both the 
PC and the substrate analogue are required for the tightest binding of the PI-PLC to 
vesicles. Furthermore, the tightest binding occurred at low mole fractions of substrate-
like phospholipids. Field cycling 31P NMR (fc-P-NMR) spin-lattice relaxation studies 
provided information on how bound protein affects the lipid dynamics in mixed substrate 
analogue/PC vesicles. The combination of the two techniques could explain the enzyme 
kinetic profile for the PC activation and surface dilution inhibition: small amounts of PC 
in an interface enhanced PI-PLC binding to substrate-rich vesicles while high fractions of 
PC tended to sequester the enzyme from the bulk of its substrate leading to reduced 
specific activity. FCS binding profiles of mutant proteins were particularly useful in 
determining if a specific mutation affected a single or both phospholipid binding modes. 
In addition, an allosteric PC binding site was identified by fc-P-NMR and site directed 
spin labeling. A proposed model for PC activation suggested surface-induced 
dimerization of the protein. Experiments in support of the model used cysteine mutations 
to create covalent dimers of this PI-PLC. Two of these disulfide linked dimers, formed 
from W242C or S250C, exhibited higher specific activities and tighter binding to PC 
surfaces. In addition, single molecule total internal reflection fluorescence microscopy 
was used to monitor the off-rate of PI-PLC from surface tethered vesicles, providing us 
with a direct measure of off-rates of the protein from different composition vesicles. 
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Chapter 1 Introduction 
1.1 Phospholipids 
1.1.1 Membrane lipids 
Cell membranes consist of three classes of amphipathic lipids: phospholipids, 
glycolipids, and steroids. Phospholipids are the most abundant class of molecules, 
comprising 20-80% of the membrane mass. The membrane composition varies for 
different types of cells, and correlates with the types of processes occurring across the 
membrane, regulated by local lipid metabolism and lipid transport. For instance, in 
mammalian systems, the major phospholipid is often phosphatidylcholine (PC), whereas 
in bacterial systems, phosphatidylethanolamine (PE) and phosphatidylglycerol (PG) are 
the predominant phospholipids (1). Bulk lipids, including PC, PE, phosphatidylserine 
(PS), sphingomyeiln, and cholesterol, mainly serve structure roles. On the other hand, 
low abundance lipids, such as diacylglycerol (DAG), phosphatidic acid (PA), ceramide, 
or phosphoinositides (PI), function as signaling molecules (2). However, many of the 
bulk lipids also exhibit regulatory functions. For example, in addition to its function as a 
component of cellular membranes and as a precursor for other phospholipids, PS is an 
essential cofactor that binds to and activates protein kinase C, a key enzyme in signal 
transduction (3). In additon, PS externalization is known to have an important role in the 
regulation of apoptosis (4, 5). Understanding the functions of these lipids requires the 
knowledge of structural and conformational properties of these phospholipids. 
1.1.2 Structure of phospholipids 
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The general structure of phospholipid is shown in Figure 1-1. Phospholipids are 
amphipathic molecules, with hydrophilic headgroups and hydrophobic acyl chains. 
Different groups can be linked to the phosphate as the polar head group. Naturally 
occurring phospholipids are classified into zwitterionic (e.g.,PC, and PE), and anionic 
(e.g., PS, PI, PG, and PA) phospholipids. In naturally occurring phospholipids, the fatty 
acyl chains contain an even number of carbons typically ranging between 12 to 22 
carbons. In mammals, the acyl chain in the sn-1 position is usually saturated, whereas the 
sn-2 acyl chain is usually unsaturated with the double bond in the cis conformation. This 
kink influences packing and movement in the lateral plane of the membrane.  Both the 
number and positions of unsaturated bonds along with the number of carbon atoms of 
fatty acyl chains have profound effects on membrane fluidity. Natural phospholipids 
generally have the R (or D) configuration. 
1.1.3 Phospholipid aggregation  
Due to the amphipathic character, phospholipids form a variety of aggregates in 
aqueous solution mainly through hydrophobic interactions of the acyl chains. As shown 
in Figure 1-2, at the air-water interface, all phospholipids, regardless of chain length or 
headgroup, form a monolayer with the polar head group solvated in water and the acyl 
chains sticking into the air. Structures in solution depend on chain length and lipid 
concentration. In general, synthetic short chain symmetric (both chains the same lengths) 
phospholipids with chain lengths no longer than 8 carbons form micelles above a critical 
micelle concentration (CMC). Below the CMC, phospholipids are mostly present as 
monomers in solution. The CMC depends on the length of lipid acyl chains, with a lower 
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Figure 1-1. General phospholipid structure. 
 
Lipid Name R Net Charge  at physiological pH 
Phosphatidic Acid (PA)  -2 
Phosphatidylmethanol (PMe)  -1 
Phosphatidylserine (PS) 
 
-1 
Phosphatidylglycerol (PG) 
 
-1 
Phosphatidylinositol (PI) -1 
Phosphatidylethanolamine (PE)  0 
Phosphatidylcholine (PC)  0 
  
H
CH3
CH2CHNH3
COO-
CH2CHCH2OH
OH
HO
HO
HO
OH
OH
CH2CH2NH3
CH2CH2N(CH3)3
4 
 
Figure 1-2. Various physical states of phospholipids in aqueous solution. At the air-water 
interface, phospholipids always form monolayers with polar headgroups solvated in 
water and hydrophobic tails sticking into the air. In the aqueous solution, phospholipid 
molecules are present as monomers as well as aggregates (micelles or vesicles).  
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CMC for lipids with longer chains. 
Naturally occurring phospholipids form multilamellar structures called vesicles when 
dispersed in aqueous solution. Vesicle sizes, range from tens to thousands of nanometers. 
Different methods can be used to further process these multilamellar vesicles in order to 
control the size of the vesicles and the number of bilayers associated with the vesicles. 
Unilamellar vesicles are better models for cell membranes than multilamellar vesicles. 
Highly curved small unilamellar vesicles (SUVs) of 20–50 nm diameters are typically 
prepared using sonication (6). Large unilamellar vesicles or LUVs (size range 50-10,000 
nm) have little local curvature and can be prepared by multiple passage of a multimeric 
lipid suspension through a filter (of 100 nm diameter size for instance) (7). Giant 
unilamellar vesicles GUV (size range 10,000-200,000 nm), which are approximately the 
same size as cells, are prepared by several methods including gentle hydration, solvent 
evaporation, and electroformation (8). Vesicles are generally stable above the Tm 
(transition temperature between the gel and liquid-crystalline phases) of constituent 
lipids. Intervesicle exchange rates are usually not rapid (9), although exogenous material 
(Ca2+ and lipid binding proteins or enzymes such as phospholipases) can trigger vesicle 
aggregation that leads to enhanced exchange kinetics and in some cases vesicle fusion. 
Both the micelle and vesicle systems are widely used as models to study protein-
membrane interactions or cell processes occurring on membranes.  
1.2 Phospholipases 
1.2.1 Peripheral enzymes and their biological functions 
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Many cellular processes including cell signaling and membrane trafficking involve 
recruitment of cytosolic proteins to different cellular membranes to form protein-lipid 
and/or protein-protein interactions. In contrast to integral membrane proteins, peripheral 
membrane proteins adhere only temporarily to biological membranes. This reversible 
attachment has been shown to regulate many cellular events through a variety of 
mechanisms (10). For example, the association of lipolytic enzymes with membranes will 
bring them in close proximity to their lipid substrates. These enzymes include 
phospholipases (11), lipid kinases and phosphatases (12), whose products will further 
regulate downstream cell signaling. Membrane binding may also promote conformational 
changes of many proteins, resulting in the activation (or in some cases inhibition) of the 
protein (10). The conformational change may involve a global transformation to expose 
buried secondary structure, or just a minor local adjustment (2). In addition, membrane 
recruitment regulates the assembly of multi-protein complexes by increasing the 
probability of protein-protein interactions at the membrane, such as protein kinase B 
(PKB or AKT), protein kinase C (PKC) and phosphoinositide 3-kinase (PI3K) (12, 13).  
Peripheral proteins that interact directly with the lipid bilayer are also called 
amphitropic proteins. It has been shown that the membrane binding affinity of many 
amphitropic proteins is regulated by the lipid composition of the membranes (14). In 
order to understand the biological functions of these proteins, it is necessary to 
understand how these proteins are recruited to and interact with the bilayer. Some of the 
amphitropic proteins, such as Ras proteins (15), bind to the membrane through covalently 
attached lipid anchors. However, other nonlipidated proteins can interact directly with the 
7 
 
bilayers, partially penetrating the membrane. This interaction is common across most 
peripheral proteins, and is of particular interest in this work.  
1.2.2 Phospholipases 
Phospholipases constitute a heterogeneous group of enzymes that catalyze the 
hydrolysis of the various ester linkages of phospholipids into fatty acids and other 
lipophilic substances. These enzymes are classified into four families (PLA, PLB, PLC 
and PLD) depending on the ester bonds they hydrolyze as shown in the scheme below: 
 
PLA1 and PLA2 specifically hydrolyze the fatty acyl ester bond at the sn-1 and sn-2 
position of the glycerol moiety, respectively, to generate fatty acid and the corresponding 
lysophospholipid. PLB enzymes usually possess three kinds of activities in that they act 
as a phospholipase A to sequentially remove both the sn-1 and sn-2 acyl ester bonds, 
lysophospholipase to remove the remaining fatty acid from lysophospholipids, and 
lysophospholipase-transacylase to transfer free fatty acid to lysophospholipid to produce 
phospholipid. PLC catalyzes the cleavage of the glycerophosphate ester bond to DAG 
and the phosphorylated headgroup. PLD cleaves the terminal phosphodiester bond to 
liberate phosphatidic acid (PA) and free alcohol. 
 Mammalian cells contain a large number of phospholipases that hydrolyze 
phospholipids in a structurally specific manner for production of a myriad of products, 
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many of which have potent biological activities (11). Degradation of phospholipids 
changes membrane composition and therefore alters membrane physical properties (16). 
Membranes on different leaflets or of cellular compartments have different lipid 
compositions (17), and the action of phospholipases at specific locations can provide 
unique phospholipid breakdown products that affect cell and organelle function. In 
addition, phospholipases produce both hydrophobic and water soluble products, and some 
of these products serve as important secondary messengers involved in cellular 
regulation. For example, the unsaturated fatty acid generated by PLA2, arachidonic acid, 
is an important precursor of the eicosanoid family of inflammatory mediators including 
prostaglandins, thromboxanes, lipoxins, and leukotrienes (18). PA, a product of PLD, is 
responsible for regulating cell growth and proliferation (19). PLC enzymes play a central 
role in signal transduction, releasing soluble inositol triphosphate (IP3) from PIP2, a 
molecule that is important for calcium release, and DAG, a membrane-localized product 
that activates protein kinase C (PKC).  
Besides those diverse intracellular roles, extracellular phospholipases have been 
implicated as virulence factors for bacteria and pathogenic fungi (20-22). These enzymes 
have been isolated from a wide variety of Gram-positive and Gram-negative bacteria 
such as Bacillus cereus, Clostridium perfringens, Listeria monocytogenes, Pseudomonas 
aeruginosa and Legionella pneumophila (20, 23). PLA enzymes from some protozoan 
species facilitate host cell penetration (21) and the activity of PLA in M. tuberculosis was 
found to be associated with the cell membrane and cell wall fractions (24). Studies in 
which phospholipase activity was characterized in pathogenic bacteria showed that PLC 
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is the most active virulence factor (20). The toxicity of PLC is presumed to be directly 
due to their ability to hydrolyze phospholipids located in the host cell membrane (23, 25). 
1.2.3 Phosphatidylinositol-specific Phospholipase C  
1.2.3.1 Biological function of PI-PLC enzymes  
Phosphatidylinositol (PI) is a minor phospholipid component in the cytosolic side of 
eukaryotic plasma membranes. It can be phosphorylated by different kinases on the 
hydroxyl groups at 3, 4 and 5 carbons of the inositol ring, and these phosphate groups of 
the inositol ring can be removed by PI-specific phosphatases. Phosphoinositide (PIPn) 
signaling pathways have been to shown to mediate cell growth and proliferation, 
apoptosis, insulin action and vesicle trafficking (26, 27). Phosphatidylinositol-specific 
phospholipase C (PI-PLC) enzymes are a large family of closely related enzymes that 
specifically hydrolyze the polar head group of phosphoinositide substrates. Bacterial 
enzymes prefer PI and glycosyl-PI (GPI), while most mammalian enzymes prefer 
PI(4,5)P2 > PI(4)P, PI(5)P > PI. The reaction scheme is shown in Figure 1-3. 
Both mammalian and bacterial PI-PLC enzymes utilize a general acid and base 
mechanism to catalyze the hydrolysis of PI. PI-PLC hydrolyzes the substrate in two steps. 
Using the substrate PI as an example, the first step is a phosphotransferase reaction to 
hydrolyze PI via an intramolecular nucleophilic attack of the 2-hydroxyl group of inositol 
on the phosphorus atom to form inositol 1,2-cyclic phosphate (cIP) and DAG. The 
second is a phosphodiesterase reaction that further hydrolyzes the water soluble 
intermediate cIP to inositol-1-phosphate (I-1-P). In mammalian cells phospholipase C 
cleaves PI(4,5)P2 into the second messengers I(1,4,5)P3 and DAG. I(1,4,5)P3 mediates  
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Figure 1-3. Two reactions catalyzed sequentially by PI-PLC enzymes. 
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Ca2+ release from internal stores by interaction with an IP3 receptor, whereas DAG 
contributes to the activation of protein kinase C (PKC). PKC is involved in the control of 
a MAP-kinase cascade essential for the adaptation to hypo-osmotic stress. 
PI-PLC has been studied since the 1950s, when it was recognized as a key enzyme in 
PI metabolism and calcium signaling (28, 29). Since then, PI-PLC enzymes have been 
isolated from many bacterial and eukaryotic sources (25, 30-32). In addition to the 
function in plasma membrane lipid metabolism, PLC-δ1 was also found to play important 
roles in nuclear PIPn metabolism; accumulation of the protein in the nucleus plays a role 
in the cell cycle (33).  
Bacterial PI-PLC enzymes, about 35 kDa, are secreted by various species, including 
the pathogens Bacillus cereus, B. thuringiensis, B. anthracis, L. monocytogenes, L. 
ivanovii, Staphylococcus aureus, C. novyi, Rhodococcus equii, and also non-pathogenic 
species L. seeligeri, Streptomyces antibioticus, Cytophaga sp., and some strains of lactic 
acid bacteria (LAB) such as Lactobacillus rhamnosus (31, 34, 35). These proteins are 
relatively specific for nonphosphorylated PI. Additionally, many (but not all) of them 
have the ability to cleave glycosyl-PI (31) and can release proteins that are tethered to the 
cell membrane by glycosylphosphatidylinositol (GPI) anchors. These GPI anchored 
proteins are only present in eukaryotic cells (36). B. thuringiensis is an insect pathogen, 
and earlier work showed that an avirulent mutant lacking both the broad range and PI-
specific PLC was much less potent in killing cells (37). L. monocytogenes PI-PLC plays 
roles in the escape of bacteria from phagolysosomes (38, 39) and modulation of host cell 
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signaling pathways including Ca2+ signaling in macrophages (40) and PI metabolism in 
endothelial cells and macrophages (40, 41). 
1.2.3.2 Structure of PI-PLC enzymes 
At present, thirteen distinct mammalian PLC isoforms have been identified and 
grouped into six families: PLC-β (1–4), PLC-γ (1–2), PLC-δ (1,3,4), PLC-ε, PLC-ζ, and 
PLC-η shown in Figure 1-4 (42). The PLC isoforms share four EF-hand motifs, the X and 
Y domains that form the catalytic core, and a C-terminal C2 domain (30, 43). All 
isoforms, with exception of PLC-ζ, have an N-terminal PH domain that localizes the 
enzymes to their substrate and other signaling components. In addition to these canonical 
domains, the isoforms contain family-specific regulatory domains to take differential 
positions in receptor signaling. The X and Y catalytic regions are highly conserved with 
40-60% amino acid sequence similarity among all mammalian isozymes (44). The PH 
domains are composed of 100 to 120 amino acids and found in more than 250 
mammalian proteins. About 15% of these PH domains bind phosphoinositides with 
relatively high affinity (2). The PLC-δ PH domain binds PI(4,5)P2 (45), an event that is 
essential for processive hydrolysis of substrates (46). All mammalian PLC isoforms have 
up to four helix-loop-helix EF-hand motifs. Although EF-hand motifs usually bind 
calcium ions, some of them do not have the critical residues necessary for calcium 
binding. Binding of calcium to the EF-hands of PLC-δ may be necessary for proper 
interaction of the PH domain with PIP2 (47). C2 domains usually also play a role in 
calcium-dependent membrane targeting processes (48) and are unique among membrane 
targeting domains in that they show a wide range of lipid selectivity for the major  
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Figure 1-4. Domain organization of mammalian PI-PLC isoforms (adapted from (42)) 
and crystal structure of PLC-δ1 (49). The four domains (PH, EF-hand, catalytic, and C2) 
represent the common core structure of all mammalian PI-PLC isozymes (except sperm-
specific PLC-ζ). Other subtype-specific domains contribute to their specific regulatory 
mechanisms. The structure of bacterial PI-PLC is similar to the catalytic core of 
mammalian PLC-δ1. 
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components of cell membranes, including PS and PC. However, the key calcium-binding 
residues are not conserved in all C2 domains among PLC isozymes (e.g. PLC-β and -γ). 
The C2 domains of PLC-β isozymes are unable to bind calcium; instead, they do interact 
strongly and specifically with their activator, the α subunits of Gq proteins (50).  
PLC-δ1 (85 kDa) is the eukaryotic PLC whose three-dimensional structure was 
solved first (shown in Figure 1-4 (49)). More recently, the structure of PLC-β2 
complexed to a G-protein activator has been solved (51). Several crystal structures of 
bacterial PI-PLC enzymes from different species have been reported (52-55) as shown in 
Figure 1-5. These enzymes are folded as a single, distorted (αβ)8-barrel or TIM (triose 
phosphate isomerase)-barrel with the active site at the C-terminal end of the β-strands. 
The crystal structures of B. thuringiensis PI-PLC (Y247S/251S) and B. cereus PI-PLC 
are almost identical, and are highly similar to the catalytic domain of PLC-δ1. For L. 
monocytogenes PI-PLC, most of the secondary structure superimposes well with the 
Bacillus enzymes except for the regions between strand V and VI (arrow indicated in 
Figure 1-5B). The strand Vb of B. cereus PI-PLC is missing in the L. monocytogenes 
enzyme, resulting in a more open active site groove and unfavorable binding of the 
oligosaccharide portion of GPI anchors (56). The active site pocket was identified by co-
crystallization with myo-inositol (52, 53). As shown in Figure 1-5D, the inositol ring 
binds in an edge-on orientation with the 2-, 3-, 4-, and 5- OH groups of the ring strongly 
coordinated with a network of hydrogen bonds. One or more hydrogen bond interactions 
are formed between those hydroxyl groups and the side chains of several residues which 
themselves are held in position by other residues via hydrogen bonds. There is also a  
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Figure 1-5. Structure of bacterial PI-PLC enzymes. Side by side view of the topologies 
of (A) B. cereus PI-PLC (1PTG); (B) B. thuringiensis PI-PLC (3EA2); and (C) L. 
monocytogenes PI-PLC (1AOD) with myo-inositol (blue) bound in the active site pocket. 
(D) Interaction of myo-inositol with the active site residues of B. cereus PI-PLC. 
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planar stacking interaction between the apolar side of the myo-inositol ring and the 
phenol ring of Tyr-200 to position the myo-inositol ring. No close contact is found 
between the protein and O1 or O6 of the myo-inositol moiety. These binding patterns of 
myo-inositol in the active site are consistent with the exquisite sensitivity of enzyme to 
the conformation of inositol (31).  
1.2.3.3 Catalytic mechanism of PI-PLC 
Based on the crystal structure and sequence alignment for all published PI-PLC 
enzymes, researchers suggested that the catalysis of B. cereus PI-PLC occurs via an in-
line SN2 displacement using His32 and His82 as the general base and general acid, 
respectively (52). More recent studies have suggested that His32-Asp274-inositol-2-OH 
and His82-Asp33-Arg69 form the complex catalytic triad as the general base and acid as 
shown in Figure 1-6 (31). His82 interacts with Asp33 and Arg69 to form a general acid 
triad. The function of His82-Asp33-Arg69 triad is to assist in phosphate activation by 
protonation or hydrogen bonding with the leaving group, but this triad is not in the 
optimal arrangement to perform the charge relay function. The assembly of Arg, Asp, and 
His residues into the functional catalytic triad is affected by hydrophobic interactions of 
the rim, at the active site opening, with hydrocarbon chains of the PI substrate (57). For 
L. monocytogenes PI-PLC, His45 and His93 are found in similar positions to His32 and 
His82, the critical catalytic residues, of the B. cereus enzyme. Mutagenesis studies 
confirmed the critical role of His45 and His93 for catalysis (58). Thus, the same reaction 
mechanism should be used by L. monocytogenes PI-PLC.  
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Figure 1-6. The catalytic mechanism for the hydrolysis of PI by B. cereus PI-PLC. 
His32-Asp274-inositol-2-OH and His82-Asp33-Arg69 form the catalytic triad (31). 
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The catalytic domain of PLC-δ1 is similar to the structure of bacterial PI-PLC. Most 
importantly, two histidine residues (His311 and His356) in the active site are conserved 
and have been suggested to play the role of general acid/general base (49, 59, 60). Figure 
1-7A shows the active site of mammalian PI-PLC. Many important features at the active 
site are shared by mammalian and bacterial enzymes. The active site is held in place by 
hydrogen bonding of active site polar residues and the salt bridge of Glu341 and Arg 549 
at the bottom of the active site cleft. The most significant difference is that the catalytic 
mechanism of mammalian PI-PLC (mPI-PLC) is strictly dependent on calcium (as shown 
in Figure 1-7B) as a cofactor with a Kd for this ion within the physiological range (0.01-
10 μM Ca2+) (61). The function of calcium ion, analogous to Arg69 in bacterial PI-PLC 
enzymes (bPI-PLCs), i.e. stabilization of the deprotonated 2-OH nucleophile and highly 
charged pentavalent transition state (52). This difference could cause the higher 
efficiency for eukaryotic enzymes to generate acyclic inositols as products. Due to the 
high similarity of the structure and catalytic mechanism between bacterial and 
mammalian PI-PLC, the small baterial enzyme serves as a good model for studying 
complex mammalian enzymes, particularly with respect to the details of in interfacial 
binding and activation. 
1.3 Interfacial catalysis 
A challenging aspect for studying lipolytic enzymes is that these enzymes are water-
soluble while their substrates are not soluble in water but form a separate lipid phase. 
Another characteristic property of phospholipases is called interfacial activation, meaning 
a sharp increase in lipase activity is observed when the substrate starts to form an  
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Figure 1-7. Catalytic mechanism for mammalian PI-PLC (mPI-PLC). (A) active site of 
mPI-PLC; (B) the catalytic mechanism for the hydrolysis of PIP2 by PLC-δ1 (60). 
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aggregate (micelle, emulsion, etc.), thereby presenting a well-defined interface to the 
enzyme. As a consequence, the kinetics of a phospholipase reactions do not follow the 
classical Michaelis-Menten model (62). The model shown in Figure 1-8 (63), simplifies 
the analysis of interfacial kinetics by separating the contribution of interfacial binding 
from the interfacial catalytic steps, and is widely adopted to represent Michaelis-Menten 
kinetics of enzymes at interfaces. Here, the overall catalytic process occurs in two 
discrete steps: the enzyme in the aqueous phase (E) initially binds to the interface of the 
aggregated substrate with rate constant kb where the interfacial-associated enzyme (E*) 
further undergoes a series of catalytic steps at the interface, including binding and 
catalyzing the hydrolysis of substrate, then releasing the product to regenerate free E* 
which either goes back to the aqueous phase (E) in the hopping mode or stays in the same 
interface to carry out another round of interfacial catalysis in the scooting mode. 
Ordinarily, phospholipases will show different residence times on interfaces which can 
range from long (scooting mode) to very short (hopping mode, i.e., productive interfacial 
contact results in one substrate turnover cycle). This means that a combination of 
scooting and hopping will occur in the same reaction mixture (31). 
The overall rate of catalytic turnover is thus affected not only by the kinetics of the 
interfacial catalytic steps but also by the kinetics of binding and desorption of the enzyme 
at the interface. The relative contribution of these two factors clearly depends on the 
processivity of the reaction progress. For enzymes working in pure scooting mode 
(achieved with a model system for PLA2 by confining the enzyme to the surface of 
negatively charged phospholipid vesicles), the enzyme always remains bound at the  
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Figure 1-8. Kinetic steps for the action of a soluble enzyme on an insoluble substrate 
(63). The species shown in the box are embedded in or bound to the interface. 
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membrane interface and exhibits negligible inter-aggregate fusion or exchange on the 
time scale of the reaction (64). Scooting mode kinetics provide near ideal conditions for 
the characterization and analysis of the events in the interfacial turnover cycle. Assays in 
pure hopping mode or with rate-limiting inter-aggregate exchange of substrates and 
products provide insights into the contribution of the kinetics of binding and desorption 
of the enzyme at the interface.  
Interfacial activation is observed for many peripheral enzymes. Comparing the 
activities of a phospholipase toward the same substrate in aggregated versus monomeric 
form, usually synthetic short chain phospholipids with a CMC in the mM range (i.e. diC6- 
or diC7- with various head groups), is the way to check for interfacial activation behavior 
of phospholipases. Interfacial activation can be described by increases in kcat/Km for a 
particular substrate in an interface, and can be caused by different mechanisms, including 
increased affinity to the interface, or by allosteric activation.  
Another parameter important for interfacial catalysis is concentration. For a substrate 
dispersed at interface, both the bulk concentration and two-dimensional local 
concentration should be considered. It is reasonable that in a heterogeneous system, like 
interfacial reaction progress, the local concentration instead of bulk concentration is 
important for the overall kinetic rate. In diluting the substrate at the interface by adding 
more detergents or nonsubstrate lipids while keeping the total concentration of substrate 
constant, many phospholipases exhibit lower specific activity, a phenomenon called 
“surface dilution inhibition”. Along with the decrease in surface concentration of the 
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substrate, an increase in the surface concentration of a possible competitive lipophilic 
inhibitor may also account for the reduction in activity (65).  
1.4 PC activation of PI-PLC 
Previous studies of the PI-PLC from Bacillus sp. highlight several kinetic properties 
common to a wide range of phospholipase enzymes (66). That bacterial PI-PLC exhibits 
(i) “interfacial activation”, specifically by PC, with an enhanced kcat and reduced apparent 
Km, toward aggregated PI compared to monomeric PI (67, 68), (ii) “surface dilution 
inhibition”, a decrease in specific activity as the surface concentration of the substrate, PI, 
is diluted with detergents or other phospholipids while keeping the total substrate 
concentration constant (69), and (iii) “scooting mode catalysis”, where enzyme completes 
several rounds of substrate turnover at the substrate interface before dissociating from the 
particle (68).  
B. thuringiensis PI-PLC, like other PI-PLC enzymes, catalyzes the specific cleavage 
of the sn-3-phosphodiester bond in phosphatidylinositol (PI) in two steps, an 
intramolecular phosphotransferase reaction at a phospholipid interface and a 
phosphodiesterase reaction where the substrate can be in the water phase. What is unique 
to the B. thuringiensis (and B. cereus) enzyme is that both of these steps are specifically 
activated by PI-PLC binding to PC interfaces, either in a micelle form or vesicle matrix.  
This activation involves two critical tryptophan residues, Trp47 in the helix B region 
and Trp242 in a disordered loop (70, 71) as shown in Figure 1-9A. In addition, while 
wildtype B. thuringiensis and related bacterial PI-PLC enzymes are monomeric in 
solution as shown in Figure 1-5, a B. thuringiensis PI-PLC mutant (W47A/W242A)  
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Figure 1-9. Crystal structure of B. thuringiensis PI-PLC. (A) PI-PLC monomer structure 
indicating the position of two Trp residues which are important for PC binding; (B) 
Dimer crystal structure of W47A/W242A mutant; (C) aromatic residues, from chains A 
and B, located within the hydrophobic core of the symmetric dimer interface. Figure 
adapted from (72). 
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crystallizes as a homodimer shown in Figure 1-9B (72). The symmetric dimer interface is 
stabilized by hydrophobic and hydrogen-bonding interactions, contributed primarily by a 
central swath of aromatic residues arranged in a quasi-herringbone pattern (Figure 1-9C).  
Evidence that interfacially active wild-type PI-PLC enzymes may dimerize in the 
presence of phosphatidylcholine vesicles was suggested by fluorescence quenching of PI- 
PLC mutants with pyrene-labeled cysteine residues (72). Later mutagenesis studies of the 
aromatic residues at this dimer interface found that mutation of Tyr residues that are 
likely to disrupt the dimer interface correlates with reduced interfacial catalysis, which 
could also be consistent with the dimerization activation model (55). A recent model 
proposed that the protein is a monomer in solution and an intact helix B (Figure 1-9A) 
ensures that hydrophobic residues at the correct position for the initial binding to the 
membrane; upon binding, helix B is disrupted and helps the protein dimerize at the 
membrane surface (one of the helix B residues, Gln45, is involved in stabilization of the 
W47A/W242A dimer). Transient dimerization would activate the protein toward both 
membrane bound and soluble substrates (73). Since all the evidence for this dimerization 
model is indirect, further experiments are needed to understand if dimerization really 
does occur.  
1.5 Membrane binding assays for peripheral proteins 
1.5.1 Membrane binding assays 
Since the cellular activities of peripheral membrane proteins depend on their 
membrane binding affinities, a sensitive and quantitative assay for membrane affinity is 
an essential tool for understanding the function and regulation of these proteins. 
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Traditional methods for monitoring peripheral proteins binding to membranes include 
assays that involve physical separation of membrane bound proteins and free proteins 
such as centrifugation and gel filtration assay, or direct assays that allow monitoring 
continuous membrane-protein binding, such as fluorescence and NMR methods (74). 
Briefly, variations using centrifugation to separate free and vesicle-bound protein are 
the simplest assays. However, the major drawback of these assays is that the long 
centrifugation time (and pathway) may perturb the equilibrium binding. Thus the Kd 
measured may not be the true equilibrium constant (70, 75). Chromatographic gel 
filtration assay is less sensitive and requires large amounts of both protein and lipids, so it 
is not preferred.  
For direct assays, fluorescence spectroscopy is mostly used. For a peripheral protein 
containing one or more tryptophan (or tyrosine) residues in the vicinity of the membrane 
bound surface, the intrinsic fluorescence of the protein is sensitive to the changes in 
polarity of the environment. When protein binds to hydrophobic core of membranes, the 
tryptophan fluorescence generally shifts to a shorter wavelength and exhibits an increase 
in intensity (76-78). There are some limitations for this assay. First, it requires the 
presence of intrinsic tryptophan residues at the membrane interface; however, multiple 
tryptophan residues might cancel each other out. Second, the intrinsic fluorescence signal 
may respond differently to different lipids. Third, the sensitivity of this assay is low.  
As an alternative and more sensitive assay to the intrinsic fluorescence, Förster 
resonance energy transfer (FRET) has been widely used (79-81). In these experiments, 
fluorophore containing lipids (e.g., dansyl- or pyrene- lipids) are incorporated in the 
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membranes; the absorption of the lipids strongly overlaps with tryptophan emission, thus 
association of the protein with the bilayer results in quenching of the tryptophan 
fluorescence due to FRET. Compared to intrinsic fluorescence, this assay has improved 
sensitivity, however, it still requires the presence of tryptophan on the protein in the right 
place. 
Protein binding to lipid vesicles or cells greatly retards protein translational diffusion. 
For fluorescently labeled proteins, this change can easily be monitored using fluorescence 
correlation spectroscopy (FCS) (82-84). FCS is very sensitive and uses low protein 
concentrations (<1-50 nM), comparable to what is used in kinetic assays. We have 
applied this assay to study PI-PLC interactions with SUVs composed of both zwitterionic 
lipid and negative lipid as discussed in chapter 4.  
Instead of using vesicle systems in solution, assays using immobilized lipid bilayers 
as model membranes, such as surface plasmon resonance (SPR), have also been 
developed (85, 86). In a typical SPR assay, lipids are immobilized on the sensor chip 
surface that forms a wall of the sample cell and protein solution of different 
concentrations flows through the cell. When protein binds to the membrane, the refractive 
index near the surface will be changed and the signal can be recorded in real time. The 
rate constants for association (ka) and dissociation (kd) steps can be extracted. The 
advantage of this method is that the rate constants obtained can provide further insights 
into the mechanism of protein binding. However, the assay also has limitations. First, the 
kinetic SPR data can be quite complex due to various effects, such as rebinding, and 
nonspecific binding. Second, the determined Kd = kd/ka is expressed in terms of molarity 
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of protein binding sites instead of lipid concentration. Third, the lipid surface is planar – 
it cannot be curved – a potential problem in working with the bacterial PI-PLC enzymes 
which prefer to bind to small highly curved vesicles. 
1.5.2 Kinetics of membrane-protein interactions 
Based on kinetic studies for a large number of peripheral proteins and their mutants 
by the fluorescence-based stopped-flow analysis (87), surface plasmon resonance (SPR) 
analysis (88, 89), and total internal reflection fluorescence microscopy (90), a two-step 
mechanism for membrane-protein interactions has been proposed (2). The model 
suggests that the initial formation of nonspecific collisional complexes, driven by 
diffusion and electrostatic forces, is followed by the formation of tightly bound 
complexes, which are stabilized by specific interactions and/or membrane penetration. In 
general, protein residues (e.g., cationic membrane-binding residues) and other factors 
(e.g., Ca2+ or phosphorylation) that enhance the nonspecific, long-range electrostatic 
interactions primarily accelerate the association of proteins to anionic membranes (i.e., ka 
effect), whereas protein residues and other factors that increase short-range specific 
interactions and/or membrane penetration mainly slow the membrane dissociation (i.e., kd 
effect) (91). Aromatic residues, particularly Trp, play a unique and crucial role in binding 
to zwitterionic PC membranes (92, 93) by affecting both membrane association and 
dissociation steps (91). 
1.6 Thesis directions 
The aim of this dissertation is to understand the PC activation mechanism of B. 
thuringiensis PI-PLC on a molecular level. Although previous mutagenesis studies have 
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revealed some residues that play important roles in PC binding (55, 70), it is difficult to 
determine the effects of substrate and non-substrate lipids with both the lipids present at 
the interface. So the first question we wanted to address is how the activator lipid PC will 
affect binding of the enzyme to substrate-containing SUVs. FCS will be used to answer 
this because of its detection and low protein concentration requirement. By comparing 
the binding at different lipid compositions, we should be able to separate the effects of 
the two lipids. Once we obtain the binding profile, we can compare the binding with the 
corresponding activity profile, and see whether the activation is caused by increased 
affinity.  
Mutagenesis (55) suggests this PC ‘activator site’ is spatially distinct from the active 
site, although a definite binding site could not be identified. So the second question is to 
identify the PC binding site on the protein, if it exists. This is very difficult for currently 
available methods, and a novel technique, field cycling 31P NMR (fc-P-NMR) will be 
used. This technique has previously been used to study lipid dynamics in vesicles (94, 
95). In this experiment, the idea is to introduce a large dipole at different positions on the 
protein through site-directed spin labeling and examine the effects of the spin-label on the 
31P spin-lattice relaxation rates of the phospholipids from 0.003 to 11.7 T. Distance from 
the spin label to 31P is a key parameter for these effects, and we will finally be able to 
define the position relationship between the protein and lipids.  
The PI-PLC W47A/W242A dimer crystal structure attracted our attention because a 
surface-induced dimer has an advantage in processive catalysis. However, the evidence in 
support of this model is indirect and mostly relies on mutagenesis studies (55, 73). So the 
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third question we will address is whether this dimer is a kinetically real species. To 
‘mimic’ this intermediate, we can construct covalent dimers through disulfide bonds, and 
might be able to create a dimer similar to what is proposed for the surface activated form. 
The dimer interface from W47A/W242A crystal structure can provide us with starting 
points for disulfide bond construction.  
Finally, we will study fluorescently-labeled single PI-PLC proteins binding to surface 
tethered vesicles using total internal reflection microscopy (TIR-FM). The residence time 
of the protein on the vesicle bilayer could provide us with valuable dynamic information 
that cannot be observed in ensemble solution assays. We can test the effects of vesicle 
composition or other factors that might affect the residence time.  
What’s also important for these studies is that the technique we used here could be 
applied to other peripheral membrane proteins.  
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Chapter 2 Materials and Methods 
2.1 Chemicals 
Most of the lipids used in this work were purchased from Avanti Polar Lipids, Inc., 
and used without further purification. These include the long chain lipids 1-palmitoyl-2-
oleoyl-phosphatidylcholine (POPC), 1,2-dioleoyl-phosphatidylserine (DOPS), 1,2-
dioleoyl-phosphatidylmethanol (DOPMe), 1,2-dioleoyl-phosphatidic acid (DOPA), 1,2-
dioleoyl-phosphatidyglycerol (DOPG), L-α-phosphatidylinositol (PI) from bovine liver, 
dipalmitoyl-lissaminerhodamine phosphatidylethanolamine (Rho-PE), dipalmitoyl 
phosphatidylethanolamine-N-biotinyl (Biotin-PE) and the short chain phospholipids 
dibutyroylphosphatidylcholine (diC4PC), dihexanoylphosphatidylcholine (diC6PC), and 
diheptanoylphosphatidylcholine (diC7PC). Crude PI was purchased from Sigma.  
The fluorescence labeling reagent Alexa Fluor 488 C5 maleimide (AF 488) and 1,1'-
dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine perchlorate (DiD oil) as well as 
avidin were purchased from Invitrogen. The spin labeling reagent methanethiosulfonate 
(MTSL) was obtained from Toronto Research Chemicals Inc., Canada. 
The Q Sepharose fast flow resin and phenyl sepharose resin were purchased from GE 
Healthcare. Micro bio-spin 6 columns and Dowex AG1-X8 resin were purchased from 
Bio-Rad Laboratories.  
The QuikChange site-directed mutagenesis kit and BL21-codonplus (DE3)-RIL E. 
coli competent cells were purchased from Stratagene. The plasmid purification miniprep 
kit was purchased from Qiagen. All the PCR primers were purchased from Operon 
Technology.  
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Most of the other chemicals, such as bovine serum albumin (BSA), D2O, imidazole, 
tris, sodium phosphate monobasic, sodium chloride, potassium chloride, glycine, Folin-
Ciocalteu reagent, ammonium persulfate (APS), N,N,N',N'-tetramethylethylenediamide 
(TEMED), chloroform, methanol, acetic acid as well as glycerol and Triton X-100 were 
purchased from Sigma. Tryptone and yeast extract were obtained from Fisher. SDS-
PAGE molecular weight standards, 30% acrylamide solution and bovine serum albumin 
were purchased from Bio-Rad.  
2.2  Lipids 
2.2.1  Enzymatic synthesis of dimyristoyl-d54-phosphatidylmethanol (d54-DMPMe) 
Enzymatic generation of DMPMe was carried out using phospholipase D (PLD). This 
enzyme exhibits a phosphodiesterase activity that hydrolyzes phosphatidylcholine (PC) to 
phosphatidic acid (PA) and an alcohol. In the presence of primary alcohols, PLD also 
exhibits transferase activity toward PC (96, 97). The Streptomyces sp. 
glycerophospholipid-specific phospholipase D, >95% pure, was obtained from Biomol 
(SE302). To prepare d54-DMPMe, 10 mM dimyristoyl-d54-phosphocholine (d54-DMPC, 
from Avanti Polar Lipids 860345) was mixed with 30% methanol and 50 mM imidazole 
buffer, pH 6.5 and sonicated to make SUVs. 10 μg PLD was then added to 2 ml of the 
solution and incubated at room temperature (r.t.) with stirring. The reaction scheme is 
shown below:  
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The reaction was monitored using 31P NMR spectroscopy to assess completion of the 
reaction (~ 3 hrs). Under these conditions, PMe was the only product and it was extracted 
using 2:1 chloroform: methanol solvent. The yield of the reaction was 97%.  
2.2.2 Vesicle Preparation and Sizing by Dynamic Light Scattering (DLS) 
Lipid stock solutions in chloroform were placed in glass scintillation vials. The 
chloroform was removed under a stream of nitrogen gas and the resultant film lyophilized 
overnight. The lipid film was rehydrated with buffer. Lipids supplied as powder were 
dissolved in appropriate buffer directly. Large unilamellar vesicles (LUVs) were prepared 
by multiple passages of the aqueous lipid solutions through polycarbonate membranes 
(100 nm pore diameter) using a Mini-extruder from Avanti. Small unilamellar vesicles 
(SUVs) were prepared by sonication (Branson Sonifier Cell Disrupter) of lipid mixtures 
for 10 min on ice until maximum clarity was achieved.  
The SUVs had a narrow vesicle size distribution as assessed by dynamic light 
scattering (DLS) (98) using a Protein Solutions DynaProdynamic light scattering 
instrument from Wyatt Technology (99). Data were analyzed with the Dynamics D5 
software. SUVs composed of different ratios of POPC/DOPMe (described by the mole 
fraction PC, XPC) were analyzed by dynamic light scattering to extract rDLS, the mass-
weighted average radius of the vesicles. Examples of distributions for pure PMe and pure 
PC vesicles are shown in Figure 2-1. The anionic-rich SUVs were slightly smaller with a 
narrower size distribution than the PC-rich SUVs in terms of molarity. The average 
radius for each vesicle preparation was calculated according to Rav.=Σiρi(r)Ri,where ρi(r)  
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Figure 2-1. The mass-weighted size distribution (%weight) of single component PC (), 
PMe (z) and PG (Δ) SUVs prepared by sonication and measured by DLS. The radii were 
determined from the DLS data using the Stokes-Einstein relation. 
 
 
 
  
0
10
20
30
40
50
0 10 20 30 40 50 60 70
% wt
r 
DLS
 (nm)
35 
 
is the weight percentage of the corresponding radius (calculated from the Stokes-Einstein 
relation, r=kBT/6πη D, where D is the diffusion coefficient measured by light scattering, 
kB is the Boltzmann constant, T is the absolute temperature and η is the viscosity of the 
medium) and is shown for  the different vesicles in Table 2-1. All the SUVs were used 
within one week of preparation.    
2.3  Enzymatic synthesis and purification of cIP 
Enzymatic generation of cIP by bacterial PI-PLC using crude soybean PI was 
modified from the procedure described previously (69). One gram of crude PI was 
dissolved in 15 ml Tris-HCl (pH 7.5) containing 3% Triton X-100. Bacterial PI-PLC (20 
μg) was added and the reaction was carried at 37 °C and monitored using 31P NMR 
spectroscopy. After around 50% of the PI was hydrolyzed to cIP (typically 3h), the 
reaction was quenched by the addition of chloroform. The reaction mixture was then 
treated with a 80% chloroform and 20% methanol solution to extract DAG and 
unhydrolyzed phospholipid from the aqueous phase. Usually, a clear aqueous phase could 
be achieved after 4 to 6 extractions. cIP present in the aqueous phase was further purified 
using an AG1-X8 (formate form, 100-200 mesh) anion exchange column. 10 g of AG1-
X8 resin was used pre approximiately 100 mg of crude cIP. Prior to the addition of cIP, 
the resin was equilibrated with de-ionized water at pH 7.0. The crude cIP was then 
applied and eluted with 50 mM ammonium formate (pH 7.0) with a linear flow rate of 
about 0.5 cm/min. The fractions with cIP were lyophilized several times to remove 
ammonium formate, and the resulting product is a transparent gel. Typically, 100 mg of 
pure cIP was obtained from 1.0 g of crude PI.  
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Table 2-1. Dependence of POPC/DOPMe SUV average radii on vesicle composition 
measured by DLS. 
 
XPC rDLS (nm) a 
 wt % b 
10 < r < 20 nm  
0.00 10.6 (10.0)c 98.5 (99.2)c 
0.10 12.5 98.2 
0.20 12.3 93.5 
0.35 11.6 96.6 
0.50 12.7 91.5 
0.70 17.7 84.6 
0.90 15.5 94.8 
0.95 14.2 86.2 
 
a The average radii for SUVs were calculated from the average diffusion coefficient Dav 
obtained from the light scattering experiment using the Stokes-Einstein relation.  
 
b The weight percentage of small vesicles whose radii fell between 10 and 20 nm as 
measured by DLS. 
 
c The value in parentheses is for pure DOPG SUVs prepared by sonication. 
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2.4 B. thuringiensis PI-PLC expression and purification  
2.4.1 Over-expression in Escherichia coli cells with a plasmid containing the gene 
for B. thuringiensis PI-PLC 
PI-PLC was overexpressed in E. coli and purified as described previously (70). The 
original plasmid (B. thuringiensis PI-PLC gene cloned in the pHN1403 vector) was 
obtained from Dr. Ming-Daw Tsai, Ohio State University. The DNA and corresponding 
amino acid sequences are shown in Figure 2-2. Plasmid preparations were performed 
using a Qiagen plasmid miniprep kit. BL21-codonplus (DE3)-RIL competent cells were 
transformed using the heat shock method. One colony was inoculated into 5 ml LB media 
in culture tubes and incubated with shaking overnight at 37 °C in the presence of 
appropriate antibiotics (34 μg/ml chloroamphenicol and 50 μg/ml ampicillin). 5 ml of the 
overnight culture was added to 2 L of LB media. The newly inoculated media was then 
incubated at 37 °C in the presence of 34 μg/ml chloroamphenicol and 50 μg/ml 
ampicillin. At an O.D.600 of 0.8, IPTG was added to a final concentration of 0.7 mM, and 
the culture was incubated for another 3 h at 37 °C or for 20 h at 16 °C. The cells were 
then harvested by centrifugation at 5000 rpm for 5 min (using a Beckman J2-MC 
centrifuge with JA-10 rotor) and frozen at -80 ºC overnight. The cell pellets were later 
thawed, dissolved in 20 mM Tris, pH 8.9, and lysed by sonication on ice using a Branson 
Sonifier Cell Disrupter. Cell debris was pelleted by centrifugation at 15,000 rpm (using a 
JA-17 rotor) for 30 min. The supernatant with enzyme was ready for subsequent 
purification steps. 
2.4.2  Purification of PI-PLC 
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Figure 2-2. B. thuringiensis PI-PLC DNA and corresponding amino acid sequences. 
  1 A  S  S  V   N  E  L   E  N  W   S  K  W  M   Q  P  I   P  D  N 
  1 GCTAGCTCTG TTAATGAGCT TGAAAATTGG TCAAAATGGA TGCAACCTAT ACCTGATAAT 
 
 21 I  P  L  A   R  I  S   I  P  G   T  H  D  S   G  T  F   K  L  Q 
 61 ATCCCGTTAG CACGAATTTC AATTCCAGGA ACACACGATA GTGGGACGTT CAAGTTGCAA 
  
 41 N  P  I  K   Q  V  W   G  M  T   Q  E  Y  D   F  R  Y   Q  M  D  
121 AATCCGATTA AGCAAGTGTG GGGAATGACG CAAGAATATG ATTTTCGCTA TCAAATGGAC 
 
 61 H  G  A  R   I  F  D   I  R  G   R  L  T  D   D  N  T   I  V  L 
181 CATGGAGCTC GCATTTTTGA TATAAGAGGA CGTTTAACAG ATGATAATAC GATAGTTCTT 
 
 81 H  H  G  P   L  Y  L   Y  V  T   L  H  E  F   I  N  E   A  K  Q       
241 CATCATGGGC CATTATATCT TTACGTAACA CTGCATGAAT TCATAAATGA AGCGAAACAA 
 
101 F  L  K  D   N  P  S   E  T  I   I  M  S  L   K  K  E   Y  E  D  
301 TTTTTAAAAG ATAACCCGAG TGAAACAATT ATTATGTCTT TAAAAAAAGA GTATGAGGAT 
 
121 M  K  G  A   E  G  S   F  S  S   T  F  E  K   N  Y  F   V  D  P 
361 ATGAAAGGGG CAGAAGGTTC ATTTAGTAGT ACGTTTGAAA AAAATTATTT TGTTGATCCT 
 
141 I  F  L  K   T  E  G   N  I  K   L  G  D  A   R  G  K   I  V  L       
421 ATCTTTTTAA AAACAGAAGG AAATATAAAA CTTGGAGATG CTCGTGGGAA AATTGTACTA 
 
161 L  K  R  Y   S  G  S   N  E  S   G  G  Y  N   N  F  Y   W  P  D  
481 CTAAAAAGAT ATAGTGGTAG TAATGAATCT GGAGGATATA ATAATTTTTA TTGGCCAGAT 
 
181 N  E  T  F   T  T  T   V  N  Q   N  V  N  V   T  V  Q   D  K  Y     
541 AATGAGACGT TTACCACAAC TGTAAACCAA AATGTAAATG TAACAGTACA AGATAAATAT 
 
201 K  V  N  Y   D  E  K   V  K  S   I  K  D  T   M  D  E   T  M  N   
601 AAAGTGAATT ATGATGAGAA AGTAAAATCT ATTAAAGATA CGATGGATGA AACGATGAAC 
 
221 N  S  E  D   L  N  H   L  Y  I   N  F  T  S   L  S  S   G  G  T 
661 AATAGCGAGG ATTTAAATCA TCTATATATT AATTTTACAA GCTTGTCTTC TGGTGGTACA 
 
241 A  W  N  S   P  Y  Y   Y  A  S   Y  I  N  P   E  I  A   N  D  I 
721 GCATGGAATA GTCCATATTA CTACGCTTCT TATATAAATC CTGAAATTGC AAACGATATA 
 
261 K  Q  K  N   P  T  R   V  G  W   V  I  Q  D   Y  I  N   E  K  W 
781 AAACAAAAGA ATCCTACAAG AGTAGGCTGG GTAATTCAAG ACTACATAAA TGAAAAGTGG 
 
281 S  P  L  L   Y  Q  E   V  I  R   A  N  K  S   L  I  K   E STOP 
841 TCACCATTAT TGTATCAAGA AGTTATAAGA GCGAATAAGT CATTAATAAA AGAATAA 
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Cell extract (dialyzed against 20 mM Tris-HCl, pH 8.9 overnight) was applied onto a 
Q-sepharose fast flow column (15 mm x 12 cm) equilibrated with 20 mM Tris-HCl, pH 
8.9. The protein was eluted using a NaCl gradient from 0 to 0.6 M in 20 mM Tris-HCl, 
pH 8.0 at a rate of 2 ml/min. The protein eluted around 0.2 M NaCl. The protein was 
further purified using a phenyl-sepharose column (10 mm x 10 cm) equilibrated with 1 M 
NaCl in 20 mM Tris, pH 8.0 and eluted with a decreasing NaCl gradient form 0.6 M to 0 
M at a rate of 1 ml/min and the protein eluted around 0.3M NaCl (for the W242A/W47A 
mutant protein, the NaCl gradient used was from 1 M to 0.6 M and the protein eluted 
around 0.8 M NaCl). Enzyme purity, as checked by SDS-PAGE, was >95%. The 
fractions containing PI-PLC were collected and dialyzed against Tris buffer to remove 
the salt. Millipore Centriplus 10 filters were used to concentrate the protein. Protein 
concentrations were measured by both Lowry assays and absorption at 280 nm using 
65.32 mM-1 cm-1 as the extinction coefficient (calculated with the web-based ProtParam 
software http://ca.expasy.org/tools/protparam.html (100)). 
2.5  Construction of PI-PLC mutants 
A series of PI-PLC mutants were constructed using QuikChange methodology (101) 
with a site-directed mutagenesis kit from Stratagene. Two complementary primers were 
designed with the mutated nucleotides in the middle of the primer. All of the primers 
used are listed in Table 2-2. PI-PLC mutants P42G, K44A, K44E, Y88A, and 
Y246/247/248S were constructed previously (55, 73), and the additional mutation N168C 
was introduced into these plasmids. The oligonucleotide primers, each complementary to 
opposite strands of the vector, were extended during temperature cycling by PfuTurbo  
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Table 2-2. Primers used in site-directed mutagenesis (reverse primers are not listed).  The 
mutation is indcated in bold. 
 
Mutant Forward Primers 
H32A 5’-CAATTCCAGGAACA-GCC-GATAGTGGGACG-3’ 
H82C 5’-CGATAGTTCTTCAT-TGT-GGGCCATTATATC-3’ 
N168C 5’-GATATAGTGGTAGT-TGT-GAATCTGGAGG-3’ 
N220C 5’-GGATGAAACGATG-TGC-AATAGCGAGG-3’ 
W47C 5’-CGATTAAGCAAGTG-TGT-GGAATGACGCAAG-3’ 
Y118C 5’-GTCTTTAAAAAAAGAG-TGT-GAGGATATGAAAGGGG-3’ 
M121C 5’-GAGTATGAGGAT-TGT-AAAGGGGCAG-3’ 
W242C 5’-CTTCTGGTGGTACAGCA-TGT-AATAGTCCATATTAC-3’ 
N243C 5’-CTGGTGGTACAGCATGG-TGT-AGTCCATATTACTACGC-3’ 
W280C 5’-CTACATAAATGAAAAG-TGT-TCACCATTATTGTATC-3’ 
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DNA polymerase. In this way, a mutated plasmid containing staggered nicks was 
generated through the incorporation of the two oligonucleotide primers. The 
amplification product was then digested with the Dpn I, a restriction enzyme that is 
specific for methylated and hemimethylated DNA and is used to digest the methylated 
parental DNA template. This digestion did not affect the in vitro synthesized DNA 
containing the mutation which is not methylated. After digestion, 1 μl of digestion 
product was transformed into 100 μl XL-Blue supercompetent cells for plasmid 
propagation. The QIAprep Miniprep kit (QIAGEN) was used for purification of the 
plasmid DNA. Specific mutations were confirmed by DNA sequencing (Genewiz).  
2.6  Modification of PI-PLC 
2.6.1 Covalent dimer formation 
Over time (up to a week) and in the absence of dithiothreitol (DTT), PI-PLC Cys 
mutants (W242C, N243C, W47C, N168C, D205C, S250C and W280C), stored at ~ 1 
mg/ml formed some disulfide-linked homodimers as monitored by non-reducing SDS-
PAGE. Storage of the protein at a higher concentration (~10 mg/ml) yielded over 90% 
dimers after one week. These covalent dimers were fairly stable and could be stored up to 
20 days prior to use without loss of activity. Protein monomers were generated and 
maintained in solution by storage of the PI-PLC solutions with 5 mM DTT or by adding 5 
mM DTT 20 min before use in kinetics or binding studies. 
2.6.2 PI-PLC site-directed spin labeling 
PI-PLC Cys mutants W47C, H82C, N168C, Y118C, M121C, D205C, N220C, 
N243C, S250C and W280C were specifically spin labeled on the Cys by 1-oxyl-2,2,5,5-
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tetramethylpyrroline-3-methyl-methanethiosulfonate (MTSL). The reaction scheme is 
shown below: 
 
MTSL was prepared as a 10 mg/ml stock solution in acetone and stored in the freezer. 
The purified PI-PLC variants (25 mg/ml in 20 mM Tris, pH 8.0) were first incubated with 
5 mM DTT at room temperature for 20 min for full reduction of any intermolecular 
disulfide bonds. DTT was then removed by Micro Bio-spin 6 columns (up to 50 µl 
solution could be loaded on each spin column). The protein was then diluted to 5 mg/ml 
in 20 mM Tris, pH 7.0, and 3-fold DTT was added to make sure all the Cys were reduced 
to free sulfhydryls. A 10-fold MTSL over total –SH was then added and the resulting 
solution incubated for 1 h at r.t. followed by overnight incubation at 4 °C.  The excess 
spin label reagent was removed by Micro Bio-Spin 6 columns or extensive dialysis 
against buffer with 3 changes. The labeling percentage was > 95%, confirmed by non-
reducing SDS-PAGE (these Cys mutants would form dimers if they are not well spin-
labeled as shown in section 2.6.1).  
2.6.3 PI-PLC specific Cys labeling with Alexa Fluor 488  
Fluorescently labeled PI-PLC was prepared from the N168C mutant proteins. The 
variants labeled include WT, P42G, K44A, K44E, Y88A, Y246/247/248S and H32A. 
Each protein was specifically labeled at Cys168 with the hydrophilic dye Alexa Fluor 
488 C5 maleimide (AF488) according to the manufacturer's protocol. The AF488 dye was 
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prepared as a 25 mM stock solution in anhydrous DMSO and stored at -20 °C. Prior to 
labeling, the proteins were incubated with 5 mM DTT at r.t. for 20 min. The excess DTT 
was removed immediately before conjugation using Bio-Spin 6 columns. The Bio-spin 
columns as purchased were in 10 mM Tris, pH 7.4, and we changed the buffer to 20 mM 
Tris, pH 7.0 prior to removing DTT. Once DTT was removed, a 5-fold molar excess of 
AF488 dye was added to the protein and incubated at r.t. for 2 h. The AF488 labeled 
protein was separated from free AF488 using a second spin column. Less than 50 µl 
sample was loaded onto each spin column for the efficient separation. All variants had a 
labeling ratio of 100±10%, determined by comparing the absorption of the protein at 280 
nm to that of the probe at 495 nm. The equation used for calculating the labeling ratio 
was:  [D]/[P]=(65320 cm-1 M-1/71000 cm-1 M-1)*A495/(A280-0.1A495); where 65320 cm-1 
M-1 was the extinction coefficient of PI-PLC at 280 nm, 71000 cm-1 M-1 was the 
extinction coefficient of AF488 at 495 nm and 0.1 A495 was the correction for the 
absorbance of the dye at 280 nm.  
Labeling at N168C does not affect the enzyme activity or binding properties of 
wildtype PI-PLC. N168C labeled with AF488 had a PI cleavage rate of 1600±160 μmol 
min-1 mg-1 at 28 °C toward 8 mM PI dispersed in 32 mM diC7PC micelles, the same 
value as wild-type PI-PLC assayed under the same conditions. The fluorescently labeled 
mutated proteins are denoted by the residue(s) changed and an asterisk, so that labeled 
K44A/N168C is indicated as *K44A; the control protein, N168C, is denoted as *N168C.  
2.7 Binding of PI-PLC to SUVs by centrifugation-filtration assay 
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Estimation of apparent dissociation constants for PI-PLC monomers and covalent 
dimers partitioning onto POPC SUVs was carried out using a centrifugation/filtration 
assay described previously for this system (102). Vesicle samples were incubated with 
0.03 mg/ml protein in 2 ml of 10 mM Tris, pH 7.5. The bulk POPC concentrations ranged 
from 0.02 to 1.2 mM. When the binding of Cys mutant protein monomers was examined, 
all buffers contained 5 mM DTT. After incubation for 10 min, the solutions were 
centrifuged through a cellulose filter (100 kDa cut-off) to separate free enzyme from 
vesicle bound enzyme (Figure 2-3A). Filtrates were lyophilized and analyzed by SDS-
PAGE. Band intensities were quantified by NIH Image 1.61 software and used to 
calculate the free enzyme concentration, Ef, by comparing intensities from vesicle-
containing samples to the total enzyme, Et, value of the control without vesicles. The 
percentage protein bound to the vesicles can then be calculated by fb(%)=100 x (Et-Ef)/Et; 
alternatively the fraction bound was estimated, fb=(Et-Ef)/Et. An example of a PI-PLC 
binding experiment and the SDS-PAGE quantifying free enzyme is shown in Figure 2-3. 
The fraction bound, fb, was determined using Equation [1]: 
fb= [PL]/(Kd+ [PL])                                                  [1]
where Kd is the apparent dissociation constant, and [PL] is the total phospholipid 
concentration. 
2.8 31P and 1H NMR at 11.7 T 
2.8.1 Enzyme kinetic assay by 31P NMR 
The specific activity of PI-PLC was measured using 31P NMR spectroscopy (at 202.3 
MHz on a Varian INOVA 500 spectrometer). NMR parameters were based on those  
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Figure 2-3. Dependence of W280C covalent dimer partitioning into POPC SUVs on the 
bulk PC concentration: (A) Flow chart of binding assay; (B) SDS-PAGE of free W280C, 
Ef, as a function of POPC concentration; (C) Titration curves of fraction bound fb as a 
function of phospholipid concentration. The solid line indicates an apparent Kd=37±8 
μM.  
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previously reported (103, 104). Two types of assays were used, for both, the buffer was 
25 mM HEPES with 1 mM EDTA and 0.1 mg/ml bovine serum albumin (BSA), pH 7.5. 
BSA was used to stabilize the protein at the very low assay concentrations. For PI-PLC 
Cys mutant monomers, 5 mM DTT was included in the buffer to avoid intermolecular 
disulfide bonds. The amount of enzyme was adjusted so that less than 20% of the 
substrate was hydrolyzed in 20 minutes. The cleavage of PI or hydrolysis of cIP in 
micelles was monitored directly by measuring the increase of product resonance (cIP or 
I-1-P, respectively) intensity as a function of reaction time.  
Specific activities of PI-PLC toward PI in SUVs with varying mole fractions of PC 
were measured using a fixed time point assay. Three types of experiments were carried 
out. (i) To assess the effect of the apparent Kd for vesicles on enzymatic activity, we 
carried out assays with fixed XPC = 0.2 and various total phospholipid concentrations: 10 
mM (0.4 ml), 4 mM (1 ml) and 0.5 mM (8 ml). Wildtype or Y88A/N168C PI-PLC (0.1 to 
0.15 μg) was added to the solution and incubated at 28°C for fixed times chosen so that 
less than 20% of the PI was cleaved. The reaction was quenched by incubating the 
sample in a boiling water bath for 4 min, and the sample was then lyophilized. The 
lyophilized powder was rehydrated in 30% D2O, and 1-2 drops of Triton X-100 were 
added (to solubilize the remaining phospholipids in detergent micelles) for acquisition of 
the 31P NMR spectrum. (ii) For “surface dilution” experiments, the PI concentration was 
10 mM and increasing amounts of PC were incorporated in the vesicles. The reaction 
volume was 0.5 ml containing 0.1 to 0.4 μg PI-PLC. Samples (in duplicate) were 
incubated at 28°C, and the reaction was quenched by adding 30 μl acetic acid. Triton X-
47 
 
100 (50 μl) was added to solubilize the phospholipids for analysis by 31P NMR. (iii) 
Another variation used a fixed concentration (10 mM) of total phospholipid with XPC 
varied from 0.0 to 0.9 and workup as indicated above. The amount of enzyme added, 0.2 
to 5μg (corresponding to concentrations of 5.9 to 58.8 nM), and the incubation time were 
chosen to allow less than 20% PI cleavage for each sample. In these assays, myo-inositol 
1,2-(cyclic)-phosphate (cIP) was the only product and the specific activity was calculated 
according to integration of the cIP resonance compared to the total PI and PC resonance. 
(protons were not decoupled in these experiments so there is no NOE).  
2.8.2 Binding study of spin labeled PI-PLC to SUVs by 31P and 1H NMR 
The binding to PC/PMe vesicles by spin labeled PI-PLC (SL-PI-PLC) was measured 
at 28oC using 31P and 1H NMR spectroscopy on a Varian INOVA 500 spectrometer. The 
parameters for 31P included an 8000 Hz sweep width and a 90° pulse width. The free 
induction decays were processed with a 50 Hz line broadening. The linewidth was 
measured at half-height of each peak. In order to acquire 1H spectra, the solution must be 
in a deuterated buffer system. The buffer used for all these titrations was 25 mM 
imidazole, pH 7.0 in D2O with 1 mM EDTA; for titrations using non-spin-labeled PI-
PLC, 5 mM DTT was also present. An SUV stock solution (20 mM with 1:1 
POPC/DOPMe in the deuterated buffer) was prepared by sonication as described above. 
The purified protein, stored in 20 mM Tris, pH 8.0, was exchanged into the imidazole 
buffer either by dialysis or using a bio-spin 6 column. The protein was lyophilized and 
rehydrated with the deuterated buffer to a final concentration of 1 mg/ml. Some of the PI-
PLC variants, such as W242C, will denature after lyophilization. In this case, the protein 
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buffer was exchanged to the deuterated imidazole using a bio-spin 6 column. For the 
titration, 0.4 ml of 1 mg/ml protein solution was put into the 5 mm NMR tube and a 
background 1H spectrum was taken. Aliquots from the 20 mM PC/PMe SUVs (10 µl, 10 
µl, 30 µl, 50 µl and 50 µl) were added into the 0.4 ml protein solution to generate lipid 
concentration of 0.49, 0.95, 2.2, 4, and 5.45 mM. 31P and 1H spectra of the phospholipids 
dispersed in the vesicles were taken after each titration.  
The large dipole introduced by the nitroxide of the spin-label can affect the linewidth 
of nearby nuclei. If the spin label attached at a particular position of the protein is in close 
proximity to the 31P or 1H of a lipid, it should broaden the resonance. An example NMR 
spectrum was shown in Figure 2-4. The 31P resonance of the PC and PMe are well 
separated, so we were able to examine the effects of spin-labeled (SL) protein binding to 
each lipid in the mixed-component SUVs simultaneously. Figure 2-4C and D indicate the 
lipid linewidth changes at different ratios of protein to lipid using 1 mg/ml SL-W47C. 
For 1H broadening, effects on acyl chain (CH2)n can be separated if one component has 
perdeuterated chains. Plotting the linewidth (Δυ1/2) as a function of the total phospholipid 
concentration is shown in Figure 2-5. Assuming that all of the PI-PLC partitioned onto 
vesicles (verified by FCS for almost all of these mutant proteins), the plot fits to equation 
[2]: 
Δυ1/2=Δb. [PLC] / [PL]                                                   [2]
where [PLC] is the protein molar concentration, [PL] is the lipid molar concentration, and 
Δb is the bound linewidth (the parameter we extract). As a control, a similar titration with 
the same enzyme without spin-label (with DTT present to make sure the protein was in a  
49 
 
Figure 2-4. NMR spectra of lipids (1:1 POPC/DOPMe dispersed as SUVs). (A) 31P 
spectrum of the SUVs, PC and PMe have distinct chemical shifts; (B) 1H spectrum of the 
SUVs, and the different resonances where we examined the proton linewidth; 31P (C) and 
1H (D) spectra of vesicles titrated into 1 mg/ml SL-W47C (total phospholipid 
concentration [PL] = 0.5, 1, 2, 4, 5.5 mM).  
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Figure 2-5. Effects of spin-labeled W47C on the 31P linewidths of the two phospholipids 
in PC/PMe (1:1) vesicles. Linewidths (Δυ1/2) of PC (circles) or PMe (squares) are plotted 
as a function of total phospholipid concentration. The specific nitroxide induced bound 
linewidth can be obtained by comparing the effects of the spin labeled protein (SL-W47C; 
solid symbols) with the corresponding non-labeled protein (open symbols). The lines in 
the figure show best fits to equation [2].  
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monomer conformation) was carried out to separate the line broadening due to the large 
protein binding to the bilayer and that caused by the spin-label. The specific nitroxide-
induced bound linewidth (ΔΔb) was calculated using the following equation: 
ΔΔb =Δb(SL)- Δb(PI-PLC)                                                  [3]
where Δb(SL) or Δb(PI-PLC) is the bound linewidth of the spin-labeled protein or monomeric 
non-spin-labeled PI-PLC.   
2.9 High resolution 31P field cycling NMR 
The 31P field-cycling spin-lattice relaxation rate (R1) experiments were carried out at 
25oC on a Varian Unityplus 500 spectrometer using a standard 10-mm Varian probe in a 
custom-built device that moves the sample, sealed in a 10 mm tube, from the sample 
probe location to a higher position within, or just above, the magnet, where the magnetic 
field is between 0.06 and 11.7 T (95, 105). Spin lattice relaxation rates at each field 
strength were measured using 6-8 programmed delay times and the data are analyzed 
with an exponential function to extract R1 = 1/T1. Details of the spin-lattice relaxation 
rate measurement and the analysis to obtain and model R1 as a function of field have been 
described previously (94, 95), based on an extension of the standard model-free method 
based on previous work of Kubo, Tomita, and Solomon. Data are fitted to 
R1 =  Rdv +  Rdc  + CL ωP2 J(τc, ωP) +  CH ωP2 J(τh, ωP)  [4]  
where the function J(τ, ω) is 2τ/(1+ (ωτ)2) and 
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Rdv = Rv(0) D(ωH; ωP, τv);        [5] 
Rdc = Rd(0) D(ωH; ωP, τc).                [6] 
The first terms Rdv and Rdc are from the phosphorus-proton nuclear dipolar interaction, 
predominantly between the nearest protons on the glycerol and the polar side chain on the 
lipid with assumed correlation times τv and τc , on the order of 10-6, and 10-8 s, 
respectively.  These correlation times are due to overall rotational diffusion of the vesicle 
combined possibly with individual translational diffusion of a phospholipid about the 
vesicle surface for τv and some internal motion within the phospholipid previously 
identified with diffusion-within a cone (“wobble”) for τc (106). The function D(ωH; ωP, τ) 
is 
D(ωH; ωP, τ) = (2τ)-1{[0.1 J(τ, ωH - ωP)]+[{0.3 J(τ, ωP)]+[0.6 J(τ, ωH + ωP, τ)]},  [7] 
and the parameters Rv(0) and Rd(0) are 
 Rv(0) = Sv2 τv  Kn rPH-6;  [8] 
Rc(0) = Sc2 τc Kn rPH-6, [9] 
where the order parameters Sv2 and Sc2 are the fractions for the noise power of the 
stochastically varying dipolar interactions with correlations times τv and τc, respectively. 
Kn is a product of known constants (95) including the squares of the gyromagnetic ratios 
of the nuclear spins involved (here phosphorus and protons).  The latter multiply the 
applied low field to which we cycle, B0, to give the values of ωH and ωP that are used in 
the expressions above to finally get the field dependence of R1.  The expression “rPH-6” 
above is shorthand for Σ<rPH-3)2>, where rPH is the distance from the phosphorus to a 
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particular proton, the < > denotes a time average, and  Σ denotes a sum over all protons 
(in practice only the nearest ones). 
                                            CL = KC  SC2; [10] 
CH = 2 τh KC (1-SC2), [11] 
where KC is a product of known constants including effectively the square of the size of 
the chemical shift anisotropy (CSA) interaction, and SC2 is the fraction of the CSA power 
spectrum with the same internal correlation time τc mentioned earlier. The last term in eq. 
[4] results from fast short range (~1 nm) fluctuations with times scale  τh ~ 10-11 s. 
Our fitting procedure is simplified as follows, in ways that do not affect the important 
output parameters.  (i) We use the same correlation time τc  and order parameter Sc2 in the 
second and third terms of Eq. [4] even though these terms arise from different vectors in 
the phospholipid. The τc for the dipolar and CSA terms may differ, according to a 
simulation of pure dipalmitoylphosphatidylcholine vesicles, by a factor of 2-3 (106).  (ii) 
Eq. [4] omits the dipolar fluctuations with the high-frequency correlation time τh, and the 
CSA fluctuations with correlation time τv, neither of which are possible to observe with 
our method. However, all the order parameters for each interaction (dipolar, and CSA) 
must add to one so that Sv2 + Sc2 will be less than one, though probably not small 
compared to one; and the factor (1-SC2) in Eq. [11] should be replaced by a smaller 
number. (iii) The spectral density J(τh, ωP) in the last term of eq. [4] is replaced by 2τh,  
because (ωPτh)2 in its denominator is small compared to one. 
 While our fitting procedure may appear complex, in fact, much of what we use 
later can be evaluated by eye directly from our data, without use of a computer. These 
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will be illustrated with the field dependence for pure PMe SUVs (Figure 2-6). (i) The 
parameters Rv(0) and Rc(0) are the maximum low frequency values of the first two 
(dipolar) terms in Eq. [4], and are easily estimated because the other (CSA) terms are 
negligible at the low fields (below ~2 T) where these dispersions are large. They can be 
evaluated directly because the correlation times involved are so different (~1 µs versus 
~10 ns). Rc(0) is close to the value of R1 at around 0.1 T for our samples, and the sum of 
Rv(0) and Rc(0) is estimated by the limit of R1 at zero field (in practice at ~0.003 T). The 
correlation time τv is likewise fairly well estimated from the point in field where R1 is 
midway between Rv(0) and Rc(0), divided by the proton gyromagnetic ratio, because the 
function D (Eq. [7]) is approximately equal to 1/2 when ωH τ = 1 (Figure 2-6A). The 
internal correlation time τc can likewise be estimated, less accurately (because of the 
contribution from CSA) from the half point in field between where R1 ~ Rc(0) and where 
it becomes nearly independent of field, around 2T. We can use changes in Rc(0) to 
estimate changes in τc according to Eq. [8] if Sc and  rPH-6  are nearly constant.  For 
comparison the R1 field dependence above 0.07 T is broken down into dipolar and CSA 
terms with τc, as well as the CSA term for the faster motion characterized by τh (Figure 
2-6B). 
 Finally, the parameter SC2, as deduced from the field variation of CSA relaxation 
above about 5 T, has been found to be a useful indicator of internal dynamics (105) for 
nucleic acids.  It can be determined from the ratios of the last 2 terms of Eq. [4] because 
the dipolar terms are negligible at high fields. The correlation time τh cannot be 
determined as is possible for the longer correlation times, as described in the last  
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Figure 2-6. Field dependence of the 31P R1 for PMe in pure SUVs at 25oC: (A) low field 
region from 0 to 0.08 T; (B) region from 0.1 to 12 T. The upper x-axis shows the 1H 
frequency scale for comparison. The lines represent best fits of (A) total dipolar R1 = Rdv 
+ Rdc, and (B) Rdc + CL ωP2 J(τc, ωP) + CH ωP2 J(τh, ωP). Arrows indicate R(0) in each 
region as R1 is extrapolated to zero field; two arrows indicate how τ can be visually 
estimated and its value on the 1H frequency scale. In (B) the relaxation is also shown 
broken into dipolar (___  ___  ___) and CSA (– – –) contributions with τc and the faster τh 
responsible for the increasing high field CSA ( .  .   .  . ).  
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paragraph, but can be estimated from the size of the square-law variation of Eq. [11], by 
iterative fitting of the high-field rates. 
2.10 Fluorescence Correlation Spectroscopy study of Alexa Fluor 488 labeled PI-
PLC binding to SUVs 
FCS experiments were performed using a previously described (107) home-built 
confocal setup based on an IX-70 inverted microscope (Olympus) as shown in Figure 2-7. 
Briefly, the 488 nm line of an air-cooled argon-krypton laser (Melles-Griot) was used to 
excite the sample, a 500drlp dichroic mirror (Chroma Technology) reflected the laser 
light into a 60X water objective (Olympus, NA=1.2) mounted on an inverted microscope 
(IX-70, Olympus). The same dichroic passed the fluorescence emission, and any 
remaining scattered laser light was blocked by a 505lp filter (Chroma Technology). A 30 
µm confocal pinhole (Thor Labs) in the conjugate image plane was used to define the 
observation volume and to block out of focus fluorescence. The fluorescence was 
collimated, split by a non-polarizing 50-50 beam splitter (Newport) and focused unto two 
avalanche photodiodes (SPCM-AQR-14, Perkin-Elmer). For AF488 labeled protein, 
HQ535/50 bandpass filters (Chroma Technology) before the focusing lenses blocked the 
Raman scattering. Rhodamine-labeled SUVs were excited using the 520 nm laser line 
with a 535drlp dichroic mirror and HQ450lp longpass filter in the microscope, and the 
filters in front of the photodiodes were replaced by HQ645/75 bandpass filters (Chroma 
Technology). The photon counts from the photodiodes were collected by a 2-channel data 
acquisition card, and associated software was used to calculate and analyze the auto- and 
cross-correlations (ISS). 
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Figure 2-7.  FCS experimental schematic. Individual laser lines from an air-cooled 
argon-krypton, multi-line laser (Melles Griot) are separated using a quartz prism, P. The 
488 nm laser line is picked off, expanded 5 times using two lenses, L1 & L2, in order to 
overfill the back aperture of the microscope objective and reflected into the sample using 
a 500drlp dichroic (Chroma Technology), D1. In the IX-70 inverted microscope 
(Olympus), the 60X water objective, Obj, with a numerical aperture of 1.2 focuses the 
laser light into the sample and collects the emission. The emission passes through D1 and 
any remaining scattered laser light is blocked by a HQ505lp long pass filter (Chroma 
Technology), F1. The emission is then focused onto a 30 μm pinhole (Thor Labs) by the 
tube lens, L3, in the microscope to limit the detection region and collimated by lens L4. 
To calculate the cross-correlation, the fluorescence signal is spilt by a 50-50 beam splitter 
((Newport)), D2, and pass through a HQ535/50 bandpass filter (Chroma Technology), 
F2, F3 and focused on two avalanche photodiodes, APD1, APD2, by lenses L5 and L6, 
respectively. The rhodammine-labeled SUVs were excited using the 520 nm laser line 
with a 535drlp dichroic mirror (D1) and HQ450lp longpass filter (F1) in the microscope, 
and the filters in front of the photodiodes (F2 & F3) were replaced by HQ645/75 
bandpass filters (Chroma Technology). 
 
 
58 
 
FCS experiments were carried out at 22°C on 300 µL samples in phosphate buffered 
saline (PBS), pH 7.3, plus 1 mg/ml bovine serum albumin, to stabilize PI-PLC, in 
chambered coverglass wells (LabTek). Prior to use, the chambers were coated with 10 
mg/ml bovine serum albumin and rinsed with PBS buffer to prevent protein adhesion to 
the sides of the wells. For PI-PLC vesicle binding experiments, 3.5 nM labeled protein 
was titrated with unlabeled vesicles. The substrate, PI was not used for FCS experiments 
(except in the case of H32A where the enzyme has been inactivated) because PI cleavage 
by PI-PLC produces DAG leading to vesicle fusion (108). Thus, the anionic 
phospholipids PMe, PG, PA or PS were used as substrate analogues.  PG is a PI-PLC 
substrate and can be cleaved over a period of days by mg/ml concentrations of PI-PLC 
(68, 103). However, at the low protein concentrations used in the FCS experiments, no 
detectable hydrolysis of PG occurred. 
The crosscorrelation, Gj,k(τ)  is calculated from the time dependent  fluorescence 
intensities. I(t), is, according to (109, 110): 
              [12]
where Ij(t) and Ik(t) are the time dependent fluorescence signals detected in channels j and 
k respectively and <> indicates a time average. δIk(t) is the time dependent fluorescence 
fluctuation on channel k and is given by δIk(t) = Ik(t) - <Ik(t)>. For one-photon excitation 
and a small, 30 µm, confocal pinhole, the observation volume can be approximated as a 
3-dimensional Gaussian with radial and axial dimensions of ωo and zo respectively (82, 
G j,k τ( )= δ I j t( )δ Ik t + τ( )I j t( ) Ik t( )
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111). If the solution contains only a single species diffusing in three dimensions, the 
correlation curves can be fit according to (82, 110): 
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where <N> is the time averaged number of molecules in the effective volume. Here D is 
the diffusion coefficient in µm2/sec, and ωo is the radial extent of the observation volume. 
S is the ratio of the axial to the radial dimension (S = zo/ωo). The diffusion time, , is 
given by τD = ωο2/4D. The observation volume defined by S and ωo was characterized at 
the beginning and end of each day of experiments using the calibration dye rhodamine 
110 or rhodamine 6G with a reported diffusion coefficient of 280 µm2/sec for rhodamine 
at 22°C (82).  For 488 nm excitation, values of S were between 6.8 and 8 and values of 
ωo ranged from 0.194 to 0.241 µm. The values of S and ωo determined from global fits of 
the dye data were used to fit the protein and/or SUV data.  
To measure the average diffusion coefficient of the SUVs, FCS experiments were 
performed on SUVs containing a small amount of rhodamine-labeled PE (Figure 2-8A). 
Diffusion coefficients of free, AF488 labeled PI-PLC (DPI-PLC) and labeled SUVs (DSUV) 
were 58±5 µm2s–1 (corresponding to a diffusion time, τD=173 μs) and 10.4±1.0 µm2s–1 
(τD=1.48 ms), respectively. The corresponding hydrodynamic radius of the SUVs is 24±2 
nm as estimated by the Stokes-Einstein equation. The 24 nm average SUV radius derived 
from FCS is significantly larger than the 14.9 nm radius determined from the DLS mass 
weighted average; however, it is similar to the 27.0±7.7 nm radius determined from the 
intensity-averaged DLS data. This disagreement between the DLS intensity average and  
Dτ
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Figure 2-8. FCS analysis of *N168C binding to PC/PMe SUVs: (A) Crosscorrelation 
curves for free N168C-AF488-PI-PLC (*N168C) (), Rho-labeled PC SUVs (), and 
Rho-labeled PMe SUVs (▲).  The lines through the data represent the best fit to Eq. [13].  
The crosscorrelation for 3.5 nM *N168C binding to 0.5 mM PC/PMe (XPC = 0.50) SUVs 
(X), corresponding to 48% bound protein. The line through these data is the best fit to Eq. 
[14]. (B) Titration curves for *N168C binding to pure PC SUVs (z) and to 9:1PMe/PC 
SUVs (). The lines through the data represent the best fits to Eq. [15]. At high XPC, the 
binding is not cooperative, although at low XPC, the binding curves are clearly sigmoidal.  
 
61 
 
FCS results likely arise from the enhanced contribution of larger vesicles to the DLS 
intensity average and of brighter, larger SUVs to the fluorescence fluctuations monitored 
by FCS. 
In the presence of labeled PI-PLC and unlabeled lipid vesicles, FCS auto and cross-
correlations, G(τ), were analyzed using 2 component, diffusion only fits (82, 112):   
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[14]
where τfree  and τbound are the diffusion times for free and vesicle-bound PI-PLC 
respectively. For fits to eq. [14], τbound was either fixed to the diffusion time for free 
vesicles or globally floated. The maximum value of f, the fraction of protein bound to the 
vesicles, was typically 50-60%. It should be noted that, for all of the variants, apparent Kd 
values were relatively insensitive to the fitting procedure, and Kds obtained with fixed or 
floated τbound were within 10% of each other. Comparisons between independent datasets 
collected using different protein and phospholipid preparations for *Y88A, *H32A and 
*N168C, reveal that variations in the fraction bound between preparations, obtained from 
fits to equation [14], are approximately ±30%.  
A single PI-PLC binding site may be formed by multiple lipids, and the apparent 
dissociation constant Kd, representing the partitioning of the enzyme to the vesicle 
surface, as well as a cooperativity coefficient, n, were determined using the empirical 
equation: 
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f  = fmax[PL]n / (Kdn+ [PL]n)   [15]
where the fraction of PI-PLC bound, f, was determined from the FCS experiments for 
different total lipid concentrations, [PL], and fixed XPC (Eq. [14]). n equals 1 in the 
absence of apparent cooperativity (i.e., n=1 if, even at the lowest lipid concentrations, 
there are enough lipids to serve as a binding site for the protein)  and fmax is the maximum 
fraction bound. An example of AF-488 labeled N168C-PI-PLC (*N168C) binding to 
PC/PMe SUVs is shown in Figure 2-8B. 
2.11 Single Molecule Total Internal Reflection Fluorescence Microscopy (TIR-
FM) study of Alexa488 labeled PI-PLC binding to surface tethered SUVs 
2.11.1 Surface and sample cell preparation 
To minimize non-specific adsorption of proteins and lipids, we prepared flow 
chambers with glass slides and coverslips using the following procedure. First, the glass 
slides and coverslips were cleaned by sonication in a water bath with the following 
sequence: 1 hour in detergent, 1 hour in ethanol, 45 minute in KOH and then 1 hour in 
water. The cleaned slides can be stored in ethanol or water for up to one week. The slides 
were then derivatized with an aminosilane reagent (Vectabond, Vector Laboratories; 
Burlingame, CA) according to the manufacturer’s instructions except that the acetone 
presoak was eliminated to reduce background surface fluorescence (113). Before 
aminosilane reagent treatment, the previously cleaned slides were sonicated in KOH for 
15 min followed by a 5 min sonication in water. The dried slides were soaked in a 1% 
Vectabond-acetone solution for 5 min. After this treatment, we formed a sample cell by 
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drawing lines of silicone vacuum grease sandwiched between two coverslips (the typical 
volume of the flow cell lane is 20 µl). The coverslip surfaces were then derivatized with a 
mixture of succinimidyl (NHS) polyethylene glycol (PEG), and NHS-PEG-biotin 
(Nektar; Huntsville, AL). Into a flow cell lane, we introduced freshly prepared 20% 
(w/w) NHS-PEG, 0.20% (w/w) NHS-PEG-biotin, 0.1 M NaHCO3, pH 8.3. The cell was 
incubated >3 h at room temperature and can be stored in refigerator for up to one week. 
The PEG surface should prevent non-specific vesicle binding or PI-PLC binding.  
2.11.2 Surface tethering small unilamellar vesicles (SUVs) 
Small unilamellar vesicles (SUVs) in PBS, pH 7.3, were prepared by sonication 
(Branson Sonifier Cell Disrupter). Briefly, lipid stock solutions (1-palmitoyl-2-oleoyl-
phosphatidylcholine (POPC), dioleoylphosphatidylglycerol (DOPG), or 
phosphatidylinositol (PI)) in chloroform were mixed with 1% lipophilic fluorophore DiD 
(1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine perchlorate from Invitrogen 
D307, stock solution prepared in ethanol) and 1% biotinylated dipalmitoyl 
phosphatidylethanolamine (Biotin-PE) in a glass vial. The chloroform was removed 
under a stream of nitrogen gas and the resultant film lyophilized overnight. The lipid film 
was rehydrated with PBS buffer (with a total lipid concentration 1 mM) and SUVs were 
then prepared by sonication.  The SUVs were tethered to the PEG surface using biotin-
avidin chemistry (114). The flow cell was washed with 3 x 100 μl 1xPBS buffer, pH7.3, 
and all subsequent additions and washes used this buffer containing 0.1 mg/ml bovine 
serum albumin (BSA, from Sigma). After the wash, 0.01 mg/ml steptavidin (from 
Invitrogen) was introduced into the cell and incubated for 3 min followed by washing 
64 
 
with 2 x 100 μl buffer. Then SUVs at a total lipid concentration of 10 µM were added 
into the flow cell and incubated for about 5 min and washed away. To observe the 
distribution of the surface tethered vesicles, buffer containing the glucose oxidase O2 
scavenging system (4.5 mg/ml glucose/0.2 mg/ml glucose oxidase/0.035 mg/ml catalase) 
(115) was introduced into the cell. To observe PI-PLC interaction with the surface 
tethered vesicles, a solution of 0.2 nM Alexa488 labeled PI-PLC (AF488-PI-PLC) 
containing the glucose oxidase O2 scavenging system (115) was introduced into the cell. 
At this very low protein concentration, only a single AF488-PI-PLC will bind to one 
vesicle. A schematic of the methodology is shown in Figure 2-9. 
2.11.3 Multiwavelength TIRF microscopy 
Binding of AF488-PI-PLC to surface tethered SUVs was recorded using a 
multiwavelength single-molecule TIR fluorescence microscope that has been previously 
described (113). A TIR-FM uses an evanescent wave to selectively illuminate and excite 
fluorophores in a restricted region of specimen immediately adjacent to the glass-water 
interface. The evanescent wave is generated only when the incident light is totally 
reflected at the glass-water interface. The evanescent electromagnetic field decays 
exponentially from the interface, and thus penetrates to a depth of only approximately 
100 nm into the sample medium. In this case, people can minimize the background 
fluorescence by minimizing the excitation volume. In the setup we used, simultaneious 
excitation with multiple laser wavelengths was enabled by directing the input and exit 
laser beams using small broadband mirrors through-the-objective fluorescence 
microscopes. The focus was stabilized by periodically sensing the objective-slide  
65 
 
Figure 2-9. Scheme of the experimental setup for single molecule studies. The glass 
surface is coated with PEG to prevent nonspecific interaction of the vesicles or protein 
with the surface. Small unilamellar vesicles (SUVs) were attached to the glass surface 
using biotin-avidin chemistry. DiD incorporation into the vesicles enables colocalization 
of the Alexa488-PI-PLC with the vesicle.  
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distance using a 785-nm infrared laser beam (Power Technology). Any focus drift that 
altered the exit angle of the 785-nm beam was automatically corrected through the 
piezoelectrically actuated stage that positions the sample slide (113, 116).  
Microscope operation and image acquisition were controlled by custom software, 
GLIMPSE (http://www.brandeis.edu/projects/gelleslab/glimpse/glimpse.html), that was 
integrated with LabView (National Instruments; Austin, TX). This software also operated 
the laser shutters (Uniblitz, Vincent Associates; Rochester, NY) and the electron 
multiplying charge coupled device (EMCCD) camera (iXon 87, Andor Technology; 
South Windsor, CT ). Uncompressed digital images were streamed continuously to disk; 
each frame was identified with respect to both the excitation wavelength and acquisition 
time to facilitate subsequent reconstruction and analysis of the image sequence. Offline 
image analysis was performed with custom software implemented with MATLAB 2007b 
(The MathWorks; Natick, MA) written by Dr. Larry Friedman. 
2.11.4 Data acquisition and analysis 
The 488 nm laser was used for AF488-PI-PLC excitation and the 633 nm laser was 
used for DiD excitation. In order to observe the short dwell time of AF488-PI-PLC 
binding to SUVs, we set the laser exposure time to 50 ms/frame and the power for the 
488 nm laser at 3.1 mW. The emission optics produced a spectrally discriminated dual 
view of a sample region: fluorescence emissions at wavelengths < 635 nm were imaged 
on one region of the CCD camera, while those with wavelengths > 635 nm were imaged 
on a second region of the camera. Since the emission spectra of the Alexa488 dye and the 
DiD are well separated by 635 nm, as shown in Figure 2-10A, we were able to observe 
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Figure 2-10. The dual view optics enable colocalization of the DiD incorporated vesicles 
with the vesicle bound AF488-PI-PLC. (A) Excitation (dashed line) and emission spectra 
of Alexa488 (green) and DiD (red). The emissions of the two are well separated. (B and 
C) Fluorescence images (17x18 µm) of the same field of view excited with two lasers 
(488 nm and 633 nm) simultaneously. Emitted fluorescence (Em) images were collected 
from either the long- (>635 nm; B) or short- (<635 nm; C) wavelength area of the dual-
view optics image. The squares indicatd the locations of labeled vesicles and the arrow in 
C indicates an AF488-PI-PLC binding at a vesicle location. 
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the location of the vesicles from the long wavelength image while looking at the protein 
binding to the vesicles from the short wavelength image as shown in Figure 2-10B and C. 
Image alignment between the two fields of the dual view apparatus was performed using 
a function that accommodates small fixed differences in the relative magnifications and 
rotational orientations of the two fields. In order to compare the position information of 
the two fields, we need a dye that is visible in both fields, and in this case, Cy3-labeled 
oligonucleotide (generously provided by Dr. Larry Friedman at Brandeis University) was 
used. The Cy3-oligo was attached to the glass surface using similar biotin/avidin 
chemistry to what we used to attach the vesicles. The 532 nm laser was used to excite 
Cy3 and the emission was recorded in both the long and short wavelength fields as shown 
in Figure 2-11. A mapping file containing information on the relative position of the two 
fields could then be generated. This mapping file was used to localize the vesicle position 
from the long wavelength field (the blue squares in Figure 2-11B) to the short wavelength 
field (the blue squares in Figure 2-11C). 
At each identified SUV location, we recorded the fluorescence of the short wavelength 
field, which monitors emission from the *N168C. A typical trajectory of *N168C binding 
to SUVs is shown in Figure 2-12. When *N168C binds to the surface tethered vesicle, 
there will be a fluorescence peak. It was demonstrated that these peaks were specifically 
introduced by the enzyme binding to the vesicles by checking the background signals at 
the position where there are no vesicles; or using competing experiments by adding a 
large amount of unlabeled PI-PLC. We also checked that the Alexa488 dye itself does not 
bind to the vesicles.  
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Figure 2-11. Using Cy3-oligonuleotide to align the two fields of the dual view apparatus. 
(A) Excitation (dashed line) and emission spectra of Cy3 dye. The dye is excited using 
532 nm laser and the emission can be recorded for both the long (>635 nm; B) and short 
(<635 nm; C) wavelength fields. The position information (blue squares) in B and C 
could be used for the alignment.  The boxes indicate the oligonucleotide locations. 
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Figure 2-12. Time records of fluorescence from 0.2 nM AF488-PI-PLC binding to a 
surface tethered SUV (composed of PC/PG (7:3)). Emission at wavelengths <635 nm was 
recorded with 50 ms/frame time resolution using 3.1 mW 488 nm excitation. Each peak 
indicates AF488-PI-PLC binding to and then leaving the SUV. (B) is the blow up of the 
peak indicated by the arrow in (A), each black dot indicates one frame length (50 ms); 
The peak shown in (B) corresponds to an interaction lasting 10 frames (500 ms).  
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The trajectories contain detailed dynamic information, which is extractable from 
statistical analyses. For a simple binding system:  
 
where in our case ‘E’ is the enzyme PI-PLC and ‘L’ is the ligand vesicle, the most 
straightforward analysis of the trajectories is the distribution of the ‘on’ times. The 
distribution of the on-times should be an exponential function, with a time constant 1/koff 
due to Poissonian statistics (117, 118) as shown in Equation [16]:  
pon(t) = koff  exp(- koff t) [16]
where pon(t) is the probability density and koff  is the off or dissociation rate constant.  
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Chapter 3 Disulfide linked homodimers of PI-PLC 
3.1 Introduction 
For B. thuringiensis PI-PLC, phosphatidylcholine has been shown to activate the 
enzyme at the interface (103). PI cleavage, either in detergent mixed micelles or 
unilamellar vesicles, is enhanced with PC added to the interface (76). Part of the 
activation in the vesicle system involves binding of the enzyme to the substrate-
containing bilayer with the tightest requiring the presence of both PC and anionic 
phospholipid. However, other evidence led to the proposal that part of this activation 
involved dimer formation of the protein when bound to interfaces (72). This suggestion 
was based on the crystal structure of an interfacially impaired mutant where two Trp 
residues that appear critical for membrane binding (Trp47 and Trp242) were changed to 
Ala (70), and the modified protein crystallized as a dimer (72). This bacterial PI-PLC is 
an αβ-barrel with a fairly open active site and hydrophobic residues at the rim of the 
barrel that aid in anchoring into the interface (52). However, release of the water-soluble 
product cIP would appear to require the enzyme to desorb from the interface. The 
advantage of a surface-induced dimer is that it could aid in processive catalysis (119) – 
possibly by allowing one subunit to release the water-soluble product cIP with the other 
still anchoring the dimer to the interface. If a dimer forms on membranes, it would appear 
to be transient since this PI-PLC is monomeric in solution (120). Thus far, most of the 
evidence in support of transient dimer formation is indirect and relies primarily on 
mutagenesis of residues in the W47A/W242A dimer interface which generally leads to 
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reduced interfacial catalysis (55), although these changes could be caused by disruption 
of a specific PC binding site on the protein as well.  
Therefore, we constructed a series of single cysteine mutants to see if they could form 
covalent dimers, and if the dimers showed changes in catalytic activities or surface 
binding affinities. 
3.2 Construction of PI-PLC covalent dimers 
W242C, N243C, W47C, S250C, D205C as well as W280C were constructed (Figure 
3-1) since in each case these residues are at or close to the dimer interface observed in the 
W47A/W242A dimer (72). Asn168 is at the opposite side of the αβ-barrel protein – not 
close to the dimer interface nor likely to interfere with any interactions at that position. 
Thus, both monomers and dimers of N168C should exhibit the kinetic characteristics of 
wild type protein.  
All of these mutants formed disulfide-linked dimers, as monitored by SDS-PAGE, 
after incubation at high concentrations (~10 mg/ml) in the absence of any reducing agent 
(as an example see Figure 3-2). Monomers of each species could be regenerated by 
incubation with 5 mM DTT.  
3.3 Catalytic activities of PI-PLC monomers and covalent dimers  
The specific activities of each monomer (with DTT present) and dimer PI-PLC were 
measured for PI cleavage with the substrate dispersed in diC7PC (and sometimes TX-
100) micelles or for cIP hydrolysis in the absence or presence of diC7PC (Table 3-1). For  
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Figure 3-1. PI-PLC crystal structure showing where single Cys mutations were 
introduced: (A) the positions are mapped onto the monomer crystal structure (PDB: 1ptd); 
(B) with the exception of N168C these residues are at or close to the dimer interface 
observed in the W47A/W242A dimer (PDB: 2or2). N168C is at the opposite side of the 
αβ-barrel protein, and serves as a control position.   
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Figure 3-2. Non-reducing SDS-PAGE analysis of PI-PLC mutant S250C showing the 
proportions of monomers and dimers. Lane 1, Protein standard; Lane 2, S250C with 
5mM DTT; Lane 3, 10mg/ml S250C incubated for 5 days in the absence of any reducing 
agents. 
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Table 3-1. Specific activities and apparent binding constant for monomer and dimer 
forms of B. thuringiensis PI-PLC single cysteine mutants. a 
 
PLC Formb Specific Activity  (μmol min-1 mg-1) app Kd 
  PI/diC7PC c PI/TX-100 c cIP  cIP/diC7PC d (mM) 
N168C M      1630     
 D      1500     
W47C M        811    0.30±0.030 
 D          16    > 10 
D205C M      1230  1.2 42.6  
 D        750  1.4 39.6  
W242C M        815        215 3.4 35.6 0.031±0.010 
 D      1530        225 3.4 45.7 0.003±0.004 
N243C M        620        389  27.7 0.006±0.001 
 D        258        172  15.6 0.014±0.0034
S250C M      1480      1230 1.7 27.5 0.042±0.024 
 D      2150        250 1.8 29.7 0.010±0.006 
W280C M      1780        680  35.6 0.010±0.002 
 D      1390        390  40.3 0.038±0.008 
a Errors for the specific activities are within 15%. Errors for the apparent Kd are standard 
deviations determined from the titration curve fittings. 
b M is the PLC monomer with 5 mM DTT in the assay or binding buffer; D is the 
disulfide-linked dimer. All assays were carried out at 28oC except for N243C, which 
was assayed at 24oC. 
c PI (8 mM) dispersed in 32 mM diC7PC or 16 mM TX-100 in 25 mM HEPES, 1 mM 
EDTA, pH 7.5. 
d Assays used 20 mM cIP in the absence or presence of 8 mM diC7PC in the HEPES 
buffer.  
e The apparent dissociation constant for pure POPC SUVs was measured in 10 mM Tris 
HCl, pH 7.5. 
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cleavage of PI in diC7PC micelles, N168C exhibited no difference between monomers 
and covalent dimer forms as we expected making it a good control. W280C showed a 
small decrease for the covalent dimer. However, many of the other covalent dimers, 
particularly W47C, were much poorer in the phosphotransferase reaction than their 
monomeric form. These dimers must have an altered conformation that prevents the 
enzyme from adopting the activated conformation. In contrast, W242C and S250C 
covalent dimers exhibited significantly higher specific activity (88 and 45% increase, 
respectively) than their monomeric counterparts in this phosphotransferase assay system. 
Interestingly, presentation of the substrate PI in a neutral TX-100 assay system rather 
than in diC7PC led to a much lower activity for W242C and no activation for the covalent 
dimer; for S250C, dimer formation significantly inhibited PI cleavage in the TX-100 
mixed micelles. Thus, enhanced activity of a covalent dimer toward PI is only associated 
with the presence of PC. 
The second step of the PI-PLC reaction, hydrolysis of cIP to I-1-P, was examined for 
several of these mutant proteins. These enzymes were all activated by diC7PC, but most 
showed little difference in monomer versus covalent dimer. A slight increase (28%) was 
observed for W242C, while the N243C dimer had significantly lower activity (44% 
decrease) towards cIP in the presence of diC7PC. Thus, the large enhancement in 
PI/diC7PC cleavage by W242C and S250C covalent dimers is only observed with the PI 
substrate. 
3.4 Vesicle binding of disulfide-linked PI-PLC dimers  
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The activity differences between the monomer and dimer forms of PLC single 
cysteine mutants could be related to differences in the affinity of the proteins for 
activating PC interfaces. To probe this, the partitioning of the different proteins onto 
POPC SUVs was examined using a simple SUV filtration/centrifugation assay (102). The 
binding curve of the W280C pair is shown in Figure 3-3A. For each monomer/dimer pair 
examined, the higher specific activity correlated with a smaller apparent Kd (Table 3-1). 
In particular, disulfide-linked dimers of W242C and S250C had lower apparent Kd values 
than their corresponding monomers (Figure 3-3B). This strongly suggests that dimer 
formation on interfaces will keep the protein on the surface for a longer time allowing it 
to carry out processive catalysis. Since processive catalysis cannot occur with cIP 
hydrolysis, one would not expect much of a rate difference for monomers versus covalent 
dimers.  
3.5 Discussion 
For two of the PI-PLC disulfide-linked dimers (W242C and S250C), chosen to 
position the Cys near the putative dimer interface (72), the PI cleavage rate increases 
significantly concomitant with a large decrease in the apparent Kd of the protein for pure 
PC SUVs. These results are consistent with interface-induced dimerization of this PI-
PLC, and likely tighter binding of the transient dimer that enhances processive catalysis.  
N243C is right next to W242C, and also close to the dimer interface of the surface 
impaired W47A/W242A dimer crystal structure (72). The two Asn243 residues are also 
fairly close to one another in the W47A/W242A dimer. N243C preserves Trp242, the  
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Figure 3-3. Apparent binding of B. thuringiensis PI-PLC single cysteine mutant 
monomers and dimers to POPC SUVs: (A) Binding curves for W280C monomer () and 
dimer (z) forms; (B) comparing the apparent dissociation constant for monomers 
(hatched bars) and dimers (white bars). Error bars in panel B represent standard 
deviations from the titration curve fitting.  
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residue that plays important roles in PC binding, in the loop and was thought to be a good 
way of stabilizing the homodimer of PI-PLC. We expected that the N243C covalent 
dimer would have higher activity than the corresponding monomer. However, our results 
shows the reverse. A likely explanation is that when protein binds to the membrane, there 
is a conformational change that alters the orientation of this side chain and that it cannot 
occur when a N243C-dimer is formed. This strongly implies that a surface activated 
transient dimer conformation, should it occur with wildtype protein, must be different 
from the crystal structure of W47A/W242A. Changes of the loop and the location of 
N243C are strongly suggested by the different effects of SL-S250C and SL-N243C on 
lipid spin-lattice relaxation rates that are discussed in Chapter 5.  
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Chapter 4 B. thuringiensis PI-PLC binding to unilamellar vesicles 
4.1 Importance of and methods to quantify protein binding to vesicles 
Bacterial phosphatidylinositol-specific phospholipase C (PI-PLC) enzymes aid in 
infectivity of the organism (121), while the structurally homologous mammalian PLCδ1 
and related enzymes are required for phosphoinositide metabolism and are important for 
intracellular signaling (43, 122). These peripheral membrane proteins often have distinct 
binding modes for substrates and for other lipids that either anchor the protein to the 
surface or adjust its conformation to enhance catalysis (123). However, using traditional 
methods it has been difficult to determine how lipid composition affects phospholipase 
binding.  
Traditional methods for monitoring peripheral proteins binding to membranes include 
assays that involve physical separation of membrane bound proteins and free proteins 
such as centrifugation and gel filtration assay, or direct assays that allow monitoring 
continuous membrane-protein binding, such as fluorescence and NMR methods (74). 
Other methods are also used to measure membrane affinity of peripheral proteins such as 
surface plasmon resonance (SPR) (85, 86), calorimetric assays (124), and fluorescence 
anisotropy measurements (125, 126). Many of these methods require protein 
concentrations well above the amounts used in enzyme kinetics. Therefore, even when 
binding to multicomponent vesicles can be measured, it has been difficult to separate how 
substrates (or substrate analogues) and activators interact with enzymes such as PI-PLC 
that catalyze interfacial reactions. 
82 
 
Protein binding to lipid vesicles or cells greatly retards protein translational diffusion. 
For fluorescently labeled proteins, this change can easily be monitored using fluorescence 
correlation spectroscopy (FCS) (82-84). FCS uses low protein concentrations (<1-50 
nM), comparable to what is used in kinetic assays, and experiments can be performed in 
minutes. Thus, FCS allows us to quickly screen different phospholipid compositions and 
to identify conditions that can be studied in detail by other techniques aimed at probing 
how protein binding alters the lipid environment.  
4.2 PI-PLC binding to vesicles measured by FCS 
4.2.1 PI-PLC activity toward PI in PI/PC SUVs 
The specific activities (μmol min-1 mg-1) of PI-PLC towards PI-containing SUVs with 
a fixed enzyme and total lipid concentration (10 mM) and increasing mole fractions of 
the activator PC, XPC, were determined. To emphasize the initial activation and eventual 
inhibition, the PI-PLC relative activity (specific activity normalized to the value for pure 
PI SUVs) is presented in Figure 4-1. Although there is considerable error when averaging 
different series of experiments with SUVs, the trends are always the same. With this high 
concentration of PI, as little as 0.10 XPC increases the enzyme activity toward PI 2 to 3-
fold, and the activity is more or less constant from 0.10 to 0.50 XPC. The magnitude of 
this activation depends on the concentration of PI and on the PC species; for example a 7-
f o l d  a c t i v a t i o n  w a s  r e p o r t e d  p r e v i o u s l y  u s i n g  0 . 2  m o l e  f r a c t i o n 
dimyristoylphosphatidycholine and a lower concentration of PI (76). Apparent Km values 
for pure PI SUVs (derived from treating the system as if it followed Michaelis-Menten 
kinetics) have been estimated as 3-5 mM (76), which might suggest that much of the PC 
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Figure 4-1. Relative activity of B. thuringinesis PI-PLC toward SUVs containing 10 mM 
total phospholipid as a function of the mole fraction of PC, XPC. The arrow indicates the 
XPC at which there is half-maximal enzyme activity as the amount of substrate is 
decreased. Error bars represent the standard deviations from triplicate assays. 
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kinetic effect is from enhanced binding of the protein to substrate-containing SUVs (76, 
120).  
Further increases in XPC lead to a drop in PI-PLC specific activity toward PI. In this 
case the total phospholipid concentration is kept constant while the total and surface 
concentration of PI are decreased. Operationally, one can extract an interfacial ‘Xm’ that 
represents the mole fraction of substrate in the interface needed for 50% of the maximum 
activity (analogous to a 2-dimensional Km for substrate). For B. thuringiensis PI-PLC 
such a Xm is ~0.3 mole fraction PI (XPI = 1 – XPC). A wide variety of factors, including 
overall decreased vesicle binding, binding of non-substrate lipid in the active site, and/or 
altered lipid dynamics that make the substrate less accessible to bound protein, could 
decrease the specific activity as XPC is raised while the total lipid concentration is fixed. 
To understand such kinetic effects, we need a separate analysis of bulk PI-PLC 
partitioning to vesicles with different compositions as well as insight into how the 
dynamics of each of the two lipids are affected when PI-PLC binds to the different 
interface compositions. 
4.2.2 *N168C binding to binary component SUVs 
Changes in bulk binding of PI-PLC to SUVs can be assessed by FCS as long as a 
fluorescent probe attached to the protein does not alter the binding or enzyme activity. B. 
thuringiensis PI-PLC was labeled with AF488 maleimide at a single Cys residue 
introduced at Asn168 (*N168C). Asn168 is on an exterior helix of B. thuringiensis PI-
PLC, far from both the proposed protein dimerization interface (55, 72) and the lipid 
interface. *N168C had a PI cleavage rate of 1600±160 μmol min-1 mg-1 at 28oC toward 8 
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mM PI dispersed in 32 mM diC7PC micelles, the same value as for wild-type PI-PLC 
assayed under the same conditions. 
4.2.2.1 Preference of PI-PLC for smaller vesicles 
Large unilamellar vesicles (typically > 1000 Å diameter) have generally been used for 
FCS studies of peptide or protein association with vesicles due to their higher 
thermodynamic stability and relatively uniform size (83, 84), although SUVs have 
occasionally been used (84, 112). The B. thuringiensis PI-PLC preferentially binds to 
small vesicles of PC (102) necessitating the use of SUVs for these binding experiments. 
SUVs composed of different ratios of PC to dioleoylphosphatidylmethanol (PMe), or 
other anionic phospholipids, prepared by sonication, exhibited a narrow distribution of 
vesicle sizes as measured by DLS (Figure 2-1 shows the size distribution for PMe/PC 
SUVs). The average mass-weighted radius of the SUVs was 14.9±2.7 nm, with 85 or 
more weight-percent of the lipids in vesicles with radii between 10 and 20 nm for all 
compositions. 
The reported preference of B. thuringiensis PI-PLC for smaller, more curved vesicles 
(102) was confirmed by examining how the enzyme partitioned to PC LUVs (Figure 4-2). 
The Kd of PI-PLC binding to these LUVs was 60-fold higher than that for PC SUVs. The 
average radius for the population of LUVs to which the enzyme bound was determined 
using the Stokes-Einstein equation and Dbound, which was obtained from global fits to 
equation [13]. The calculated rFCS was 25±3 nm (corresponding to 8±1 µm2s–1 extracted in 
this experiment), considerably smaller than the size of rho-PE labeled LUVs measured by   
FCS (rLUV = 40±9 nm, corresponding to D = 5±1 µm2s–1), or the mass-weighted  
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Figure 4-2. Fraction of labeled PI-PLC bound to PC LUVs, determined by FCS as a 
function of PC concentration. The line is the best fit to Eq. [15]  (n=1). Error bars 
represent the standard deviations from three time points for the same titration.  
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average size of LUVs measured by light scattering (rDLS = 53±7 nm), indicating that PI-
PLC binds primarily to the smaller vesicles in the LUV population. 
4.2.2.2 SUV size distribution and FCS fits 
The fraction of PI-PLC bound to the vesicles, f, obtained from fits to the FCS data 
tends to an asymptote at less than 100% binding.  Fits to the FCS data using equation [14] 
assume that only 2 species are present, free PI-PLC and SUV bound PI-PLC with 2 
corresponding diffusion coefficients Dfree and Dbound.  However, as observed in dynamic 
light scattering experiments, the SUVs have a variety of radii resulting in diffusion 
coefficients ranging from ~7 to ~35 µm2/s, corresponding to diffusion times of ~2 to ~0.5 
ms. The SUV distributions are dominated by smaller vesicles, and SUVs with diffusion 
coefficients greater than 15 µm2/s (diffusion times less than 1 ms) constitute 
approximately 70% of the population (Figure 2-1).   
How do these distributions affect the correlation curves for proteins binding to SUVs?  
Taking the SUV distributions into account, the correlation, G(τ), is expressed as: 
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[17] 
where <N> is the time averaged number of PI-PLC molecules in the effective volume, 
τfree  and τbound are the diffusion times for free and vesicle-bound PI-PLC respectively, and 
S is the ratio of the axial (z), zo, to the radial (x-y) dimension, ωo,  for the effective 
volume. The diffusion time for each species is given by τspecies=ωo2/4Dspecies where ωo is 
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the radius of the observation volume in the x-y plane. The probability that the protein 
binds to a particular size vesicle and that this vesicle is detected in an FCS experiment is 
given by P(τbound,j).  This probability is a convolution of at least three probabilities: (i) the 
relative population of SUVs with a particular size, (ii) the probability that the protein will 
bind to a particular size vesicle, and (iii) the probability of detecting different sized 
vesicles with different fluorescence intensities (brightnesses). Because these probabilities 
are not easily measured, they could be determined from fits to the correlation curves.  
Fitting the probabilities would, however, lead to grossly underconstrained fits; therefore, 
we and others (112, 127) have instead fit SUV binding data to a 2 species model with a 
single value for τbound (Equation [14]). 
How does this 2 species approximation affect the values of Kd and the maximum 
fraction bound, fmax? Dr. Gershenson, our collaborator, used the DSUV distribution from 
either the pure PG or pure PC light scattering data (Figure 2-1) to calculate G(τ) 
(Equation [17]) for f values ranging from 0 to 1. The simulated G(τ) was then analyzed 
using a two species fit in analogy to the experimental analysis with either fixed values of 
Dbound or globally floated Dbound. What Dr. Gershenson found is that fmax is quite sensitive 
to the fitting method and generally asymptotes at values that are less than 100% due to 
the two species approximation. In contrast to what was observed with fmax, values 
obtained for Kd for both model and experimental data are quite robust and almost 
independent of the fitting procedure used. These modeling results ensure that the 2 
species fits, which while still an approximation are easy to implement, provide reliable 
values for the apparent Kd. 
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4.2.2.3 Synergistic PI-PLC binding to mixed component SUVs  
We find that the composition of the vesicles (i.e., XPC) as well as the identity of the 
anionic phospholipid affect PI-PLC binding to SUVs. The binding of the enzyme to 
SUVs as a function of XPC was examined quantitatively using DOPMe, DOPG, DOPA or 
DOPS as the anionic phospholipid.  PG, PMe, and PA inhibit the enzyme competitively 
and serve as substrate analogues (96). While PA can potentially have a charge of -2, its 
pKa2 is sufficiently high (8.3 for pure PMe SUVs and 7.8 in vesicles with PC:PA = 4:1 
(128)) that it is primarily a monoanion as are the other anionic phospholipids examined. 
The titration curves of PI-PLC binding to PC/PX (where PX is an anionic phospholipid) 
mixed vesicles as a function of XPC are shown in Figure 4-3. In these mixed vesicles, PS 
was the poorest PI-PLC binder consistent with kinetic studies where it is the weakest of 
the anionic phospholipid inhibitors (96, 104), and the protein has the highest affinity for 
mixed PC/PG SUVs (Figure 4-4A). With the exception of PS, binding curves are 
sigmoidal for low XPC vesicles with the cooperativity coefficient, n, greater than 1 
(Figure 4-4B). While the average XPC is known, individual SUVs can have XPC values 
that are higher or lower than the average, and at low XPC, PI-PLC may bind more tightly 
to the small subpopulation of vesicles with higher PC content (the number of vesicles in 
this subpopulation would of course increase as the total concentration of vesicles 
increased). Alternatively, several PC lipids may be needed to form the initial PI-PLC 
binding site, and the probability that PI-PLC will encounter such a transient PC-rich 
region increases in a cooperative fashion as the number of SUVs increases at low XPC. 
Regardless of the detailed explanation for the sigmoidal appearance of the curves, it is 
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Figure 4-3. Titration curves for AF488-PI-PLC (*N168C) binding to PC/PG vesicles at 
varies XPC. (A) XPC=0.35 (■), XPC=0.9 (Δ), XPC=0.95 (▲) and XPC=1 (x); (B) XPC=0 
(○), XPC=0.1 (●), XPC=0.2 (□). The lines through the data represent the best fits to 
equation [15]. At high XPC, the binding is hyperbolic, although at low XPC, the binding 
curves are clearly sigmoidal. Error bars represent the standard deviations from three time 
points for the same titration.  
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obvious from our observations that a small amount of PC helps to anchor the enzyme to 
the mostly anionic phospholipid SUVs. 
For all of the anionic phospholipids mixed with PC, the apparent Kd decreases as XPC 
continues to increase (Figure 4-4A). There is more than a 10-fold drop in Kd for PG and 
PA at XPC= 0.1 while PMe and PS show smaller, but still significant decreases in Kd. The 
value of Kd continues to decrease and reaches a minimum at XPC = 0.9 for all of the two-
component vesicle systems. Kd then increases (typically 5- to 20-fold) for XPC> 0.90. The 
observation of a minimum Kd as a function of XPC demonstrates that both anionic 
phospholipid (substrate analogue) and PC help anchor the protein to these small vesicles. 
In other words, the anionic phospholipid and PC have synergistic effects for PI-PLC 
binding to the binary component vesicles.  
4.2.3 Dependence of Kd on PI-PLC concentration – estimation of protein binding 
footprint 
For a simple monomer binding model, the addition of unlabeled protein to the FCS 
experiments will lead to competition between labeled and unlabeled protein for SUV 
binding sites. If, at all lipid concentrations, there are adequate binding sites for the 
unlabeled protein, the fraction bound of labeled protein will be unaffected. However, if 
the unlabeled protein competes for available binding sites, the apparent Kd determined by 
FCS will increase. When 0.02 or 0.05 μM unlabeled PI-PLC was added to 3.5 nM 
*N168C, the apparent Kd values were essentially the same (Figure 4-5).  Further 
additions of unlabeled PI-PLC leads to small increases in Kd. Kd increased by 
approximately an order of magnitude in the presence of 5.7 μM unlabeled PI-PLC  
92 
 
Figure 4-4. Dependence of the PI-PLC dissociation constant, Kd, for mixed anionic 
phospholipid/PC SUVs on XPC: (A) variation of Kd with XPC; (B) variation of the 
cooperativity coefficient, n, with XPC. The SUVs contained PC along with either PMe 
(___z___), PG (___▲___), PA ( – –  – –) or PS (- -X- -).  
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Figure 4-5. Fluorescently labeled PI-PLC protein (3.5 nM) bound to vesicles as a 
function of total lipid concentration with (1:1) PG/PC SUVs: *N168C with 0.02 µM (), 
0.57 µM (z) or 5.7 µM (X) unlabeled wildtype PI-PLC added. The points shown are 
from two different titrations with different enzyme preparations and different vesicle 
preparations. (B) Variation in apparent Kd for 3.5 nM *N168C binding to PG/PC (1:1) 
SUVs with unlabeled PI-PLC concentration. 
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indicating that there is significant competition for binding sites and most of the sites are 
occupied by unlabeled protein at this concentration. Even at these high PI-PLC 
concentrations, there are unlikely to be interactions between monomers in solution, since 
the protein crystallizes as a monomer at even higher concentrations and the diffusion 
times of free *N168C are essentially the same in the absence and presence of 5.7 μΜ  
unlabeled protein. Under these conditions, the fraction bound reaches a maximum around 
0.3 mM phospholipid (Figure 4-5A).  If we assume that all of the fluorescently labeled 
protein is bound at 0.3 mM phospholipid then we can estimate how many phospholipids 
comprise a PI-PLC binding site on the vesicle. Assuming 2/3 of the lipids are in the outer 
leaflet of the small vesicle, when the binding is saturated the outer leaflet lipid to protein 
ratio is around 35 to 1, suggesting that on 1:1 PG/PC SUVs, a single protein binding site 
requires around 35 phospholipids. This estimate assumes that the maximum of the 
titration curve corresponds to 100% binding; however, while we have shown that 2 
species fits to the correlations tend to underestimate fmax, we do not know that the 
asymptote in the titration curve represents 100% binding.  We can, therefore, estimate an 
upper limit for the PI-PLC footprint by assuming that the fraction bound at 0.3 mM 
phospholipid, i.e. f =50%, is the actual fraction bound rather than an underestimate.  In 
this case, with the same small vesicles, the outer leaflet phospholipid to protein ratio is 70 
to 1. Previous crude estimates of the number of phospholipids required to form the PI-
PLC binding site, based on a Langmuir binding analysis using much higher PI-PLC 
concentrations and anionic vesicles (102), suggested 50-150 lipids per PI-PLC. The 
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determination, by FCS, of 35-70 lipids per PI-PLC provides a better estimate of this 
parameter. 
4.2.4 *N168C tighter binding does not mean better activity 
Clearly, the enzyme specific activity (Figure 4-1) does not track bulk PI-PLC affinity 
for SUVs (Figure 4-4A).  While activity reaches a plateau between 0.1 and 0.5 XPC and 
then significantly decreases, the apparent Kd continues to decrease until XPC= 0.9. In 
kinetic models for surface active enzymes (65, 119), a decrease in activity with 
increasing mole fraction of diluent is often attributed to the reduction of the substrate 
surface concentration below a threshold two-dimensional Km. While one can think about 
bulk and two-dimensional binding constants to describe enzyme binding to phospholipids 
in vesicles, neither way of quantifying binding can explain the kinetic behavior on a 
molecular level. Such a description of surface dilution inhibition is provided by 
monitoring lipid motions upon protein binding using fc-P-NMR discussed in chapter 5.  
4.3 PI-PLC mutants 
4.3.1 Effect of specific mutations on PI-LC binding to SUVs  
The complicated relationships between binding and enzymatic activity as well as the 
synergistic effects of PC and anionic lipids make it difficult to tease out how interactions 
with multiple types of phospholipids differentially affect protein binding, conformational 
changes, and activity. For example, do mutations in the active site also alter binding to 
non-substrate lipids? To address such questions for bacterial PI-PLC, we have determined 
how mutations that should directly alter lipid binding or protein conformational changes 
affect both binding to and enzymatic activity towards multi-component lipid vesicles. 
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The importance of helix B and the Trp residues at the 240s loop for PI-PLC binding and 
activity form the basis of a recent model of PI-PLC membrane binding and activity (73). 
In this model (Figure 4-6B), membrane binding is mediated by a hydrophobic plug 
containing Trp47 in helix B and Trp242 on an adjacent loop as well as electrostatic 
interactions between Lys44 in helix B and anionic phospholipids. An intact helix B 
ensures that these residues are correctly oriented for membrane binding, and subsequent 
disruption of helix B may also allow Pro42 and Gln45 to form part of a PI-PLC 
homodimer interface that also includes a Tyr zipper involving Tyr residues 246-248, and 
251 (55, 73). It has been proposed that such transient dimerization on the membrane 
surface activates PI-PLC towards both membrane bound and soluble substrates (55, 72).  
Previous studies (55, 73) using micelles or pure PC small unilamellar vesicles (SUVs) 
revealed that mutations in the helix B region or at the putative dimer interface both 
weaken binding to pure PC vesicles and impair activity (Table 4-1). However, for 
wildtype PI-PLC, membrane binding and activity are enhanced for vesicle systems 
containing both PC and anionic lipids, with the highest activity occurring between 0.2 
and 0.5 mole fraction PC (XPC) and the tightest binding around XPC= 0.9. This 
phospholipid 'synergy', where highest activity and tightest binding require the presence of 
both anionic phospholipids and zwitterionic PC, suggests that anionic lipid binding site(s) 
and the PC binding site(s) may communicate with each other. To rigorously test the 
model for PI-PLC membrane binding and activation as well as to determine the 
differential effects of substrate and non-substrate lipids, we have used fluorescence  
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Figure 4-6. B. thuringiensis PLC monomer structure (from the Y247S/Y251S crystal 
structure (55)) outlining the active site pocket in orange and the surface residues altered 
in this work (Asn168, red; Pro42, yellow; Lys44, green; Tyr88, brown; Tyr246, Tyr247, 
Tyr248, magenta; Trp47, cyan and Trp242, blue). Each mutant was labeled at N168C 
with AF488 maleimide. The short helix B contains Lys44 and Trp47 and is capped by 
Pro42 at the N-terminal end. (B) Proposed roles of the mutated residues in PI-PLC 
vesicle binding and activation (which may include dimerization). PI-PLC is a monomer 
in solution.  After the initial Lys44 mediated attraction to the anionic membrane, an intact 
helix B orients Trp47 for membrane insertion. Subsequent disruption of helix B allows 
Pro42 to help stabilize the PI-PLC homodimer interface including a Tyr zipper involving 
Tyr residues 246-248. The dimer structure in this model is based on the W47A/W242A B. 
thuringiensis dimer crystal structure (72). The lipid bilayer is shown schematically in 
light blue.  
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Table 4-1. Activities, apparent Kd (determined by non-FCS methods) for pure PC SUVs, 
and kinetic defects of B. thuringiensis PI-PLC variants extracted from published work 
(52, 55, 73, 102). 
PI-PLC Rel. Act. 
(PI/diC7PC) 
PC activation 
of cIP hydrolysis 
Kd (mM), PC 
SUVs (non-FCS) 
comment / kinetic defect 
N168C 1.00 22 0.064±0.010 a,b both enzyme activities enhanced by PC 
binding; synergistic effect of PG/PC on Kd for 
SUVs determined by FCS 
P42G 0.70 5.8 0.77±0.30 a PC activation of cIP hydrolysis impaired, 
while PI cleavage close to wildtype; PC 
binding impaired 
K44A 0.98 33 0.087±0.005 b PI cleavage in PI/diC7PC micelles and PC 
activation of cIP hydrolysis like wildtype; 
binding to PC SUVs like wildtype 
K44E 0.44 4.5 0.5±0.2 b PI cleavage in PI/diC7PC micelles and PC 
activation of cIP hydrolysis are significantly 
impaired; binding to PC vesicles weaker  
Y88A 2.92 28 0.94±0.05 c PI cleavage in PI/diC7PC micelles is 2-fold 
higher than wildtype; PC activation of cIP 
hydrolysis comparable to wildtype; binding to 
PC SUVs weakened  
3YS d 0.36 2.9 0.5±0.2 d PI cleavage in PI/diC7PC micelles about 30% 
of wildtype; PC activation of cIP hydrolysis 
significantly reduced; binding to PC SUVs 
much weaker than wildtype 
 
a Measured by intrinsic fluorescence of PI-PLC when titrated with pure SUVs (11). 
b Measured by filtration assay, which briefly concentrates the sample (24). 
c Unpublished results from S. Guo, Boston College. 
d Data from (13). 
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correlation spectroscopy (FCS) to monitor binding of these PI-PLC variants to 
multicomponent SUVs. 
4.3.1.1 Mutations in helix B 
The rigid residue Pro42 at the N terminus of helix B is likely important for orienting 
the helix for membrane binding. In the mutant dimer structure Pro42 also forms part of 
the dimer interface (72) and it may therefore be involved in the conformational changes 
associated with interfacial activation.  Replacing Pro42 with a flexible Gly only slightly 
reduced phosphotransferase activity but severely impaired the cyclic phosphodiesterase 
step (Table 4-1,(73)).  FCS experiments reveal that the binding of *P42G to pure PG or 
pure PC SUVs is much weaker than *N168C (Figure 4-7). In fact, the interaction with 
pure PG SUVs is so weak that an apparent Kd could not be measured, while the 
interaction with pure PC SUVs increased Kd 40-fold compared to *N168C.  As indicated 
in Table 4-1, this low affinity is consistent with the failure of pure PC SUVs to activate 
P42G towards the soluble substrate 1,2-cyclic inositol phosphate (cIP) (73).  However, 
despite the low affinity for PC, tightest binding is still only observed in the presence of 
both PC and PG with Kd reaching a minimum of ~4 mM at XPC  ~ 0.7. The Kd for pure PC 
SUVs is 5-fold greater than this minimum Kd, well outside the uncertainties in the Kd 
values.  More importantly, the improved binding in the presence of both PC and PG 
suggests that as long as the total phospholipid concentration is above Kd, the 
phosphotransferase reaction is still efficient and specific activity will be close to that of 
the wildtype enzyme. 
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Figure 4-7. Binding of PI-PLC variants to PG/PC SUVs as a function of XPC. The 
apparent Kd values were measured by FCS for variants labeled with AF488 at N168C:  
*N168C (z), *P42G (▲), *K44A (), *K44E (), *Y88A (Δ), and *3YS (). The two 
dotted lines indicate XPC = 0.2 and 10 mM total phospholipids. The error bars are the 
standard deviations of Kd from 2 independent protein and SUV preparations. 
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Lys44 is the only charged group in both helix B and the adjacent 240s loop region. In 
the monomer crystal structures of a B. thuringiensis PI-PLC variant (Y247S/Y251S) 
(kinetically similar to wildtype PI-PLC) (55) and the nearly identical B. cereus PI-PLC 
(52), the Trp47 side chain, which interacts with the membrane (70, 71), points outward 
into solution and Lys44 is nearby but directed away from Trp47. However, high B factors 
for this region in both structures suggest that helix B may be flexible. If Lys44 is 
important for electrostatic interactions with anionic membranes, then mutations that alter 
its charge should reduce PI-PLC affinity for anionic surfaces. Mutation of Lys to Ala 
does not change the enzyme activity towards PI dispersed in diC7PC micelles or, in the 
presence of diC7PC, towards the soluble substrate cIP, and binding to pure PC SUVs is 
similar to that of wildtype PI-PLC (102). However, if the cationic Lys is replaced by 
anionic Glu, the specific activity in the PI/diC7PC system and the PC activation of cIP are 
significantly impaired (Table 4-1, (73)). FCS experiments reveal that affinity of the 
Lys44 variants for anionic SUVs is decreased significantly, as expected if Lys44 
mediates interactions with anionic lipids (Figure 4-7). For the charge reversal mutant, the 
apparent Kd could not even be measured for XPC below ~0.3, and above this XPC it 
decreased continuously with increasing XPC (Figure 4-7).  Neither Lys44 variant shows 
the significant increase in Kd between 0.9 and 1 XPC observed for *N168C, indicating that 
anionic lipids and PC no longer have synergistic effects on Kd when Lys44 is mutated. 
These results confirm the importance of this cationic residue for protein binding to 
surfaces rich in negatively charged phospholipids. Clearly, PC facilitates interaction of 
K44A protein with bilayers resulting in activities comparable to wildtype PI-PLC in PC-
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rich assay systems such as PI/diC7PC and cIP/diC7PC (73). The weaker binding of the 
Glu variant suggests that like-charge repulsion hinders the initial interaction between the 
helix B region and the substrate-containing vesicle (or micelle) as well as the subsequent 
promotion of the protein conformation optimized for both binding and catalysis. This 
leads to the observed lower phosphotransferase (and cyclic phosphodiesterase) activity 
for K44E.  
4.3.1.2 Mutating the putative dimer interface 
Tyr residues 246-248 are key components of the dimer interface formed by the 
interfacially impaired PI-PLC W47A/W242A (72), and mutation of these Tyr residues to 
Ser should disrupt the dimer interface. The Y246S/Y247S/Y248S (3YS) mutant has 
reduced affinity for pure PC bilayers and lower phosphotransferase and 
phosphodiesterase activities (55). However, it is not known whether removing these 
residues alters the initial interactions of the protein with anionic phospholipids. From 
Figure 4-7, we can see that the Y246S/Y247S/Y248S/*N168C (*3YS) variant and 
*N168C have similar affinities for pure PG vesicles; while the apparent Kd of *3YS for 
pure PC vesicles is ~3 orders of magnitude higher than that of *N168C. As shown in 
Table 4-1, previous estimates of 3YS binding to pure PC SUVs yielded much lower 
apparent Kd values (0.6-1.0 mM (55)) than those obtained by FCS (64±20 mM). Those 
earlier experiments used a filtration/centrifugation assay that requires much higher 
protein concentrations.  The filtration step, which separates free and SUV-bound PI-PLC, 
likely concentrates both PI-PLC and the vesicles (102). These increased concentrations 
enhance the affinity of PI-PLC for the membranes. In contrast, FCS requires only 
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nanomolar protein concentrations, similar to the concentrations used in the activity 
assays, avoiding the complications resulting from filtration.  
What about multicomponent vesicles? There is a 3-fold drop in the apparent Kd up to 
XPC = 0.5, suggesting that the presence of both phospholipids still improves binding. 
However, as the bilayer becomes more PC-rich, protein affinity is significantly reduced. 
The apparent Kd of *3YS towards SUVs with XPC = 0.9, is about 1000-fold higher than 
that of the control, *N168C. These results indicate that tight binding to PC rich vesicles 
requires the protein conformation stabilized by these Tyr residues. In *3YS the poor PC 
binding could be consistent with three or more of the Tyr residues inserting into the 
membrane. However, these Tyr residues are located on helix G, and proper orientation of 
the active site opening towards the membrane, allowing substrate diffusion into the active 
site, along with Tyr insertion into the membrane would require significant unwinding of 
helix G. A better possibility is that these Tyr residues form a specific binding site for an 
individual PC molecule – perhaps providing a π-cation interaction for a choline moiety. 
Alternatively, the *3YS results are also consistent with surface-induced dimerization of 
PI-PLC via the Tyr zipper observed in the mutant dimer structure (72). 
4.3.1.3 Y88A, a mutation near lipid binding region 
Tyr88 is at the top of the barrel rim and could directly interact with the bilayer 
(Figure 4-6). The Y88A variant is an extremely active enzyme whose specific activity is 
3-fold higher than recombinant PI-PLC using a PI/diC7PC (1:4) assay system (S. Guo, 
unpublished results). In the presence of diC7PC, it has a cyclic phosphodiesterase activity 
comparable to wildtype. Its apparent Kd for pure PC SUVs as determined by a 
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filtration/centrifugation assay (102) is approximately an order of magnitude higher than 
that of wildtype PI-PLC, consistent with this side chain partitioning into a PC bilayer 
(73). Since two types of phospholipids are involved in anchoring PI-PLC to surfaces, it is 
extremely useful to examine a more complete binding profile for this mutant protein in 
order to understand why the enzyme is more active than wildtype PI-PLC. Therefore, the 
variation of the apparent Kd with XPC for *Y88A was determined by FCS (Figure 4-7). 
The profile is qualitatively similar to that of *N168C with similar affinity for pure PG 
SUVs but with a smaller and more gradual drop in the apparent Kd as XPC increases. 
From 0 to 0.7 XPC, Kd decreased 880-fold for *N168C but only 140-fold for *Y88A. The 
minimum Kd also decreased from XPC = 0.9 for *N168C to XPC = 0.7 for *Y88A.  Such 
behavior is consistent with interactions between this surface aromatic group and PC, but 
not PG, molecules in the bilayer  (potentially via the π-cation as well as partial insertion). 
The shape of the Kd versus XPC curves for *Y88A closely resembles that of the *P42G 
mutant. However, *Y88A has much higher affinity for lipid surfaces with the lowest Kd 
values of all the studied mutants. Thus, as long as the total phospholipid concentration is 
high (typically 4-8 mM in the phosphotransferase micelle system, and 5 mM PC in cIP 
activation kinetics experiments), the specific activities of Y88A and wildtype PI-PLC 
should be similar.  
4.3.1.4 Mutation of the PI-PLC active site PI-PLC and the loss of synergistic 
binding 
While Lys44 is important for initial interactions between anionic lipids and PI-PLC, 
PI and anionic substrate analogue lipids must also bind to the active site.  Mutations in 
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the active site could perturb anionic lipid binding as well as the synergistic effects of 
binding to anionic lipids and PC. Alternatively, mutating residues that are crucial for 
catalysis could degrade activity with only modest effects on binding. 
His32 acts as a general base in PI cleavage, and mutating this residue abolishes catalytic 
activity (129, 130). *H32A has negligible activity, but binds to pure PG and pure PC 
SUVs with essentially the same affinities as *N168C. However, the binding affinity of 
*H32A for multicomponent vesicles is strikingly different than wildtype (Figure 4-8). 
Unlike *N168C binding (Figure 4-7) with its concave dependence on XPC and minimum 
Kd around XPC=0.9, for *H32A the dependence of Kd on XPC gradually decreases as XPC 
increases. The apparent lack of a minimum in the Kd vs. XPC curves (Figure 4-8) 
demonstrates that an active site mutation can destroy the synergistic effects of anionic 
lipid and PC binding. However, unlike mutations to Lys44 which degrade both synergy 
and binding to pure PC vesicles, this active site mutant has Kd values for single 
component SUVs that are comparable to wildtype protein.  
FCS studies on active PI-PLC variants are limited to SUVs containing PC and 
substrate lipid analogues due to the production of DAG which leads to vesicle fusion 
(131).  This is not a problem for the inactive H32A; thus, we used FCS to examine the 
interactions of this inactive variant with SUVs containing the substrate PI dispersed in PC 
(Figure 4-8). Interactions between *H32A and pure PI SUVs are essentially the same as 
those with pure PG SUVs.  However, *H32A binding to 1:1 PI/PC SUVs is noticeably 
weaker than that to 1:1 PG/PC SUVs (Figure 4-8). This difference between PI and PG, a 
substrate analogue, indicates that at intermediate XPC, PI-PLC may bind more tightly to  
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Figure 4-8. Binding of inactive *H32A to SUVs as a function of XPC. The apparent Kd 
values were determined from FCS measurements of *H32A binding to PG/PC (z) or 
PI/PC () SUVs. The error bars are the standard deviations of Kd from two independent 
protein and SUV preparations. 
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substrate analogues than to substrate, but this difference in binding affinity does not alter 
the observed trends. 
4.3.2 Correlation of vesicle binding and observed phosphotransferase activity 
towards PI in SUVs 
For a better understanding of the relationships between vesicle binding affinity and 
activity, we need to measure enzyme kinetics towards PI presented in SUVs. Two types 
of activity experiments were performed. In the first type of kinetic experiment, XPC is 
kept constant and the total phospholipid concentration is varied. In the second type of 
experiment, ‘surface dilution’, XPC is varied by conducting experiments at constant PI 
concentration with increasing amounts of PC, thus increasing XPC.  
4.3.2.1 PI-PLC activity at constant XPC 
In the presence of PC, all of the mutants have higher Kds than does *N168C. This 
reduced affinity for membranes should result in decreased activity at lipid concentrations 
below the mutant Kds. We therefore compared the enzyme activity of wildtype PI-PLC 
and Y88A (Y88A/N168C) at fixed XPC = 0.2 and total phospholipid concentrations of 10, 
4 or 0.5 mM (Figure 4-9A). Only wildtype and Y88A PI-PLC were used for these 
experiments due to the high apparent Kd values of the other variants at low XPC. At XPC = 
0.2, the chosen total lipid concentrations are all well above the 30 μM apparent Kd 
determined for *N168C.  In contrast, 0.5 mM phospholipid is below the 0.6±0.06 mM 
apparent Kd of *Y88A. Above the dissociation constant, the protein should bind well to 
the lipids but the binding should drop dramatically when the total lipid concentration is 
below Kd. Indeed, the specific activity (Figure 4-9A) parallels the binding. The unaltered  
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Figure 4-9. Relative activities of PI-PLC enzymes toward PI/PC SUVs. (A) Activities at 
fixed XPC = 0.2 with different concentrations of total phospholipid for wt () and Y88A 
(///) enzymes.  (B) Relative activities (compared to wildtype activity towards pure PI 
SUVs) of wildtype (z), K44A (), Y88A (Δ), and 3YS () towards 10 mM PI in the 
presence of increasing concentrations of PC. (C) Relative activity of wildtype (z) and 
K44A () at fixed total phospholipid (10 mM) with varying XPC. Assays for K44A were 
carried out in duplicate; error bars, at 15% of the values determined represents the 
maximum error for these assays. 
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PI-PLC has similar specific activities at each of the three concentrations. In contrast, 
the Y88A specific activities at 10 and 4 mM are similar but there is a pronounced drop 
for the 0.5 mM phospholipid sample. This confirms that PG is a good substrate analogue 
in this anionic lipid-rich region, and indicates that vesicle binding controls the enzyme 
activity towards these PI-rich vesicles.  
4.3.2.2 Diluting the substrate and PI-PLC activity 
While both high and low Kd values can be tolerated at high substrate concentrations, 
at low substrate concentrations where the enzyme may need to diffuse around the surface  
in order to find the next substrate molecule, and tight binding may be a disadvantage. To 
investigate this, we performed surface dilution experiments in which the PI concentration 
is fixed at 10 mM and XPC is raised by increasing the PC concentration (Figure 4-9B). 
Wildtype PI-PLC showed a large (~9-fold in this particular experiment – the variation in 
the fold-activation with PC also depends on the average SUV sizes as well as PI 
concentration) increase in activity with a small amount of PC (XPC= 0.2). The activity 
increased a bit further, then decreased steeply by XPC = 0.67. The increase with a small 
amount of PC and the decrease in activity in PC-rich bilayers were similar to what has 
been observed using SUVs with a fixed total phospholipid concentration and varying PC 
(Figure 4-1). At high XPC, this decreased enzyme activity was tentatively explained as 
sequestration of the enzyme in the PC-rich regions.  
As expected from the FCS experiments (Figure 4-7), the activity of Y88A more or 
less parallels that of the wildtype enzyme (Figure 4-9B). However, Y88A PI-PLC is 
substantially more active than wildtype PI-PLC against SUVs with XPC = 0.67. 
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Interestingly, at this XPC, Y88A binds more weakly to SUVs and exhibits higher specific 
activity in the PI/diC7PC (1:4) mixed micelle system than does the wildtype protein. 
These results support the idea that PI-PLC's ability to hop and/or scoot between or around 
vesicles is particularly important at low substrate concentrations. 
In the surface dilution experiment, the specific activity of K44A (K44A/N168C) for 
pure PI SUVs was very low (~26 fold less than wildtype), in agreement with the very 
high apparent Kd for pure PG SUVs.  The dependence of the relative activity on XPC was, 
however, similar to that seen for wildtype PI-PLC (Figure 4-9B). With fixed PI, 
increasing PC caused a substantial increase in activity followed by a decrease at high XPC 
(Figure 4-9). A different comparison of the two enzymes is provided by keeping the total 
phospholipid concentration fixed and altering XPC (Figure 4-9C). K44A activity 
increased more gradually than wildtype enzyme with increasing XPC. This likely reflects 
the poorer binding of this variant to PC-poor vesicles as observed by FCS. However, the 
activity decreases at high PC are similar to those observed for wildtype PI-PLC. As will 
be seen in chapter 5, the field cycling NMR studies of wildtype PI-PLC interacting with 
phosphatidylmethanol (PMe)/PC vesicles suggest that such a decrease is likely to be the 
result of enzyme-induced demixing of PMe (substrate analogue) and PC (activator) 
leading to sequestration of the enzyme in PC-rich regions resulting in reduced substrate 
accessibility.  
The interaction of vesicle binding and activity as a function of XPC is particularly 
interesting for the putative dimer interface mutant, 3YS (Y246S/Y247S/Y248S/N168C). 
The fluorescently labeled mutant has apparent Kd values for SUVs that decrease slightly 
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as PC increases, with a possible minimum at XPC = 0.5 followed by dramatic increases in 
Kd and very weak binding above XPC = 0.8 (Figure 4-7). In contrast, the specific activity 
in the surface dilution experiment increased gradually as PC was added, reaching a 
maximum at XPC ~ 0.7 (Figure 4-9B). The gradual 8-fold increase in activity, in a regime 
where Kd varies only 2-3 fold and is at least 1 order of magnitude higher than that of 
Y88A or wildtype PI-PLC indicates that PC must do more than just bind the protein to 
the surface. It has been proposed that PI-PLC dimerizes when bound to SUVs, and that 
the three mutated Tyr residues are important in stabilizing the homodimer interface (55, 
72). A number of other intersubunit interactions could still lead to dimer formation, but 
these interactions are expected to be much weaker. Thus, the gradually increasing 
specific activity likely reflects not just partitioning of the enzyme to the vesicles but the 
surface active conformation that is promoted by PC.  
At XPC= 0.8 with a total phospholipid concentration of 50 mM, there was a decrease 
in 3YS activity similar to that seen for other variants at slightly lower XPC. Since 50 mM 
is considerably above the apparent Kd for high XPC, the protein would be expected to bind 
to these SUVs. Therefore, the observed decrease cannot reflect poor partitioning of the 
enzyme to the vesicles. More likely this reflects either a reduced affinity for or reduced 
accessibility to the PI in the PC-rich interface.  
Pro42 is also associated with the putative dimer interface, and previous kinetic 
characterization of P42G showed that while cleavage of PI (8 mM) in 32 mM diC7PC 
was about 70% that of wildtype enzyme, diC7PC (8 mM) activation of cIP hydrolysis was 
severely reduced (73). The FCS binding studies clearly indicate that binding of *P42G to 
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both anionic phospholipids and PC is impaired, but with high enough PC, activities may 
approach that of the unaltered enzyme. To test this, we examined the kinetics of cIP 
hydrolysis with increased diC7PC to see if increased PC binding would promote the 
water-soluble reaction. With 5 mM and 25 mM diC7PC present, the specific activities 
toward 20 mM cIP were similar (12.6 μmol.min-1.mg-1). Increasing the diC7PC to 50 mM 
roughly doubled the enzyme specific activity to 21.4 μmol.min-1.mg-1, 7-fold higher than 
the value in the absence of PC. However, this level of activation is still far lower than 
what is observed for wildtype enzyme (20- to 30-fold activation). These results are 
consistent with very weak binding of this variant to pure PC aggregates. It also 
emphasizes that the anionic lipid/PC synergy, presumably mediated by communication 
between the active and activator lipid binding sites, requires the anionic substrate 
analogue to have acyl chains.  
4.4 Discussion 
The model for PI-PLC membrane binding and activity predicts that helix B is crucial 
for binding PI-PLC monomers to the membrane while Tyr residues 246-248 and 251 as 
well as Pro42 in helix B help mediate dimerization on the membrane surface.  For 
interfaces containing even small amounts of PC, possible dimerization and the 
conformational changes resulting from vesicle binding activate B. thuringiensis PI-PLC 
towards both phosphotransferase and phosphodiesterase substrates (69, 96, 120).  The 
combination of FCS to measure vesicle binding and NMR to measure activity allow us to 
test this model and to determine correlations between binding and activity. 
4.4.1 PI-PLC wildtype binding and activity 
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FCS experiments on wildtype enzyme show that the composition of the vesicles (i.e., 
XPC) as well as the identity of the anionic phospholipid affect PI-PLC binding to SUVs 
(Figure 4-4). The binding of the enzyme to SUVs was examined quantitatively using 
PMe, PG, PA or PS as the anionic phospholipid. The protein has the highest affinity for 
mixed PC/PG SUVs and PG serves as the best substrate analogue.  For all of the anionic 
phospholipids mixed with PC, the apparent Kd decreases as XPC continues to increase. 
Low XPC also enhances PI-PLC activity, presumably because PC assists in anchoring the 
protein to the surface, allowing it to access the lipid substrate. While small amounts of 
PC decrease the apparent Kd, the tightest binding is observed not in pure PC vesicles but 
rather for PG/PC vesicles containing approximately XPC = 0.9. However, for PI/PC 
vesicles, optimal enzymatic activity is found from 0.2 to 0.5 XPC. Thus, the activator PC 
and the substrate PI or substrate analogue PG have synergistic effects on membrane 
binding and activity, and the model must account for both membrane binding and 
synergism between substrate and non-substrate phospholipids.  
4.4.2 Helix B stability and lability.   
Helix B is a short, 6 amino acid helix preceded by a Pro with the sequence 
PIKQVWG (52). Replacement of the N terminal Pro helix cap with a flexible Gly should 
destabilize the helix, at least with the orientation seen in the crystal structure (132). As 
expected, this disruption greatly reduces the affinity of PI-PLC for PG/PC SUVs no 
matter what the XPC while preserving the PG/PC synergy (Figure 4-7). This implies that 
efficient interactions of PI-PLC with bilayers are facilitated by the rigidity of the proline 
residue, which keeps the helix B hydrophobic groups solvent exposed and properly 
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oriented for membrane insertion. However, Pro42 could have multiple roles both 
stabilizing the monomer conformation and contributing to the homodimer interface as it 
does in the dimeric W47A/W242A PI-PLC mutant (72). Thus, the reduced binding of 
P42G to PC vesicles could also reflect changes in the monomer-dimer equilibrium in 
solution and/or on the membrane surface.   
Electrostatic attraction between anionic lipids and cationic amino acids also facilitate 
membrane binding (10). Mutation of Lys44, the only cationic residue in the helix B 
region, has a pronounced effect on the affinity of PI-PLC for anionic surfaces.  In fact, 
the affinity of the charge switch mutant, K44E, for pure PG SUVs is too low to measure 
by FCS. The K44A and K44E mutations also severely impair PG/PC synergy. The 
importance of Lys44 for binding to anionic surfaces, along with higher crystallographic B 
factors observed for helix B but not for the surrounding loops (52), suggest that this short 
helix may be labile allowing Lys44 to orient itself towards the membrane.  
The results for the P42G and Lys44 mutations seem to be contradictory with the 
former arguing for helix B stability while the latter argues for helix B lability. This 
suggests that for the short B helix there may a balance between too much flexibility, 
which could alter the interaction of the hydrophobic residues with the membrane and too 
little flexibility, which could reduce electrostatic attractions. While our results are 
suggestive, this hypothesis needs to be tested by directly measuring the dynamics of helix 
B and its surroundings. 
4.4.3 Synergism between active and activator sites.  
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Only two classes of PI-PLC mutants failed to show the pronounced synergistic effect 
of both lipids on PI-PLC binding: (i) Lys44 mutants and (ii) the active site mutant H32A. 
Both K44A and K44E have dramatically diminished affinity for PG-rich vesicles and 
slightly reduced affinity for PC-rich vesicles.  However, the K44 mutations should not 
alter the active site and in high PC assay systems, PI-PLC cleavage of PI is reasonably 
efficient. This is consistent with the role of Lys44 in driving the protein to anionic 
surfaces, and this initial interaction appears to be crucial for binding to PG-rich vesicles.  
The active site mutant behaves differently with unaltered PC sites and binding 
affinities for pure PG and pure PC SUVs that are comparable to wildtype. What H32A 
fails to show is the dramatic increase in binding affinity at low XPC and tightest binding at 
an XPC <0.9, implying that both substrate and PC aid in anchoring the enzyme. This 
strongly suggests that a fully functional active site is needed for the synergism between 
the PC and substrate binding sites. Such an interaction also hints that crosstalk between 
both sites results in PC interfacial activation of the enzyme. 
Interestingly these single site mutations both impair binding to anionic vesicles and 
abrogate anionic lipid/PC synergy.  In contrast, mutants with seriously impaired PC 
binding, e.g. P42G and 3YS, still bind most tightly to mixed lipid vesicles.  This suggests 
that either we have yet to identify the key residues that bind to PC and/or mediate PI/PC 
crosstalk from the PC end or that PC binding as well as the PC contribution to crosstalk 
between lipid binding sites is more distributed than anionic lipid binding and thus more 
difficult to disrupt. 
4.4.4 Tight lipid binding versus catalytic activity 
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 All of these PI-PLC mutant enzymes show dramatically decreased specific activity at 
XPC > 0.8. This surface dilution inhibition is often attributed to the reduced two-
dimensional concentration of the substrate PI. However, at that XPC the substrate 
concentrations are still quite high (for example, at XPC=0.8 there are still 20 substrate 
lipids per every 100 lipids), and if two-dimensional scooting about the vesicle or three-
dimensional hopping around or between vesicles is efficient, the drop in activity should 
be more gradual assuming that the lipids are randomly distributed. What then happens to 
PI-PLC at XPC>0.7? Our field-cycling NMR experiments (Chapter 5) suggest that PC is 
not randomly distributed in PC-rich vesicles, possibly due to enzyme-enhanced demixing 
of PI and PC, and that PI-PLC is sequestered in these PC-rich regions. This demixing and 
sequestration would increase the distance PI-PLC has to move in order to find the next 
substrate molecule. In this work, the late onset of surface dilution inhibition for Y88A is 
associated with higher Kds, indicating that tight binding of PC hinders efficient 
movement of wildtype PI-PLC, again making it harder to find the next PI.  Thus, at 
moderate XPC (0.6<XPC<0.8) the tighter binding of wildtype PI-PLC to PC-rich vesicles, 
likely associated with PI-PLC sequestration in PC-rich regions, enhances the effects of 
diluting PI in the membrane resulting in a precipitous rather than gradual decline in 
activity. 
In summary, our results support many of the steps previously proposed for activation 
of B. thuringiensis PI-PLC and provide details on how some key residues interact with 
mixed phospholipid surfaces. For highly anionic membranes, but not PC-rich vesicles, 
binding correlates well with relative activity. The mutant PI-PLC binding studies suggest 
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that Lys44 mediates the initial electrostatic interaction of the protein with substrate, 
orienting PI-PLC at the vesicle surface followed by Trp47 (and likely Trp242) insertion 
(73), which requires PC interaction with the protein. PI-PLC binding to both types of 
phospholipids then promotes conformational activation, possibly due to transient 
dimerization. Strikingly, this work also shows that very tight binding of the protein to 
PC-rich vesicles can actually reduce catalytic efficiency. Optimization of PI-PLC binding 
to substrate-containing vesicles is a balancing act between anchoring the protein in the 
correct conformation and orientation while also allowing it to dissociate in order to find 
substrate phospholipids or GPI anchored proteins by scooting and/or hopping. 
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Chapter 5 High resolution 31P field cycling NMR (fc-P-NMR) to 
characterize PI-PLC binding to specific phospholipids 
5.1 Introduction 
Many cellular proteins that participate in cell signaling pathways, such as 
phospholipases, protein kinase C, and phosphatases, temporarily translocate to cellular 
membranes for their biological function. The close association between the protein and 
the membrane can provide the enzyme with access to a lipid substrate, or might promote 
conformational changes of the protein, resulting in an activation of biological activity 
(10). To understand the function and regulation of these proteins, it is necessary to 
understand how the protein interacts with the membranes. Researchers have used various 
techniques to study the bulk partitioning of peripheral proteins to membranes (74), and 
we have used FCS to study PI-PLC interacting with multi-component vesicles. The FCS 
studies reveal that the presence of both activator lipids and substrate lipids are important 
for the optimal binding. However, it is much harder to assess specific interactions of the 
protein with a given type of phospholipid in a mixed component bilayer, or to determine 
how the protein is partially docked onto the membrane. One method to directly observe 
protein-membrane interactions is based on the quenching of an intrinsic fluorophore, Trp.  
In this method, proximity to a quencher such as a dibromo and nitroxide group added to a 
phospholipid reduces the Trp fluorescence (133-135). A second method uses the 
quenching of the electron paramagnetic resonance (EPR) signal of a site-directed spin 
label attached to the protein by a second paramagnetic species on the phospholipid (2). 
This approach was used to determine the key geometric parameters of membrane-docked 
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proteins, including their penetration depths and angular orientations relative to the 
membrane surface (136, 137). However, these methods both require attaching a probe on 
the phospholipid which can affect its interactions with proteins (as well as with other 
phospholipids). 
Bacterial PI-PLC enzymes recognize the headgroups of substrate, substrate analogue, 
and activator phospholipids, making 31P NMR an obvious choice for studying protein-
lipid interactions. A traditional method to do this is to monitor the increase in linewidth 
(proportional to 1/T2, the spin-spin relaxation rate) of the 31P resonance upon protein 
binding (138). Measurements of dipolar relaxation rates could, in principle, determine the 
effects of protein binding on headgroup orientation with respect to the bilayer normal as 
well as correlation times for different headgroup motions. However, in a typical modern 
spectrometer, the slow rotational diffusion time of lipid vesicles, the dominance of 
chemical shift anisotropy (CSA) relaxation, and a plethora of faster motions at higher 
fields preclude obtaining information on lipid structure and dynamics from 31P relaxation 
rates.  
This limitation is avoided by high resolution field cycling 31P NMR (fc-P-NMR) spin-
lattice relaxation techniques that resolve the dynamics of each phospholipid component 
in mixed phospholipid vesicles by monitoring relaxation rates over a wide field range of 
magnetic fields. To vary the magnetic field, the sample is mechanically shuttled between 
the center high field region of the commercial NMR magnet's probe, and a substantially 
lower magnetic field located above the probe before, and after, the delay times normally 
used in conventional NMR relaxation sequences (95). Analysis of the field dependence of 
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spin-lattice relaxation rates over a wide field range (0.002 to 11.7 T) provides several 
correlation times (τ) for each phospholipid molecule on timescales ranging from ps to μs 
(94, 95). Of particular interest is the intermediate 5-10 ns τc that appears to be dominated 
by the wobbling of each phospholipid in the membrane (106). This τc provides a direct 
probe of lipid dynamics in these multicomponent membranes. A longer correlation time 
in the μs range, τv, provides information on how vesicle tumbling and lateral diffusion 
affect the phosphorus nuclei for each type of phospholipid. 
5.2 Surface dilution inhibition, a phospholipid centric view 
5.2.1 Effects of PI-PLC binding on lipid dynamics 
As discussed in chapter 4, our current model for kinetic activation of B. thuringiensis 
PI-PLC, based on the crystal structure of an interfacially impaired mutant protein (72) 
and extensive mutagenesis of surface residues (70, 71, 73), is that specific binding to PC 
in the lipid membrane allows key loop residues to penetrate the interface promoting an 
enzyme conformation (suggested to be a transient dimer (55, 72, 73)) with enhanced 
catalytic activity. However, in all PI vesicle assay systems examined, when the bulk PI is 
kept constant but the surface concentration decreases, PI-PLC specific activity decreases 
dramatically above XPC = 0.50 ((68, 76) and Figure 4-1). This surface dilution inhibition 
is often interpreted as the result of the substrate surface concentration decreasing below a 
two-dimensional Km measured in XPI units (65, 119). The affinity of the diluent (in this 
case, PC) for the enzyme, can also complicate a detailed interpretation of this kinetic 
effect. To truly understand this PI-PLC, where two discrete phospholipids are critical for 
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optimal catalysis, we need a molecular level description of surface dilution inhibition. 
Such a description is provided by fc-P-NMR which monitors lipid motions. 
Anionic phospholipids such as PMe serve as nonhydrolyzable substrate analogues for 
PI. The fact that PI-PLC binding affects the dynamics of pure PC SUVs was previously 
shown using fc-P-NMR and measuring the 31P spin-lattice relaxation rate for PC in small 
unilamellar vesicles in the absence and presence of the protein (95). Here, we carry this 
observation further by studying the field dependence of the 31P spin lattice relaxation rate, 
R1, for PI-PLC binding to mixed PC/PMe SUVs. The total phospholipid concentration in 
these experiments was kept constant at 10 mM, above the apparent Kd of bulk protein 
binding to the vesicles examined by FCS (Figure 4-4). Examples of R1 field dependence 
profiles for each phospholipid in the very low field region (0 to 0.05 T) and higher field 
region (0.07 to 11.74 T) are shown in Figure 5-1 for two different mole fractions of PC 
(XPC) values. In the presence of PI-PLC, the field dependence above 0.07 T for PC 
(Figure 5-1B) and PMe (Figure 5-1D) are similar at XPC = 0.2 but noticeably different at 
XPC = 0.8, where Rc(0) is clearly larger for the PC component. The relaxation profile in 
the absence of PI-PLC is shown as a gray line in each panel in Figure 5-1. Without 
protein, τc for the two phospholipids is the same, 5.6 ± 0.5 ns, and does not vary 
significantly with XPC. Quantifying the changes induced by protein provides insight into 
how PI-PLC binding affects the dynamics of each phospholipid. 
The rise in relaxation rate, R1, below 1 T is caused by dipolar relaxation, principally 
through dipolar interactions with the glycerol C(3) protons (95). As the field is increased 
above 1 T, relaxation due to CSA becomes important. As described in detail in Chapter 2,  
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Figure 5-1. Field dependence of R1 for PC and PMe in mixed SUVs with with XPC=0.20 
(filled symbols) or XPC= 0.80 (open symbols) and 3 mg/ml (86µM) PI-PLC. (A) field 
dependence of the PC R1 from 0 to 0.05 T; (B) PC R1 from 0.07 to 11.7 T.  The field 
dependence of the PMe R1 is shown (C) from 0 to 0.05T and (D) from 0.07 to 11.7 T. 
The curves through these points represent the best fits to the simple model for R1 
dependence on field with two correlation times (τv from (A) and (C) and τc from (B) and 
(D)). The profile exhibited by the phospholipid in the absence of protein is shown in each 
panel by the gray line. 
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a model-free approach was used to fit the field-dependent profile for R1 from 0.07 up to 
11.7 T as a sum of dipolar and CSA terms associated with a slow, τc (ns), and fast, τh (ps), 
motions and to estimate Rc(0), the maximum relaxation rate caused by τc -associated 
motions. This τc has been modeled by diffusive and wobbling motions of each 
phospholipid treated as a relatively rigid cylinder encompassing the phosphorus-glycerol-
acyl chains in a hexadecane-like medium (106). 
The addition of PI-PLC to pure PMe SUVs had very little effect on τc and Rc(0) (95) 
under conditions (10 mM PMe) where the FCS Kd (3 ± 1 mM) indicates that most of the 
protein is associated with the SUVs. Therefore, the average PMe molecular environment 
is not significantly perturbed, and interactions between the SUVs and PI-PLC are 
probably electrostatic and nonspecific. In contrast, when PI-PLC was added to pure PC 
vesicles, it significantly increased τc (from 5 to 13 ns) as well as Rc(0) (increased 2–3-
fold). The tight binding of PI-PLC to PC SUVs, as measured by FCS (Figure 4-4A), 
clearly involves significant retardation of PC motion in the ns range. An order parameter, 
Sc2, extrapolated from the CSA portion of relaxation (95), is 0.5 for both phospholipids 
in the absence of enzyme. For PC SUVs with PI-PLC bound, this parameter has a value 
greater than 1 (95). Given uncertainties in several of the input parameters used to 
determine Sc2 (e.g. CSA interaction size and asymmetry), the absolute value of this order 
parameter may not be correct. However, for these two-component SUVs, changes in Sc2 
serve as a convenient way to compare the effects of PI-PLC binding on lipid motions as a 
function of XPC.  
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For XPC between 0 (pure PMe) and 1 (pure PC), both phospholipids show changes in 
the field dependence of R1 only when the PI-PLC is present. In these experiments, as in 
the activity assays, the total concentration of phospholipids was fixed at 10 mM, but the 
PI-PLC concentration was considerably higher (86 µM), resulting in a lipid/PI-PLC ratio 
of 116:1. Centrifugation of samples through an Amicon Centricon-100 filter showed that 
about 20–40% of the protein was associated with the SUVs under these conditions. This 
suggests that there is adequate enzyme to saturate all vesicle binding sites. Two XPC 
points, 0.1 and 0.65, used a lipid/PI-PLC ratio of 700:1 with only minor effects on τc  
and Rc(0) compared with the higher protein concentration. All protein was bound to the 
vesicle at the end of the experiment where the total phospholipid/PI-PLC in the outer 
monolayer was 400–500. 
At each XPC, analysis of the field dependence of R1 from 0.06 to 11.7 T in the 
presence of PI-PLC was used to extract Rc(0) and τc for each of the two phospholipids in 
the SUVs. As shown in Figure 5-2, as little as 0.1 XPC increased Rc(0) and τc for PMe 
significantly, and both parameters were roughly constant from 0.1 to 0.5 XPC and similar 
to the values for PC in the same vesicle. The presence of PC in these mostly anionic 
phospholipid SUVs enhances PI-PLC binding, and as a consequence, the ns motion of 
both phospholipids is hindered, and τc increases from 5 ns. (This is easily seen in Figure 
5-1, B and D, where R1 at 0.1 T is significantly higher in the presence of PI-PLC than it 
is in the absence of protein (gray line)). These effects of PI-PLC are also reflected in the 
SC2 values for PMe, which increase as soon as PC is added (Figure 5-2C). The PC 
resonance in the SUVs is broader than for PMe, so the field dependence of R1 for PC at  
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Figure 5-2. Variation of parameters extracted from high resolution 31P field cycling for 
PC (z) and PMe  () in mixed vesicles as a function of XPC. (A) Rc(0), (B) τc, (C) SC2 
and (D) τv The concentration of PI-PLC was 3 mg/ml (86µM) for all XPC except 0.65 and 
0.90, for which 0.5 mg/ml (14µM) PI-PLC was present. The dotted lines in (A) and (B) 
show the values for PMe in the absence of protein.  
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XPC = 0.10 could not be obtained with any accuracy. Nonetheless, the fc-P-NMR data 
reveal that for XPC values of 0.5 or less, the phosphorus motions of both PMe and PC are 
similarly restricted with PI-PLC present. These effects of the protein on phospholipid 
dynamics could reflect chemical exchange between active site or activator site and bulk 
phospholipid or else a generalized change in membrane fluidity/viscosity as long as the 
protein is transiently anchored to the bilayer.  
At XPC > 0.5, there is a switch in phospholipid behavior with PI-PLC, resulting in a 
significantly increased Rc(0), τc , and Sc2 for PC but not for PMe in the same SUV (Figure 
5-2). For PC, the extracted value of Sc2 is greater than 1, a likely reflection of our not 
quite correct assumption that τc is the same for CSA and dipolar terms. However, what is 
important is that Sc2 increases for PC but not for PMe as this lipid becomes the major 
component in these vesicles. Clearly, PI-PLC differentially hinders the PC motions at XPC 
> 0.5. The difference in parameters for the two phospholipids suggests that chemical 
exchange (between protein-bound and "free" in the bilayer) rather than bulk membrane 
fluidity is the major determinant of τc for each phospholipid.  
So what does PI-PLC actually do to PC in high XPC bilayers? One interpretation is 
that PC can now interact with the enzyme active site. The motion of the larger (compared 
with PMe) PC headgroup might be more restricted at this second binding site. However, 
the FCS results indicate that even at high XPC, PMe and PC behave synergistically when 
binding to PI-PLC. It has also been shown that PI-PLC bound to pure PC SUVs is 
activated toward the soluble substrate myo-inositol 1,2-(cyclic)-phosphate (69). Thus, the 
active site is unlikely to be occupied by PC acting as a competitive inhibitor. A different 
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explanation for the observed fc-P-NMR effects is that there is a preferential interaction of 
PI-PLC with PC, resulting in lipid clustering.  
The field dependence of the relaxation rate at very low (<0.06 T) fields provides hints 
that PI-PLC-induced partial separation of PC and PMe may occur at XPC > 0.5. From the 
low field rise in relaxation rate (Figure 5-1, A for PC and C for PMe), we can determine a 
correlation time, τv, for each phospholipid, which in the absence of protein is related to 
the vesicle size and includes contributions from vesicle tumbling, lateral diffusion, and 
possibly other slower (100 ns) motions of the phospholipids (94). For these sonicated 
vesicles, the average diameter, as measured by DLS, is relatively constant as XPC is 
increased from 0 to 0.8 (Table 2-1). At low XPC, τv is similar for both phospholipids (0.4–
0.5 µs). This value is 2–3 times shorter than would be expected for overall rotation of 
SUVs (94), consistent with some contribution from lateral diffusion. However, as XPC 
increases above 0.5, τv for PC increases slightly (from 0.51 ± 0.03 µs at XPC = 0.5 to 0.62 
± 0.06 µs at XPC = 0.8), whereas the value for PMe decreases to 0.25 ± 0.07 µs at the 
highest XPC where relaxation in the low field region was examined (Figure 5-2D). That τv 
for PMe is reduced can be seen in Figure 5-1C, where the curves for both XPC values have 
similar Rv(0) values but the midpoint for this change occurs at a higher field for XPC = 
0.8, the hallmark of a shorter correlation time. For comparison, the analysis of the low 
field dependence of pure PMe SUVs (see Figure 2-6) yields a τv of 0.39 ± 0.03 µs. In the 
PC-rich SUVs with PI-PLC added, τv for PMe is considerably less than that for PC, and 
the decrease in τv for PMe as XPC increases is statistically significant. The decrease in τv 
for bulk PMe indicates that the PMe lateral diffusion, unfettered by protein (and perhaps 
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neighboring PC molecules), is now more effective at relaxing the residual magnetization 
of 31P. This would occur if PC molecules sequester the protein from PMe, which now has 
a shorter path around the vesicle in areas devoid of PC/protein clusters.  
5.2.2 PC Activation and Inhibition of PI-PLC on a molecular level 
The fc-P-NMR results clearly indicate a role for lipid dynamics in PI-PLC activation 
by PC at low XPC and reduced activity of PI-PLC at XPC> 0.5. Specifically, the 
combination of FCS and fc-P-NMR reveals the following. (i) A relatively small amount 
of activator PC in the anionic lipid membrane promotes PI-PLC binding to vesicles. (ii) 
The affinity of the protein for vesicles increases as the amount of PC is increased, 
reaching a maximum for very PC-rich, but not pure PC, bilayers, indicating that both 
phospholipids contribute to tight vesicle binding (a synergistic effect between activator 
and active site binding of lipids). (iii) At moderate XPC, 0.1< XPC <0.5, the dynamics of 
both phospholipids are affected similarly and the, restricted, slower motions, which are 
more or less independent of XPC, parallel the high enzymatic activity. (iv) In the regime 
of tight binding to PC-rich bilayers, PC dynamics are preferentially slowed suggesting 
that this activator lipid sequesters PI-PLC from the bulk of the substrate analogues. If PI 
were the anionic phospholipid used, this would lead to significantly lower specific 
activity than expected. This latter observation provides a very specific interpretation of 
surface dilution inhibition as the result of tight binding of the protein to PC-rich regions 
that prevents its access to the bulk of the PI. 
 These experiments provide new insights into the role of PC in B. thuringiensis PI-
PLC-catalyzed PI cleavage. In moderate ionic strength buffers, PI-PLC has very weak 
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affinity for SUVs containing only anionic lipids, in this case the substrate PI (or analogue, 
such as PMe), and relatively small amounts of PC serve to anchor the protein to the 
mixed component bilayers. The hallmark of that binding is that the rotational/wobbling 
motion of both substrate analogue (PMe) and activator (PC) molecules is similarly 
reduced for each phospholipid. However, tight binding does not necessarily correlate with 
higher enzyme activity. As the relative amount of PC, XPC, is increased above 0.5, 
specific activity decreases, and there is a change in the dynamics of PC bound to PI-PLC; 
in contrast, the affinity of the protein for SUVs (as measured by the apparent Kd) 
continues to increase up to 0.90 XPC.  
In kinetic models for surface active enzymes (65, 119), a decrease in activity with 
increasing mole fraction of diluent is often attributed to the reduction of the substrate 
surface concentration below a threshold two-dimensional Km. Our data reveal that 
decreased B. thuringiensis PI-PLC activity at high PC is correlated with changes in 
substrate (PI) and diluent (PC) lipid-protein interactions and lipid dynamics. Assuming 
that PMe is a reasonable stand-in for the substrate, at high XPC, PC dynamics, reflected in 
τv, τc, and Sc2 for the PMe/PC system, would be much slower than PI dynamics in the 
same vesicle. PI may still be bound at the active site even at high XPC, as reflected by the 
continued synergy between the two types of phospholipids in vesicle binding, but it would 
not be rapidly exchanging with the bulk PI pool. By analogy to the PMe/PC system, the 
tightly bound enzyme is clustered with PC and sequestered from much of the PI substrate 
in the bilayer. This sequestration probably inhibits PI-PLC diffusion around a given 
vesicle as well as release from one vesicle and binding to another for cleavage of more PI. 
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We propose that the changes in protein-lipid interactions detected by fc-P-NMR generate 
the observed decrease in PI-PLC activity at high XPC, either in the kinetic experiment 
shown here, where total phospholipid is a constant and XPC is varied, or in the more usual 
surface dilution experiments, where PI is constant and XPC increases. Such behavior, 
differential interactions of an enzyme with substrate and diluent amphiphiles that affect 
substrate accessibility to enzyme as well as lipid dynamics in the bilayer, may also be 
responsible for the decreased activity seen in the high diluent regime for many other 
phospholipases. The combination of FCS and fc-P-NMR encompassing bulk binding and 
phospholipid dynamics can be easily generalized to other, less well studied 
phospholipases or other peripheral membrane proteins where specific phospholipids are 
thought to have differential binding effects on enzymes.  
5.3 Exploration of PI-PLC substrate and activator lipid binding sites using site 
directed spin labeling and NMR at 11.7T.  
5.3.1 Introduction  
The combination of FCS and fc-P-NMR provides information on the PC activation 
mechanism of this peripheral membrane protein, PI-PLC, from the view of bulk 
membrane partitioning and lipid dynamics upon protein binding. Previous mutagenesis 
studies (55) together with our FCS binding studies of various mutants, also suggest that 
the ‘activator site’ is spatially distinct from the active site, although a definite binding site 
could not be identified. For peripheral membrane proteins such as this PI-PLC, 
understanding the catalytic activation on a molecular level requires identifying the 
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regions of PI-PLC that interact with each type of lipid and orienting the protein on 
vesicles.  
To identify sites and try to orient the protein on a vesicle surface, we introduced a 
spin label at different positions on PI-PLC (shown in Figure 5-3) and monitored the lipid 
dynamics by NMR. Various positions were chosen – some of the positions (W47C, 
W242C) were previously shown to be important for PC binding and activation, some are 
thought to be close to the lipid interface (Y118C, M121C), while some are near/at the 
proposed dimer interface (D205C, S250C, W280C), and H82C is in the active site. Two 
of the mutants, N168C and N220C, are far away from any interfaces, and thus serve as 
controls. The large dipole introduced by the spin label can affect relaxation and thereby 
the linewidth (proportional to 1/T2) of nearby nuclei. When the spin labeled protein is 
bound to a bilayer, any nearby nuclei should be relaxed. For SUVs composed of activator 
lipids (PC) and substrate analogue lipids (PMe used in these experiments), the 31P 
chemical shifts of each lipid are distinct from each other (shown in Figure 2-4), so we 
were able to study the effects of the spin label on each lipid simultaneously.  
5.3.2 Effects of spin label on 31P resonances 
The vesicle titration experiments provide information through examination of the PC 
and PMe peak linewidths. Our previous FCS binding study indicated that the presence of 
both activator lipids PC and substrate analogues are important for protein optimal 
binding. Taking into consideration the binding and surface dilution inhibition kinetics of 
PI-PLC, we started our titration using SUVs composed of PC/PMe (1:1). PI and PG were  
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Figure 5-3. PI-PLC structure with a myo-inositol at the active site pocket (PDB: 1PTG).  
Residues colored in blue show positions where a single Cys mutation was made and a 
spin label was introduced.  The structure of the spin label, MTSL, attached to a Cys 
residue is shown on the left. 
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not used because under the experimental conditions, with 1 mg/ml protein present, these 
lipids were slowly hydrolyzed during the titration procedure. For SUVs composed of 
PC/PMe (1:1) without any protein bound, the 31P resonance of each lipid is shown in 
Figure 2-4A. These ‘free vesicle’ linewidth was determined to be 60±10Hz. Before 
examining the effects of spin-labeled proteins on the lipids, we first looked at the line 
broadening of the lipids with the large unlabeled protein bound. Vesicles with 0.5, 1, 2, 4 
and 5.5 mM total phospholipid were titrated into 1 mg/ml (0.029 mM) PI-PLC. Even 
without the large dipole of the spin label, both PC and PMe in the vesicles were 
broadened, consistent with interactions between the protein and the phospholipids. A 
sample spectrum is shown in Figure 5-4A for vesicles titrated into N220C. In general, the 
PC resonances were affected more than the PMe resonances, especially at relatively high 
protein/lipid ratio (0.029 mM protein/0.5 mM lipid). Figure 5-4B compares the PC and 
PMe resonances for three PI-PLC variants. All of them show the similar trends with a 
higher bound linewidth (Δb) for PC than PMe. Table 5-1 lists the bound linewidth of the 
PC and PMe for all of the mutants, the average bound linewidth is 3460±2240 Hz for PC 
and 1280±630 Hz for PMe. This broadening confirms the interaction of the protein with 
both lipids in the bilayer; the stronger interaction with the PC component for the 1:1 
PC/PMe SUVs is hard to interpret but is consistent with a specific PC/PI-PLC interaction.  
To get information about the orientation of protein bound to the membranes, similar 
titration experiments were carried out with the spin labeled proteins. This bound 
linewidth (Δb(SL)) was compared with the bound linewidth of the non-labeled protein  
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Figure 5-4. Line broadening of 31P resonances of PC/PMe (1:1) by non-spin-labeled PI-
PLC. (A) 31P spectra of SUVs titrated with 1mg/ml N220C; (B) 31P titration curves of 
non-spin labeled protein N220C (square), H82C (circle) and W47C (triangle). The line 
widths of the PC (solid symbols and lines) and PMe (open symbols and dashed lines) 
were plotted as a function of total phospholipid concentration. The lines in these figures 
are the best fits to equation [2].  
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Table 5-1. 31P bound linewidth (Δb) and the specific spin label induced bound linewidth 
(ΔΔb) of PI-PLC variants. The bound linewidth was calculated according to equation [2], 
assuming that all phospholipids are affected. In fact, only 2/3 of the phospholipids are on 
the outer monolayer, so all ‘bound linewidth’ should be reduced by 2/3. The standard 
deviations were calculated through duplicate titrations.  
 
mutants 
PI-PLC monomer Spin labeled PI-PLC 
Δb(Hz), PC Δb(Hz), PMe ΔΔb(Hz), PC ΔΔb(Hz), PMe 
W47C 2860±490 1035±355 6230±460 1770±680 
H82C 8610±130 1630±170 1380±890 2720±730 
Y118C 1510±635 280±15 690±190 750±170 
N168C 3623±3192 694±17 260±180 54±55 
M121C 990±40 530±350 0±450 0±240 
D205C 2370±350 1260±830 1420±510 1380±160 
N220C 2320±990 840±48 0±560 200±250 
W242C 4295±690 2070±1285 5500±4000 570±570 
N243C 1126±787 412±194 350±400 1250±240 
S250C 2635±800 1290±605 1600±610 410±240 
W280C 4420±75 2180±1190 1120±970 1670±840 
 
 
  
136 
 
(Δb(PI-PLC)), and the specific effect of  the nitroxide was extracted (ΔΔb) as equation [3]. 
The results for all the variants we studied are listed in Table 5-1. Duplicate titrations were 
carried out for each mutant and standard deviations were calculated. The errors for these 
titrations are large. One reason is that for some of the extremely broad peaks (notably for 
high protein to lipid ratios), both PC and PMe resonances partially overlap. Considering 
the errors, we considered ΔΔb > 2000 Hz as an indication of proximity of the spin-label 
site to the phospholipid headgroup. Spin labels attached to the control positions, N220C 
and N168C, induced no significant broadening for either PC or PMe indicating that large 
shifts in the linewidths (ΔΔb > 2000 Hz) correspond to specific residue-lipid interactions 
(Table 5-1). 
The spectra for titrations of 1 mg/ml SL-W47C with PC/PMe (1:1) SUVs are shown 
in Figure 2-4C; corresponding titration curves are shown in Figure 2-5. SL-W47C is the 
residue with the largest effect on the PC 31P resonance linewidth among the proteins we 
studied. Trp47 is a key residue for PC binding and kinetic activation (70), and the spin 
label at this position broadened the PC resonance dramatically. There’s also a preferential 
broadening for PC over the PMe headgroup. This large broadening could due to the tight 
interaction or deep insertion of this residue into the bilayer, or there could be several PC 
lipids around this residue.  
SL-H82C had one of the largest effects on the PMe resonance. His82 is an active site 
residue and serves as the general acid in the phosphotransferase reaction. It is expected 
that this position should be close to the substrate or the substrate analogue. The effects of 
this protein on PC and PMe in the 1:1 PC/PMe vesicles are shown in Figure 5-5 A and B.  
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Figure 5-5. 31P titration curves for PC/PMe vesicles titrated into SL-H82C (solid 
symbols) or H82C (open symbols) containing solutions: (A) 31P resonance of PC in 
PC/PMe (1:1) vesicles; (B) 31P resonance of PMe in PC/PMe (1:1) vesicles; (C) 31P 
resonance of PMe in PC/PMe (1:4) vesicles. 
 
60
80
100
120
140
160
180
Δυ 1/ 2
Hz
60
80
100
120
140
160
180
200
220
Δυ 1/ 2
Hz
50
60
70
80
90
100
110
0 1 2 3 4 5 6
PL (mM)
Δυ 1/ 2
Hz
A
B
C
138 
 
The titration curves for the PC component have no large difference as shown in Figure 
5-5A, while the PMe resonance was significantly broadened (Figure 5-5B). We also 
wanted to see whether the vesicle composition would affect the broadening; so a similar 
titration was carried out using SUVs composed of 1:4 PC/PMe. As shown in Figure 5-5C, 
there was a similar line broadening to that observed for the 1:1 PC/PMe vesicles, with a 
specific bound linewidth of 1870±690 Hz for PMe. Since the H82C enzyme is inactive, 
we also carried out a titration with 1:4 PC/PI vesicles, and again, we were able to see the 
specific line broadening for the PI resonance.  
Similar to Trp47, Trp242 is another key residue for PC binding and activation (70). 
SL-W242C showed a preferential interaction with PC over PMe (although with very 
large errors), consistent with its role as a hydrophobic anchor in the membranes. N243C 
is adjacent to Trp242, however, the spin label at this residue induced no apparent 
broadening of PC lipids (Table 5-1). Two residues near the proposed dimer interface, 
D205C and W280C, showed moderate broadening of both PC and PMe 31P resonances.  
The linewidth information provided by the 31P NMR indicates whether a particular 
position interacts with each phospholipid in the mixed-component vesicles. However, at 
high fields (11.7 T), the relaxation mechanism for 31P is mostly from CSA and a fast 
motion. The contribution of dipolar relaxation is very small (95), which makes it hard to 
convert the linewidth changes caused by the spin label to something meaningful, such as 
an average distance of the label to a particular type of phospholipids. One needs to 
measure dipolar interactions of the spin label with the lipids to extract a distance. 
Although dipolar interactions do contribute to the linewidth, we found that we need 
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relatively high protein/lipid ratios to see much of an effect. To get distance information 
for small peptides that stay anchored on membranes is difficult but this becomes even 
more complex for a protein that is rapidly (on NMR time-scales) cycling on and off the 
membrane. 
5.3.3 Effects of spin labels on phospholipid  1H resonances 
1H resonances were also recorded for the same titration experiments,. A sample 1H 
spectrum of free SUVs composed of 1:1 PC/PMe is shown in Figure 2-4B; Figure 2-4D 
presents the spectra for SUVs titrated into 1 mg/ml SL-W47C. The 1H spectrum provides 
us with resonances for the lipid acyl chain (CH2)n, the α-CH2, and the N+(CH3)3 head 
group of PC. Dipolar relaxation should be the dominant relaxation mechanism for these 
resonances, so proximity of the spin labeled protein should be more easily monitored. No 
difference was observed for the 1H bound linewidth of the α-CH2 group between the 
spin labeled and non-labeled protein variants. However, this is a complex pattern (sn-1 
and sn-2 groups has overlapping multiplet patterns that are broad for the PC in vesicles) 
and not a useful screen for interactions with protein. 
The 1H resonance of the N+(CH3)3 group could provide information about interactions 
of the protein with the PC head group, supplementing the information provided by 31P 
resonances. However, the bound linewidth of this group was difficult to assess due to 
resonance splitting as shown in Figure 5-6. PC molecules on the outer monolayer of the 
SUV have a slightly altered chemical shift compared to those in the inner monolayer and 
this gives rise to the two distinct resonances (trans-bilayer flip-flop is slow so that the two 
environments are magnetically nonequivalent and in slow exchange). At higher  
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Figure 5-6.  1H spectra of -N+(CH3)3 for SUVs (1:1 PC/PMe)titrated into 1 mg/ml (A) 
W424C and (B) SL-W242C. 
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protein/lipid ratios, the splitting is more apparent likely because the outer monolayer PC 
is broadened compared to that of the inner monolayer; there are also small chemical shifts  
of this resonance with protein bound The overlap of the two peaks and shifting of the 
bound resonance made it difficult to examine the bound linewidth.   
In contrast, the bound linewidth of the hydrophobic long acyl chain, (CH2)n, of these 
phospholipids is quite interesting, easy to monitor and fairly easy to interpret (Table 5-2). 
The spin label at two positions, W242C and W47C, induces the largest line broadening of 
the acyl chain resonance. This result is consistent with the insertion of these two Trp 
residues into the lipid bilayer through hydrophobic interactions. In order to separate 
interactions with the PC long chain from interactions with the PMe long chain, we 
prepared vesicles using one component with perdeuterated acyl chains. For example, we 
will only be able to see the 1H of the PC long chain for vesicles composed of PC/d54-
PMe. The d54-PMe was produced through an enzymatic reaction using phospholipase D 
and chain perdeuterated dimyristoyl-PC (d54-PC) as the substrate as described in chapter 
2. Alternatively, we could monitor the PMe acyl chain resonance with d54-PC/PMe 
SUVs. The SL-W47C broadened the PC and PMe (CH2)n resonance to the same extent 
while W242C mainly broadened the PC (CH2)n. From the crystal structure (Figure 5-3), 
Trp47 is right above the active site pocket, while Trp242 is further away, and closer to 
the putative dimer interface, which is also linked to PC activation. Thus, one might 
expect that SL-W47C might broaden both lipid chain resonances while SL-W242C might 
be more selective for PC. 
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Table 5-2. 1H spin label induced bound linewidth of the lipid acyl chain. SUVs used in 
column 2-4 were 1:1 PC/PMe; column 3 used PMe with deuterated acyl chain while 
column 4 used PC with deuterated acyl chain. SUVs used in column 5 were PC/PI (2:8). 
The bound linewidth was calculated according to equation [2], assuming that all 
phospholipids are affected. In fact, only 2/3 of the phospholipids are on the outer 
monolayer, so all ‘bound linewidth’ should be reduced by 2/3. 
 
           ΔΔb(Hz) 
 
    mutants 
(CH2)n (CH2)n, (CD2)n (CH2)n 
PC/PMe PC/d54-PMe d54-PC/PMe PI 
W47C 370±20 458 543  
H82C 67±56; 950 
a
   450 
b
 
Y118C 54±15    
N168C 0±14    
M121C 63±14    
D205C 250±40    
N220C 0±15    
W242C 730±60 212 644  
N243C 270±40    
S250C 140±70    
W280C 220±80    
a. H82C binding to SUVs composed of PC/PMe (1:4) and examined PMe resonance. 
b. H82C binding to SUVs composed of PC/PI (1:4) and examined PI resonance. 
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The next most effective spin-label in terms of broadening the (CH2)n resonance was 
SL-N243C, which is right beside Trp242 and could partially insert into the bilayer. SL-
D205C and SL-W280C also yielded moderate broadening of the (CH2)n. Asp205 and  
Trp280 are close to the proposed dimer interface. The broadening of the (CH2)n by spin 
labels attached at these positions is quite interesting. It could indicate that a lipid binding 
site exists at/near putative the dimer interface. This observation is consistent with 
mutagenesis of other residues at the dimer interface. Replacement of the Tyr clusters (Tyr 
246/247/248) with Ser, yields protein with impaired PC binding and activation (55).  
SL-H82C broadens the 31P resonance of PMe headgroup in the PC/PMe mixed 
vesicles. What does it do to the (CH2)n? Three vesicle systems were examined: 1:1 
PC/PMe, 1:4 PC/PMe and 1:4 PC/PI (Table 5-2). Both PMe and PI in the XPC=0.2 
vesicles (here the (CH2)n resonance is dominated by the anionic phospholipid chains) 
were significantly broadened; again confirming that the substrate and the substrate 
analogue we used bind to the active site pocket. In contrast, the control proteins SL-
N220C and SL-N168C, showed no broadening of the (CH2)n resonance.  
5.3.4 Limitations of 31P NMR at 11.7T.  
The spin label induced increase in bound linewidth of the 31P and 1H resonances 
provides hints of the proximities between the spin labeled positions and each lipid. The 
active site, H82C, mainly broadens the headgroup and acyl chain of the substrate 
analogues. W242C broadens the the acyl chain of PMe while W47C has effects on both 
PC and PMe. 1H resonances also indicate the interaction of N243C, W280C and D205C 
with acyl chains. However, the biggest problem for this 31P linewidth assay is that it is 
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not easy to convert the line broadening effects to distance information, in part because the 
contribution of both CSA and dipolar to the relaxation rate (R2 =1/T2 where T2 is 
estimated from the linewidth). Another type of experiment is needed if we want to 
estimate the distances of discrete groups on the protein to different phospholipids when 
bound to mixed component SUVs and fc-P-NMR.  
5.4 Defining specific lipid binding sites for membrane bound PI-PLC by 31P 
NMR from 0.003T to 11.7T. 
5.4.1 Average distances from lipid 31P to spin labels on PI-PLC measured by fc-P-
NMR 
The fc-P-NMR spin-lattice relaxation experiments provide a more direct way of 
estimating the proximity of spin labels to vesicle components, since we can look in field 
regions where the dominant relaxation mechanism is dipolar. The 31P-electron interaction 
will be the major contributor to 31P relaxation if the spin-label is close to the lipid and if a 
discrete complex is formed. These experiments were carried out using 0.5 mg/ml (0.014 
mM) protein bound to SUVs composed of 10mM total phospholipid with 1:1 PC/PMe. 
When the protein is bound to a bilayer, any nearby lipid resonances should be relaxed. 
However, at high fields, the relaxation mechanism for 31P is CSA and not dipolar (94, 
95), so it is impossible to see and interpret effects of the spin-labeled protein. At a mole-
ratio of 1/700 enzyme/phospholipid molecules, there is very little effect of unlabeled 
protein on the phosphorus resonances because of its low concentration. 
31P of phospholipids in vesicles have a clear and easy-to-see dispersion at <0.02 T 
that is due to relaxation of the 31P by a few nearby protons and a correlation time around 
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1 μs that reflects overall tumbling of these 300 Å diameter vesicles (95). If spin-labeled 
PI-PLC is added, there is dramatic increase in the amplitude of this dispersion if the 31P is 
near the spin-label (Figure 5-7). What is particularly interesting is that the magnitude of 
the effect for each phospholipid varies with the position of the spin-label on PI-PLC, and 
patterns for PC, the activator, are not the same as PMe, the substrate analogue. In all of 
these measurements, the shape of the dispersion with the spin label is essentially the same 
as for the non-spin-labeled controls, suggesting strongly that the spin-label enhancement 
occurs when a lipid is bound for more than a μs to a specific site.  
What is striking about these two plots is that their width is similar, suggesting 
immediately that a given lipid on the outside sticks to the enzyme at a binding site for a 
time long compared to the correlation time for rotational diffusion of the vesicle (~1 μs). 
For PMe we tentatively conclude that the off-rate for a single PMe, from the active site 
and back to the pool of lipid diffusing about freely in the membrane outer monolayer, is 
several times longer than (1 x 10-6)-1, or in other words it dissociates from this one site at 
a rate less than 106 s-1. A simple argument also tells us a lower limit to this off-rate:  It 
must be more than the 103 s-1 range, which is the observed R1 rate times the 
[lipid]/[enzyme] ratio (~250/1 for each lipid on the outer leaflet), otherwise most lipids 
would never get swallowed by an active site during a T1, and there would be no 
appreciable extra relaxation by the spin label. These numbers are completely new and 
their ratio provides a 2D version of a binding constant. However they are not especially 
surprising for an enzyme binding a substrate analog like PMe.  
What is surprising is shown in Figure 5-7B, data taken in exactly the same way in the
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Figure 5-7. Variation of the 31P R1 of (A) PMe or (B) PC with field for vesicles of 
PC/PMe (5 mM: 5 mM) in the presence of 14.4 µM PI-PLC spin-labeled on the cysteine: 
W47C (z), D205C (),N220C (Δ), and S250C (). 
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same sample but for the PC resonance in the same set of spectra. The data indicate that a 
given effector molecule also binds at one (or a few) discrete sites on the enzyme that are 
distinct from the active site. Previously, there was no evidence to rule out the possibility 
that \kinetic activation of PI-PLC by PC involved many PC lipids interacting as a group 
with an area on the enzyme and relatively weak binding of any given individual PC to the 
enzyme.  
Based on the hypothesis of two specific sites, we can estimate distances from 31P 
bound at each site, to the spin labels. To estimate the distance from the PMe or PC 31P to 
the spin label on the enzyme, ΔRP-e(0), the relaxation rate caused by the spin label and 
extrapolated to zero field must be estimated. For this, we subtract the contribution from 
these vesicles in the presence of unlabeled protein at 0.5 mg/ml (95), and fit the residual 
R1 field dependence (below 0.05 T) with the following equation: 
ΔR1 ~ [ΔRP-e(0)/τc] x [τc/(1+ ωP2τc2]  [18]  
Only the J(ωP) term was used, since the two other dipolar terms, J(ωP±ωe), are much 
smaller (because of ωe for the electron in the denominator) and can be ignored. The plot 
showing this residual R1 for PC due to the presence of spin-labeled D205C is shown in 
Figure 5-8. A small constant correction was added to the fit of ΔR1 with field to account 
for the plateau not reaching zero at 0.03-0.05 T. Small differences in phopsholipid or 
protein concentrations affect the subtraction the non-spin-labeled R1 profile from the one 
with spin-labeled PI-PLC resulting in a non-zero baseline.  
With the other spin-labeled proteins, ΔRP-e(0) for PC (or PMe) is much smaller, so a 
fixed correlation time of 1 μs was used to extract ΔRP-e(0). From the correlation time and 
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Figure 5-8. Dependence of ΔR1 on magnetic field.   ΔR1  is the difference between R1 for 
PC (5 mM in SUVs with 5 mM PMe) in the presence of 0.5 mg/ml spin-labeled D205C 
PI-PLC and the control with unlabeled PI-PC,. The extrapolation of the fit to Equation 
[18] to 0 T (arrow) provides the value of ΔRP-e(0). 
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ΔRP-e(0), the distance between the 31P and spin label is estimated from the following 
equation:  
rP-e6 = 0.3 {[τc/(S2ΔRP-e(0))] μ2(h/2π)2 γP2 γe2} x fb  [19]  
where fb is the fraction of phospholipid bound to the enzyme and is assumed to be the 
total PI-PLC concentration relative to the total concentration of each phospholipid in the 
outer monolayer, [PI-PLC]o/(0.7[PL]o). FCS binding studies of mutant PI-PLC proteins 
to PC/PMe (or PG) vesicles indicated that at 10 mM total lipid for a 1:1 PC/PMe mixture 
all of the protein should be bound (Figure 4-7). We have not made any correction for 
motion of the enzyme relative to the lipid and assume (perhaps unrealistically) that the 
two interact like parts of a rigid body tumbling with the μs time-scale of vesicle 
tumbling. The ΔRP-e(0) values extrapolated from this analysis and the distances obtained 
are summarized in Table 5-3.  
Many of the results for PMe are consistent with this phospholipid binding to the active 
site to form a discrete complex since the largest effects are from the spin-label on W47C, 
part of helix B thought to insert into the bilayer above the active site opening, and H82C, 
the general acid in the catalytic mechanism for PI cleavage. However, the distances 
estimated for a PC molecule bound to PI-PLC are quite different. The PC phosphorus is 
closest to the spin-label on D205C – a very interesting and unexpected result. Spin-labels 
at W47C, H82C, and N243C are slightly further away. These three positions are all at the 
barrel rim and thought to be involved in membrane binding (W47C and N243C) or part 
of the active site (H82C). The control, spin-labeled N220C, and the other sites are further 
away. 
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Table 5-3. ΔRP-e(0) and extrapolated distances of the phospholipid 31P to spin-labeled 
sites (rP-e). 
 
PI-PLC ΔRP-e(0) (s-1) rP-e (Å) 
 31PC 31PMe 31PC 31PMe 
W47C 2.6±0.7 5.6±0.8 16.4 14.4 
H82C 5.3±1.0 7.9±0.9 14.3 13.8 
Y118C 2.0±0.5 0 18.6 >25 
M121C 0 0 >25 >25 
D205C 17.6±1.2 2.1±1.0 11.9 17.0 
N220C 0.2 0.16 22.2 23.8 
N243C 4.7±1.3 0.7±0.4 14.8 20.5 
W280C 3.0±1.5 2.2±0.7 15.9 16.8 
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One particular spin-labeled mutant PI-PLC, S250C, behaved quite differently from 
the rest. For both PC and PMe, the extracted correlation time was much faster (~0.1 μs 
rather than closer to the 1 μs that was observed for all the others) than that for the same 
size SUVs in the absence of protein. R(0) obtained from fitting this dispersion was also 
about 2/3 that for each phospholipid in SUVs without protein. Two different mechanisms 
could lead to this observation: (i) the two spin labels on adjacent S250C molecules might 
be interacting, an event that could only happen if transient PI-PLC dimers form and this 
particular label is near such a dimerization site (55); (ii) the spin-label is very close to the 
PC site and R1 actually is reaching a plateau rather than following the usual Lorentzian 
dispersion, and the point where the plateau begins reflects the specific off-rate of the 
phospholipid from the complex. In favor of the dimer explanation is our observation that 
the disulfide linked S250C had higher activity and PC binding than the corresponding 
monomer. Further experiments will be needed to sort out which of these explanations is 
correct. 
5.4.2 Modeling of PC and PI binding sites on PI-PLC 
The distances derived from the NMR experiments may not be absolutely accurate for 
all of the systems because some Cys mutations and/or spin labeling may weaken protein-
membrane interactions altering PI-PLC/phospholipid complex lifetimes, or in the case of 
PC, because more than one binding site may exist (139). However, the proximity of the 
spin-label attached to D205C to PC is quite notable and can serve as a starting point to 
pinpointi a binding site for this activating phospholipid. We have used the proximity of 
D205C to the PC 31P to guide docking (Autodock4) of an individual phospholipid 
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headgroup (here butylphosphocholine was used since longer chains without the 
availability of a bilayer would not lead to a stable complex in this region) to PI-PLC 
(PDB: 1PTD), followed by energy minimization to see if such a site is likely to exist. 
Although the protein may transiently dimerize on membrane surfaces, only the PI-PLC 
monomer structure with PC added was evaluated, since the reported dimer structure is of 
a mutant protein (W47A/W242A) that does not bind well to interfaces (55) and might 
therefore not reflect a membrane-bound dimer. The non-physiological nature of the 
muant dimer structure is supported by the S250C and N243C spin labeling results.  
S250C is the only spin-labeled protein where it appeared that dimers might be 
complicating the fc-P-NMR experiment, and Ser250 is near the putative dimerization site 
(55). However, in the W47A/W242A crystallized dimer, Asn243 is also close to the 
dimer interface and might be expected to show nitroxide interactions if that dimer 
structure is relevant. The lack of any fc-P-NMR  evidence for a dimer with N243C 
strongly suggests any oligomerization of PI-PLC on the bilayer surface is different. This 
also explains why the binding and activity for the disulfide linked N243C dimer is lower 
than the monomer counterparts (Table 3-1). For these reasons we chose to just dock a PC 
analog to the monomer structure. The docking also does not alter the protein 
conformation, a potential problem since it is likely some regions undergo conformational 
changes upon vesicle binding. Nonetheless, it provides a framework for explaining 
observed fc-P-NMR effects and suggesting new sites for spin labeling. 
As shown in Figure 5-9, the PC site identified in the lowest energy structures is quite 
removed from the active site. It orients the choline –N(CH3)3+ near several surface 
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Figure 5-9. Model for butylphosphocholine (‘PC’) binding site on PI-PLC, based on 
proximity of spin-label at D205C. (A) Energy minimized structure around the activator 
binding site showing PC analogue interactions with nearby side-chains. (B) Top view, 
looking down from the membrane at the spatial relationship of the novel PC binding site 
to the active site with a butylphosphoinositol bound (aligned with myo-inositol in crystal 
structures 1PTG). The butyl tail of both small molecules is green. (C) Side view. (D) 
Front view. 
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tyrosine side chains whose replacement with serine dramatically reduces affinity for PC 
(Figure 4-7) as well as kinetic activation by PC (55). Such an interaction between a 
hydrophobic cation with the aromatic amino acid side chains, termed a π-cation 
interaction, is commonly found for protein-ligand interactions (140). An example is the 
well-studied neurotransmitter, acetylcholine (ACh), binding to ACh esterase through π-
cation interactions (141). Occupation of this binding site would orient the longer acyl 
chains of a PC molecule so they would stick into the membrane. A short chain substrate 
analogue, butylphosphoinositol, was modeled into the active site pocket by aligning the 
inositol headgroup with the myo-inositol in the crystal structure of PI-PLC/myo-inositol 
complex (PDB: 1PTG). Both the modeled PC and PI orient their short alkyl chains into 
the membrane.   
We can compare the distances predicted by this simple model to be under 25 Å with 
those provided by the fc-P-NMR experiment (Figure 5-10). While several of these 
(W47C, H82C for PMe, D205C, W280C for PC) agree reasonably well, especially 
considering the flexibility of the surface spin labels, and the position of the substrate 
analogue PMe should be slightly different form PI, there are some notable differences. 
N243C in the flexible rim loop is farther away from both phospholipids than predicted – 
an observation that is consistent with the orientation of this loop changing when the 
protein is bound to vesicles (70, 72). W280C is another residue whose orientation is 
apparently closer to PMe bound to the active site, while PC is much closer to H82C than 
predicted (assuming a single defined site for each). It is possible that several PC binding 
sites may exist in PI-PLC.  
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Figure 5-10. Comparison of the distance estimated between the spin-label on a specific 
residue and 31P of PC (z) or PMe () and the same distance estimated from the model 
based on proximity of Asp205 to a discrete PC binding site. 
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5.4.3 Discussion 
The fc-P-NMR experiments clearly stress that (i) complexes for each type of 
phospholipid on the enzyme with lifetimes around 1 μs must exist (since very low field 
relaxation effects are seen with spin-labeled proteins); (ii) the discrete site for a PI analog 
(in this case PMe) is spatially different from that for activator PC; (iii) PMe is primarily 
relaxed by spin-labels near the active site; (iv) there is a discrete complex of PC at a site 
on PI-PLC that is near Asp205 and distinct from the active site; and (v) the active site 
loop with Asn243 is likely to adopt a conformation that removes it from the vicinity of 
the headgroups of both lipids.   
The distances from the spin label to the 31P of each phospholipid provided by fc-P-
NMR don’t necessarily agree with the 31P resonance line broadening in the fixed field 
study. As shown in Table 5-1, spin label at D205C only has a small effect on the PC 31P 
resonance, while fc-P-NMR indicates that these two be in close proximity. One reason 
for this difference is that different components, including both CSA and dipolar, can 
contribute to the spin-spin relaxation time T2 which is responsible for the linewidth. In 
addition, exchange of PC or PMe in different environments in the vesicle is also likely to 
differ for the two headgroups and this will affect the linewidth as well. Although a 
control system with the unlabeled protein was used to cancel this contribution, it is 
difficult for us to determine whether this strategy is effective. Since the distance is 
proportional to τ/R1 (or R2), while R2 can be estimated by the linewidth, it is difficult for 
us to estimate the correlation time τ. The correlation time for PC and PMe are likely to be 
different, and that could explain why the spin label at W47C has a large effect on the 31P 
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resonance of PC than PMe even it is closer to PMe. Therefore, linewidth information 
from the fixed field 31P NMR is not enough to provide us with distances and fc-P-NMR 
servers as a better tool. 
The substrate and activator lipid binding sites defined by the fc-P-NMR could be 
further supported by our 1H linewidth data. According to the model, the substrate is 
swallowed by the active site pocket, and is in close proximity to two residues, His82 and 
Trp47. Correspondingly, spin label attached at these two positions broadens the PMe or 
PI acyl chain protons and headgroup resonances markedly (Table 5-2). For PC, the 
phosphosrus in the head group is closest to Asp205, followed by Asn243 and Trp280. 
Among these three residues, Asn243 has the largest effects on the 1H linewidth, followed 
by Asp205 and Trp280. A spin label at N243C may insert into the hydrophobic core of 
the membrane (this could be a somewhat non-specific interaction), and thus produce a 
larger effect on the (CH2)n resonance than Asp205. 
Our results place the PC binding site near the Tyr strip of the protein (55). In the 
model, the phosphocholine is surrounded by several tyrosines (Tyr247/248/251/204), and 
should interact with the protein through π-cation interactions. Mutation of the tyrosines 
(Tyr246/247/248) to alanines significantly impairs PC binding (Figure 4-7), consistent 
with the existence of π-cation interactions. The tyrosine clusters were also thought to play 
important roles in protein surface dimerization (55). Since the PC is located at the edge of 
the dimer interface, this π-cation interaction would not necessarily affect the tyrosine 
zipper formation. Therefore, it is possible that Tyr247/248 play dual roles for the protein 
activation. 
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Chapter 6 Studies of single PI-PLC enzymes binding to surface 
tethered SUVs by total internal reflection fluorescence Microscopy 
(TIR-FM) 
6.1 Why single molecule studies? 
To understand an enzyme, it would be useful to generate a movie, including the 
details of molecular motions, showing how the enzyme initially interacts with the 
substrate, carries out the chemical reaction, then releases product. For a peripheral 
enzyme, such as PI-PLC, the movie would be quite interesting because the reaction takes 
place at the membrane interface, which is composed of different lipids. Both of the lipids, 
PC and PI (or a substrate analogue), are needed in the bilayer to attract and bind the 
enzyme. Once the protein reaches and docks on the bilayer, the active site pocket can 
swallow a substrate lipid while one or more allosteric sites of the protein will bind PC 
molecules. There is also some evidence that is consistent with the enzyme associating 
with another bound enzyme to form a transient dimer which is more efficient in carrying 
out catalysis. The protein can also diffuse around the bilayer surface in search of another 
substrate (‘scooting’ mode catalysis) or dissociate from the bilayer and bind to another 
vesicle to find a substrate (‘hopping’ mode catalysis). Several key questions need to be 
answered. How long will the protein stay on the membrane? Does the enzyme form a 
transient dimer on the bilayer surface and, if so, does this keep it on the bilayer for a 
longer time? In addition, when the PC mole fraction in the bilayer is high, and we suspect 
it is trapped in PC-rich/substrate-poor regions, is the protein lifetime on the vesicles 
considerably longer?  These questions are not easily answered using traditional ensemble 
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assays. However, they may be addressed with single molecule studies of PI-PLC binding 
to vesicles. 
Our experimental setup is illustrated in Figure 2-9. In these experiments, a small 
vesicle composed of PC/PMe and 1% DiD (for visualization) is tethered to the glass 
surface, and we directly observe association and dissociation of AF488 labeled PI-PLC to 
and from the vesicle. Using TIR-FM and assuming that binding is specific, we will only 
see the protein fluorescence when the protein binds to the surface tethered vesicle (‘on’ 
state). From statistical analysis of the single molecule trajectories of the protein (as 
shown in Figure 2-12), we can get the distribution of the ‘on times’ of the protein bound 
to the vesicle. The distribution of these trajectories also provides detailed dynamic 
information and can be compared with physical models. For example, for a simple 
binding system, we are also able to extract the off-rate. In our experiment, we will 
determine whether the off-rate is affected if we change the vesicle composition or add 
some unlabeled PI-PLC that might enhance protein dimerization. 
6.2 Optimization of the experimental conditions 
The lipophilic dye DiD was incorporated into the vesicles to make the vesicle visible 
in TIR-FM. This particular dye was used because its emission wavelength is longer than 
635 nm, so it does not overlap with the protein emission (Figure 2-10). To study how 
many DiD molecules were incorporated in each vesicle, we prepared vesicles using lipids 
composed of 2% DiD and looked at the bleaching steps of the vesicles. An example of 
the trajectory showing the bleaching steps for one vesicle is shown in Figure 6-1A. For  
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Figure 6-1. Bleaching steps of 2% DiD in surface tethered vesicles. (A) A fluorescence 
trajectory showing the DiD bleaching steps in one vesicle. For this vesicle, there are 3 
bleaching steps, indicating 3 DiD molecules are incorporated; (B) The distribution of the 
bleaching steps by studying 65 surface tethered vesicles. 
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this particular vesicle, bleaching occurred in three steps, hence there were three DiD 
molecules incorporated into the vesicle. The distribution of the bleaching steps is shown 
in Figure 6-1B, and the average number of DiD in each vesicle is 3. Since vesicle 
composition could affect protein binding, 1% DiD was incorporated into the vesicles. At 
this composition, we can use the distribution from Figure 6-1B to estimate that the 
average number of DiD molecules in each vesicle is 1.5 and 82% of the vesicles should 
be visible assuming that the incorporation of each DiD molecule into the vesicle is 
independent. 
At each SUV position, determined from the DiD fluorescence, we recorded the 
fluorescence of the short wavelength field (< 635 nm), which should be the emission 
from AF488-PI-PLC bound to the vesicle. In order to demonstrate this signal is from 
specific binding of AF488-PI-PLC to the vesicles, several background controls were 
performed. First, the PEG surface without tethered vesicles was imaged, and there were 
no signals observed for interaction of 10 nM AF488-PI-PLC with the slide surface. 
Second, we checked the interaction of 1 nM AF488 free dye interaction with the tethered 
vesicles and, again, no binding was observed. Third, with a vesicles tethered to the 
surface, we checked for non-specific interactions at positions where no vesicles were 
located. In these experiments, vesicles were labeled with 3% DiD to make sure that they 
were all visible, and we used 2 nM AF488-PI-PLC to check for binding. Instead of 
looking for protein signals at the vesicle locations, we analyzed the signals at randomly 
picked spots where no vesicles were located as shown in Figure 6-2. The result shows 
that the occurrence of the non-specific protein-surface interactions is only 0.5% of the  
162 
 
Figure 6-2. Checking for non-specific binding of AF488-PI-PLC to the PEG surface. 
SUVs with 3% DiD incorporated were tethered the glass surface (bright spots), non-
specific interaction of AF488-PI-PLC to the randomly picked position at the dark space 
was investigated with a time course for one of the spots comparable to a spot with a 
vesicle. 
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specific binding of the protein to the vesicles, and can be neglected. Lastly, the 
observation that AF488-PI-PLC was competed off the tethered vesicles by addition of 
100-fold unlabeled PI-PLC also supports that the signal we recorded was truly from the 
specific interaction of the protein with the vesicles. 
6.3 AF488-PI-PLC binding to surface tethered SUVs with different lipid 
composition 
A typical trajectory of 0.2 nM AF488-PI-PLC binding to SUVs composed of the 
activator lipids phosphatidylcholine (PC) and the substrate analogue phosphatidylglycerol 
(PG) with a PC mole fraction XPC= 0.7 is shown in Figure 2-12. Each peak represents a 
binding event. The distribution of the events (on-time) is shown in Figure 6-3. The 
distribution fits to a single exponential function with koff= 1.634±0.16 s-1, corresponding 
to an average on-time (τ) of 612 ms.  
There could be several proteins landing on each vesicle if the protein concentration is 
high enough. However, at the very low protein concentration we used, 0.2 nM, the 
probability of multiple landings is negligible. The calculated protein landing frequency 
for each vesicle is 0.02 s-1. In other words, the vesicle has to wait for average 50 s for 
another protein landing after the previous one leaves. In addition, multiple landings, if 
there were any, could be observed from the trajectories. The fluorescence intensities with 
multiple proteins on one vesicle will be multiplicative and we would observe steps for 
each protein landing and leaving. Our trajectories with 0.2 nM protein clearly show 
single binding events (see Figure 2-12).  
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Figure 6-3. Histogram of the on-times of a single molecule of AF488-PI-PLC binding to 
surface tethered SUVs (composed of PC/PG with XPC= 0.7) with total 542 events. The 
inset is fit to a single exponential with koff = 1.634±0.16 s-1 (corresponding time constant 
τ= 612±60 ms). The exposure time and 488 laser power used for the experiments were 50 
ms/frame and 3.1 mW. 
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To get an accurate off-rate (from the on-time distribution), we have to take into 
consideration the detection efficiency of the experimental set up. The original data we 
acquired is a movie composed of frames. The length for each frame is determined by the 
exposure time, and the on-time is calculated according to the frame lengths for each 
landing. For example, Figure 2-12B shows a landing lasting 10 frames, and the exposure 
time was 50 ms/frame, thus the on-time was calculated to be 500 ms. However, there 
could be minor differences between the detected ‘on-time’ and the real ‘on-time’. For 
example, using an exposure time of 50 ms/frame, for a real landing with 40 ms, ideally, it 
has 20% chance to fall into one frame length (50 ms) and 80% chance to fall into 2 frame 
lengths (100 ms). The relationship between the detected length and the real length is 
shown in Figure 6-4 (unpublished results by Dr. Larry Friedman). According to the 
figure, the detected number of events with one frame length is only half that of the real 
events. In order to get an accurate off-rate, we will mask this data point (number of 
events falling into one frame length) when we fit the ‘on-time’ distribution to the single 
exponential decay. However, this could be problematic if the average on-time τ is very 
short, say less than 3 frames, because for a single exponential decay 63% of the events 
have an on-time shorter than τ. For our current setup, the smallest exposure time we can 
use is 50 ms/frame, which means the detection limitation is koff< 6.67 s-1 (τ> 150 ms). If 
the exposure time is set to 100 ms/frame, then the detection limitation is koff< 3.33 s-1 (τ> 
300 ms). This limitation in estimating koff was confirmed by our experiments. For PI-PLC 
binding to SUVs composed of PC/PG (XPC= 0.9), koff was similar, 2.74 s-1 and 2.61 s-1, 
when the exposure time was set as 50 ms/frame and 100 ms/frame, respectively.  
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Figure 6-4. Relationship between the real frame length and the detected frame length in 
single molecule TIR-FM. The dashed line indicates that for a real landing that lasts 60% 
of a frame length, it has a 40% chance to be detected with one frame length and a 60% 
chance to be detected as two frame lengths.  
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However, the koff value was calculated to be 0.71 s-1 when a 500 ms/frame exposure time 
was used, an unreliable value because it exceeded the limit of koff< 0.67 s-1.  
The bulk partitioning of PI-PLC to multi-component SUVs is tuned by lipid 
composition (Figure 4-4) with the smallest Kd at XPC= 0.9. We wondered if in the single 
molecule experiments, the off-rate will be affected by the lipid composition as well. To 
address this question, we started with two compositions, XPC= 0.9 and 0.7, where the 
protein binds moderately tightly to the vesicles. The histogram for XPC= 0.7 is shown in 
Figure 6-3 and that for XPC= 0.9 is shown in Figure 6-5A. Both of the distributions can be 
fit into a single exponential decay but with different off-rates; the XPC= 0.7 vesicles had a 
slower off-rate (koff = 1.634 s-1) than that of XPC= 0.9 (koff =2.74 s-1). These off-rates are 
comparable with those measured for other peripheral membrane proteins. For example, 
the residence time of a phospholipase A (aPLA1) on a bilayer was ~300 ms, determined 
from a koff of 3.33 s-1 (142). The apparent Kd values for PI-PLC binding to vesicles with 
XPC= 0.7 and XPC= 0.9 were 2.8±0.6 µM and 2.2±0.2 µM, respectively (Figure 4-7). 
Interestingly, a faster off-rate does not seem to correspond to a lower apparent Kd. The 
distribution for PI-PLC binding to XPC= 0.5 is shown in Figure 6-5B; it is different from 
XPC= 0.7 or XPC= 0.9. That distribution could not be fit with a single exponential decay; 
instead, there appear to be two off-rates, a faster one with the τ around 123 ms and a slow 
τ around 700 ms. Although we are limited in measuring the fast rates due to the detection 
efficiency, the fast rates we estimate here (123 ms) could serve as an upper limit. The two 
distinct off-rates indicate heterogeneous behavior of the protein, with one population 
similar to those binding to XPC= 0.7 SUVs, while the other population cycles on and off  
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Figure 6-5. Histogram of the on-times of single molecule AF488-PI-PLC binding to 
surface tethered SUVs composed of PC/PG with different lipid compositions. (A) XPC= 
0.9 with total 808 events, the inset shows the distribution fit to a single exponential with 
koff = 2.74±0.29 s-1 (corresponding time constant τ= 365±39 ms); (B) XPC= 0.5 with total 
212 events, the distribution could not be fit with a single exponential decay, instead, two 
rates could be observed: a fast rate with koff = 8.1±0.49 s-1 (τ= 123±7 ms) and a slow koff= 
1.43±0.41 s-1 (τ= 700±200 ms). The exposure time and 488 laser power used for the 
experiments were 50 ms/frame and 3.1 mW.  
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the vesicle much faster. This faster rate is consistent with the weaker bulk binding of the 
protein to XPC= 0.5 vesicles. 
 Our recent studies also proposed a surface dimerization and activation model for this 
PI-PLC (55, 73). We therefore examined the effect of adding unlabeled wildtype PI-PLC 
(WT) to the solution with AF488-PI-PLC on single molecule binding. At a concentration 
of 0.2 nM, a single AF488-PI-PLC molecule will bind to one vesicle. If the protein is a 
monomer during the binding and catalytic activities, the added WT should have no effect 
on the off-rate. Interestingly, for vesicles of XPC= 0.9, a small amount of WT (0.6 nM, 
three times the labeled PI-PLC) actually increased the off-rate of AF488-PI-PLC from the 
vesicles shown in Table 6-1 and Figure 6-6. Further addition of WT to 2 nM did not 
change the fast rate further. This suggests that the WT protein does something to help the 
labeled protein dissociate from the vesicle, possibly through protein dimerization on the 
vesicle surface, although the mechanism is not clear. This change in the off-rate was not 
observed for vesicles with XPC= 0.7, however, giving a hint that this effect requires a 
particular surface composition. A different explanation could be that adding excess 
unlabeled protein may aid in release of some of the labeled protein from PC-rich/low 
activity domains. 
The single molecule experiment also enabled us to look at the effect of the product 
DAG on protein binding. This is not possible in a conventional ensemble solution system, 
because vesicle fusion is caused by generation of DAG (108).  However, in the single 
molecule experiments, we can take advantage of the fact that the vesicles are dispersed 
and immobilized by being tethered to the glass surface.  Fusion, which can’t occur  
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Figure 6-6. Effect of added wildtype (WT) on the off-rate of 0.2 nM AF488-PI-PLC 
binding to PC/PG SUVs with XPC= 0.9 (open bars) and XPC= 0.7 (hatched bars).  
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Table 6-1. Off-rates for 0.2 nM AF488-PI-PLC binding to surface tethered SUVs under 
different conditions. Column 1 shows the vesicle composition; column 2 shows the 
amount of unlabeled wildtype (WT) PI-PLC; column 3 shows the number of events we 
used for each statistical analysis; koff and τ represent the off-rate and average on-time. The 
exposure time and 488 nm laser power used for all these experiments were 50 ms/frame 
and 3.1 mW.  
 
SUVs WT (nM) Events koff (s-1) τ (ms) 
0.9PC/0.1PG 0 808 2.74±0.29 365±39 
0.9PC/0.1PG 0.6 579 4.38±0.49 228±26 
0.9PC/0.1PG 1.2 388 5.34±0.33 187±12 
0.9PC/0.1PG 2 256 4.52±0.26 221±13 
0.7PC/0.3PG 0 542 1.63±0.16 612±60 
0.7PC/0.3PG 0.6 587 1.77±0.12 564±38 
0.5PC/0.5PG 0 212 8.10±0.49 1.43±0.41 
123±7 
700±200 
0.9PC/0.1DAG 0 385 5.12±0.34 195±13 
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without the collision of vesicles, is therefore unlikely. In these experiments, vesicles 
composed of PC/PI (XPC=0.9) were tethered to the glass surface, and PI was then 
hydrolyzed to produce DAG by incubation with 0.1 mg/ml PI-PLC WT for 30 min. The 
WT protein and any residual compounds were flushed away after the incubation. In this 
case, the surface tethered vesicles should have a composition of PC/DAG (XPC= 0.9). The 
off-rate of 0.2 nM AF488-PI-PLC from these vesicles was about twice the value for 
PC/PG (XPC= 0.9) (Table 6-1). A possible reason for this faster off-rate is that after 
hydrolyzing the substrate, the protein binds more weakly to the product than to PI (or 
PG), and thus can be released from the surface to seek the next substrate on a different 
vesicle. However, a complication in interreting these results is that BSA, used to stabilize 
the very low concentration of protein in the solution, may actually remove some of the 
DAG and change the vesicle composition (143), which could also contribute to the faster 
release of the protein from the surface. Addition of a different protein, which does not 
bind lipophilic molecules, to stabilize the PI-PLC would be a way to see if the DAG 
really does enhance the PI-PLC off-rate. 
6.4 Summary 
We have successfully applied single molecule TIR-FM to study a fluorescently 
labeled PI-PLC binding to surface-tethered SUVs. By observing the AF488-PI-PLC 
cycling on and off the vesicles, we were able to extract the distribution of association 
times of the protein with vesicle, and thus get dynamic information through statistical 
analysis. As the lipid composition affects protein bulk partitioning to the vesicles, it also 
affects the off-rate of the protein from the vesicle surface. The existence of both a fast 
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and a slow rate for XPC=0.5 indicates two populations of protein binding, which could 
reflect the demixing of the lipids on vesicles. Addition of WT to the system also altered 
the off-rate for protein binding to XPC= 0.9 vesicles, the cooperative behavior of the 
enzyme may support our dimerization model. Whether or not this is evidence for surface-
induced dimerization remains to be seen. The results do, however, illustrate the 
sensitivity of single molecule studies to probe what alters the off-rate of proteins that 
transiently bind to membranes. 
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Chapter 7 Future Directions 
The work in this thesis aimed to understand the kinetic activation and inhibition 
mechanism of a peripheral protein, Bacillus thuringiensis PI-PLC, by PC surfaces on a 
molecular level. Different techniques were applied to study the interaction of the protein 
with vesicles composed of both the substrate lipid (or substrate analogues) and the 
activator lipid PC. While FCS was used to monitor bulk partitioning of the enzyme with 
vesicles, fc-P-NMR provides information on the lipid dynamics with and without bound 
protein. The combination of the two techniques explained the enzyme kinetic profile for 
the PC activation and surface dilution inhibition. The binding profiles of the mutant 
proteins shed light on the differential effects of the residues on the two lipids, an 
allosteric PC binding site was identified by fc-P-NMR and site directed spin labeling. The 
FCS and fc-P-NMR techniques can be extended to a wide range of peripheral membrane 
proteins that exhibit differential interactions with phospholipid components. 
Based on these results, we proposed a model for PI-PLC vesicle binding and 
activation as shown in Figure 7-1. PI-PLC is a monomer in solution. An intact helix B 
stabilized by the rigid residue Pro42 ensures the correct orientation of Lys44 and Tyr47 
for initial interaction with the membrane. After the initial Lys44 mediated attraction to 
the anionic membrane, the substrate lipid PI binds to the active site pocket and the 
activator lipid PC binds to a distinct site near Asp205. The choline headgroup is 
surrounded by several tyrosines residues (Tyr 247/248/251) and should interact with the 
protein through π-cation interactions. The 240s loop is likely to adopt a conformational  
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Figure 7-1. Proposed model of the PI-PLC vesicle binding and activation (which may 
include dimerization). PI-PLC is a monomer in solution. Pro42 is likely to ensure 
residues at an intact helix B at the correct orientation for initial interaction. After the 
initial Lys44 mediated attraction to the anionic membrane, Trp47 involves in membrane 
insertion. The substrate lipid PI binds to the active site pocket and the activator lipid PC 
binds to a distinct site near Asp205. The choline headgroup of PC at the site is stabilized 
through π-cation interactions with Tyr247/248/251. The 240s loop is likely to adopt a 
conformational change that removes Asn243 away from the headgroups of both lipids 
and inserts into the hydrophobic acyl chain of the membrane. Thus PI-PLC is activated 
by PC through increased affinity as well as the following conformational change. The 
activation may also involve surface induced dimerization. Upon initial binding of PI-PLC 
to membrane surface, disruption of helix B allows Pro42 to help stabilize the PI-PLC 
homodimer interface including a Tyr zipper involving Tyr residues 246-248. The 
monomer structure is based on B. cereus PI-PLC crystal structure (PDB: 1PTD); the 
dimer structure in this model is based on the W47A/W242A B. thuringiensis dimer 
crystal structure (PDB: 2OR2). The lipid bilayer is shown schematically in light blue.  
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change that removes Asn243 away from the headgroups of both lipids and with Trp242 
inserts into the hydrophobic acyl chains of the membrane. 
Based on a surface impaired PI-PLC dimer crystal structure (72), a surface 
dimerization and activation mechanism for this PI-PLC was  proposed as shown in Figure 
7-1. However, most of the previous evidence is based on mutagenesis studies at the 
proposed dimer interface (55, 73). In this thesis work, we constructed two disulfide 
linked covalent dimers (W242C and S250C) with higher PI cleavage rate concomitant 
with a decrease in the apparent Kd of the protein for pure PC SUVs. These results are 
consistent with interface-induced dimerization of this PI-PLC. However, these covalent 
dimers may also induce the correct protein conformation for optimal membrane binding. 
The activated dimer conformation must be different from the W47A/W242A crystal 
structure. What does the surface active dimer look like? To answer this question, the 
crystal structure of the W242C-dimer could serve as a good model because this covalent 
dimer has higher kinetic activity and surface binding ability than the corresponding 
monomer, thus its conformation should be similar to the activated conformation. So the 
next step would be to crystallize the W242C covalent dimer.  
In order to find more direct evidence for the surface-induced dimerization model, we 
used TIR-FM to examine the effects of adding unlabeled WT PI-PLC on the off-rates of 
AF488-PI-PLC binding to surface tethered vesicles. Our results indicate that a small 
amount of WT actually increased the off-rate of AF488-PI-PLC from the vesicles, rather 
than keeping the protein on the surface for a longer time to carry out processive catalysis. 
Futher investigation is necessary to provide evidence for this model.  
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The effects of PI-PLC on the two-component bilayer provide insights into the 
biological role of this enzyme secreted by different Bacillus strains. B. thuringiensis is an 
insect pathogen, and earlier work showed that an avirulent mutant lacking both the broad 
range and PI-specific PLC was much less potent in killing cells (37). In this insect model, 
wild type B. thuringiensis disappeared from the circulation hours after injection, while the 
mutant organism was still circulating. This suggested that one or both phospholipases 
contributed to the early stages of infection and association of the bacteria with insect and 
mammalian cells, since B. thuringiensis is also an opportunistic human pathogen leading 
to pulmonary infections (144). Membrane-damaging factors, such as the PI-PLC, 
apparently allow the bacteria to persist in that environment. 
More recent work with Bacillus anthracis has also provided evidence that B. 
anthracis PI-PLC, a secreted PI-PLC with high sequence similarity to B. thuringiensis PI-
PLC, contributes to bacterial pathogenicity. The B. anthracis PI-PLC, like the enzyme 
from B. thuringiensis, can cleave GPI-anchored proteins in plasma membranes as well as 
intracellular PI, providing two potential roles for this enzyme in virulence. B. anthracis 
PI-PLC has also been shown to down-modulate the immune response, and this appears to 
involve its ability to cleave GPI-anchored proteins (121). 
Access to GPI anchors on the external leaflet of a target cell would be facilitated by 
protein binding to PC (or sphingomyelin, also an activator). GPI anchors may exist in 
clustered domains (144), indicating that PI-PLC cleavage of GPI anchors may occur at 
low XPC. In B. anthracis, PI-PLC is one of three phospholipase C enzymes that contribute 
to macrophage-associated growth of the bacteria (145). Along with aiding bacterial 
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association with the macrophages, the three enzymes may have overlapping roles in 
pathogenesis by aiding in release from the phagocyte (146). Since the interior leaflet of 
the phagocyte resembles the external leaflet of the plasma membrane, PC will be present 
for PI-PLC binding. Even if PI and GPI-anchored targets are not available, the strong 
interaction of this PI-PLC with PC in the membrane could cause clustering of the PC, 
making the phagocyte more susceptible to other membrane hydrolytic factors.  
For a better understanding of the biological functions of this protein, we should 
investigate the the cleavage of GPI anchors using single molecule enzymology. In our 
current work, we have used TIR-FM to look at a single molecule PI-PLC interacting with 
surface tethered vesicles. The initial data demonstrate that this technique promises to 
provide us with valuable dynamic information, from statistical analysis of the protein-
vesicle association time distribution. We have investigated the effects of lipid 
composition as well as total protein concentration on the off-rate. In the future, we can 
incorporate GPI anchors into the vesicles and directly observe the effects on PI-PLC 
binding. We should be able to see how PC composition or other factors may affect this 
cleavage. Understanding this physiologically relevant PI-PLC mechanism could finally 
help people reduce bacterial infections.  
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Appendix I Cytotoxicity of 3-deoxyphosphatidylinositols to U937 human 
lymphoma cell line  
I.1. Introduction 
The phosphatidylinositol 3-kinase (PI3K)/Akt (or protein kinase B) signaling 
pathway is critical for cell survival and upregulated in a variety of human cancer cell 
lines (147) and solid tumors (148-150). A key step in this pathway is specific 
phosphorylation of the 3-hydroxyl group of the inositol ring in phosphatidylinositols 
(PIs) by PI3K enzymes. These lipid products affect cell growth by binding specifically to 
enzymes such as Akt and recruiting them to the membrane for activation by 
phosphorylation (151-153).  
Attempts to inhibit the PI3K/Akt pathway led to the synthesis of D-3-deoxy-
phosphatidylinositol (D-3-deoxy-PI) molecules, which can no longer be phosphorylated 
by PI3K (154). Many of these molecules have antiproliferative properties (155, 156). The 
first of these, 3-deoxydipalmitoyl-PI, was shown to inhibit growth of HT-29 human colon 
carcinoma cancer cells in vitro with a median inhibitory concentration (IC50) of 35 µM 
(155). Recent syntheses of ether-linked (rather than ester-linked) alkyl chains, e.g., D-3-
deoxymyoinositol-1-[(R)-3-(hexadecyloxy)-2-hydroxypropyl hydrogen phosphate], have 
generated a newer class of PI analogues that should have greater stabilities in vivo and 
may also have slightly better delivery properties since they are more like 
lysophospholipids (157). 3-Deoxy-PIs have also been shown to reduce drug resistance in 
human leukemia cell lines (158). Thus, these PI analogues may have a future in the 
treatment of a variety of cancers. 
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Modulating inhibitor solubility by shortening the acyl chains, so that the inhibitor can 
exist as monomers, may also contribute to understanding the mechanisms of action of 
these lipids, since this modification is likely to alter uptake and localization in the cell. A 
series of 3-deoxy-dioctanoyl phosphatidylinositol (3-deoxy-diC8PI) derivatives (Figure 
I-1) that can exist as monomers below 0.5 mM were synthesized by the group of Scott 
Miller. These 3-deoxy-diC8PI molecules were screened as cytotoxins of the U937 human 
leukemia cell line. Of all the compounds examined, only D-3-deoxy-diC8PI was cytotoxic 
to U937 cells, with an IC50 of 40 µM, which is much less than the critical micelle 
concentration (CMC) of 0.4 mM (159).  
I.2. Materials and methods 
I.2.1. U937 cell growth and incubation with PI analogues  
The U937 human leukemic monocyte lymphoma cell line was obtained from the 
American Type Culture Collection (Manassas, VA). U937 cells were maintained in 
RPMI 1640 medium supplemented with 10% fetal bovine serum, penicillin (100 
units/ml), streptomycin (100 µg/ml), 2-mercaptoethanol (50 µM), and glutamine (2 mM) 
at cell densities of 0.5−1 × 106 cells/ml at 37 °C in a 5% CO2 atmosphere at 95% 
humidity. Cells were cultured in the presence or absence of the short-chain diC8PI 
compounds at the indicated concentration. Cells were also incubated with 10 µM 
LY294002 and/or 20 nM wortmannin. At the appropriate time, 2−5 × 105 cells were 
collected by centrifugation at 400g for 8 min, washed in FACS buffer [1× phosphate-
buffered saline (PBS) containing 0.5% BSA and 0.01% sodium azide], and resuspended 
in FACS buffer containing 5 µg/ml propidium iodide. Samples were incubated on ice for  
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Figure I-1. Structures of 3-deoxy-dioctanoylphosphatidylinositol (3-deoxy-diC8PI) 
compounds synthesized. 
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10 min and then analyzed by flow cytometry using a BD FACSCanto flow cytometer 
with BD FACS Diva software (BD Biosciences, San Jose, CA). 
I.2.2. Preparation of cell extracts and Western blot analysis  
Cells were washed twice in PBS, incubated for 20 min at 108 cells/ml in RIPA 
buffer containing 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride 
protein inhibitor cocktail, 1 mM okadaic acid, 1 mM sodium fluoride, and 10 mM β-
glycerophosphate, and subjected to three freeze/thaw cycles in dry ice. Lysates were 
centrifuged at 14000g for 15 min to remove insoluble material, and then protein (20 
µg/lane) was separated by polyacrylamide−SDS gel electrophoresis and transferred to a 
PVDF membrane. The membrane was blocked for 1 h in TBS-T [20 mM Tris (pH 7.6), 
137 mM NaCl, and 0.05% Tween-20] containing 5% nonfat dry milk and then incubated 
at 4 °C overnight in TBS-T with 1 µg/ml primary antibody (Ab). The membrane was 
washed several times in TBS-T, incubated for 60 min with a 1:2500 dilution of anti-
rabbit IgG-coupled horseradish peroxidase Ab, and developed using enhanced 
chemiluminescence. Bands for the different phosphorylated proteins were quantified by 
densitometric analysis using the band corresponding to an extract from cells incubated 
with L-3-deoxy-diC8PI as a control, since this compound had no effect on the U937 cells. 
I.3. Results and discussion 
Long-chain D-3-deoxy-PI analogues are thought to inhibit cell growth by competing 
with PI(3)P for binding to the Akt1 PH domain and reducing Akt1 translocation to the 
plasma membrane (153). Short-chain 3-deoxy-diC8PI compounds could affect cell 
survival in a similar fashion. The difference is that at low concentrations, the short-chain 
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PI analogues are likely to be monomeric in the cell rather than partitioned into 
membranes (as expected for the long-chain PI analogues). There may also be specificities 
among the different deoxy-PI compounds that would shed light on key interactions of 
these modified PIs with diverse targets. To explore this, we incubated the U937 human 
leukemic monocyte lymphoma cell line with the compounds D-3-deoxy-diC8PI, L-3-
deoxy-diC8PI, D-3,5-dideoxy-diC8PI, and L-3,5-dideoxy-diC8PI at various concentrations 
and assessed the viability of the cells at different time points. Of all the compounds 
tested, only D-3-deoxy-diC8PI had any significant effect on cell viability, with an IC50 of 
40 µM (Figure I-2). The other compounds had no measurable effect on viability at 
concentrations up to 200 µM. 
To determine if the 3-deoxy-diC8PI compounds inhibited endogenous signaling via 
the PI3K pathway, we assessed phosphorylation of Akt1, a downstream target of PI3K, 
and compared the effects of the short-chain PI compounds (50 µM) to those of 
LY294002 (10 µM) and wortmannin (20 nM), which are known inhibitors of signaling 
via the PI3K/Akt pathway (Figure I-3). Since L-3-deoxy-PI had no effect on cell growth, 
the intensity of the band from cells incubated with that compound was used as a 
phosphorylation control. Phosphorylation of the transcriptional initiation factor eIF4E 
was clearly reduced after incubation of the cells with D-3-deoxy-diC8PI for 24 h. 
However, reduction in Akt phosphorylation appeared to show interesting specificity. 
Phosphorylation of Thr308 did not appear to be affected by D-3-deoxy-diC8PI; however, 
LY294002 and wortmannin led to some reduction in phosphorylation over the same time 
period, and the combination of the two was extremely effective. In contrast, Ser473  
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Figure I-2. Viability of U937 cells after incubation for 24 h with different concentrations 
of 3-deoxy-diC8PI compounds: D-3-deoxy-diC8PI (●), L-3-deoxy-diC8PI (○), and D-3-
diC8PI(5)P (x). Data for dideoxy-diC8PI compounds were the same as those for L-3-
deoxy-diC8PI. Error bars represent standard deviations from triplicate assays. 
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Figure I-3. Western blots used to monitor phosphorylation of Akt1 (at both Ser473 and 
Thr308) as well as eIF4E (at Ser209) after 24 h incubation with 50 µM D-3-deoxy-diC8PI 
(D-3-d-PI), 50 µM L-3-deoxy-diC8PI (L-3-d-PI), 10 µM LY294002 (LY), 20 nM 
wortmannin (WM), or a combination LY294002 and wortmannin (LY+W). The number 
under each lane represents the fractional phosphorylation in the presence of the indicated 
compound compared to phosphorylation in the presence of L-3-deoxy-diC8PI, which has 
no effect on the cells. 
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phosphorylation was reduced by a greater amount at this time point when the cells were 
incubated with D-3-deoxy-diC8PI than with the two other known inhibitors of the 
PI3K/Akt pathway. In previous work with D-3-deoxy-PI molecules (153), Akt Ser473 
phosphorylation was significantly reduced (to ~65% of the maximum phosphorylation 
when D-3-deoxy-diC16PI was used). Here we show that the more soluble short-chain D-3-
deoxy-diC8PI can also reduce Akt1 phosphorylation on Ser473. Whether it does so by 
preventing Akt translocation or by altering the interaction of the protein with the 
membrane remains to be seen. That this soluble specific enantiomer but not further-
deoxygenated compounds is cytotoxic and affects Akt1 phosphorylation is an exciting 
observation. 
The compound D-3-deoxy-diC8PI is the only PI in this series that is cytotoxic to U937 
cells. These leukemic cells provide a good system for evaluating the effectiveness of the 
diverse 3-deoxy-PIs because they have an activated PI3K/Akt pathway. Since neither L-
3-deoxy-diC8PI nor D-3,5-dideoxy-diC8PI were cytotoxic, the in vivo target must bind D-
3-deoxy-diC8PI in a very specific way. 
The mechanism of action of the 3-deoxy-PIs has been proposed to be the binding of 
this lipid to the PH domain of Akt1 (153). This binding is then supposed to prevent 
targeting of Akt1 to the plasma membrane for phosphorylation and subsequent activation. 
Indeed, studies have shown that this molecule inhibits growth of cell lines in which Akt1 
is the major isoform of this protein kinase (155-157). Akt1 is phosphorylated on Ser473 
and Thr308; treatment of cells with 3-deoxy-diC16PI and the ether-linked long-chain PI 
analogue DPIEL showed that phosphorylation of the Ser sites was reduced (153). Other 
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lipid-based antitumor compounds have been shown to alter Thr308 phosphorylation 
(158), so it is not clear whether one or both phosphorylation sites are critical for Akt1 
activation. In fact, one can ask whether the reduced phosphorylation of Akt1 really 
represents the mechanism by which 3-deoxy-PI molecules inhibit cell growth. All of the 
previously examined modified phospholipids are relatively hydrophobic and presumably 
could be integrated into different intracellular membranes, attracting the Akt1 to a 
membrane devoid of its activating kinase. By using short-chain synthetic 3-deoxy-PI 
compounds, which should be monomeric in the cell at concentrations less than 0.1 mM, 
and showing that only D-3-deoxy-diC8PI is inhibitory in vivo, we have provided data 
indicating that a very specific interaction of the 3-deoxy-PI with its target occurs. The 
stereochemistry of the attachment of the inositol ring to the glycerol backbone (only the D 
enantiomer is inhibitory) plays a critical role, as does the C5 hydroxyl group. The 
observation that an Akt1 downstream target (eIF4E) exhibited reduced phosphorylation 
strongly points to Akt1 as the likely in vivo target of D-3-deoxy-diC8PI. Furthermore, 
since Akt1 phosphorylation on Ser473 was reduced while that on Thr308 was unaffected, 
we can propose that the primary effect of this lipid analogue is modulation of Ser 
phosphorylation. Interestingly, recent work also suggests that PI ether lipid analogues 
activate the proapoptotic stress kinase p38α that is a subgroup of the MAPK family and 
activated via phosphorylation by MAPKKs (160). This particular interaction could also 
contribute to the cytotoxicity of 3-deoxy-PIs. 
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